UID,Searchword,API,URL,Title,Summary,Article,Title_Sentiment,Title_Positive,Title_Neutral,Title_Negative,Article_Sentiment,Article_Positive,Article_Neutral,Article_Negative,Verified,Language,Topics,Date,Load_Date,Source
50400,Clearstream,Bing API,https://www.linkedin.com/news/story/gccs-emerging-market-debt-rises-rpt-6385572/,GCC's emerging-market debt rises: rpt,GCC countries accounted for 35% of all emerging-market US dollar debt (excluding China) issued during the first quarter of the year  up from 25% in 2024  according to a new report by Fitch Ratings. This share is expected to grow further in 2025-2026 as the region increasingly relies on debt to fund projects ,ğŸ“‘ ğ”¾â„‚â„‚ ğ”»ğ•–ğ•“ğ•¥ â„‚ğ•’ğ•¡ğ•šğ•¥ğ•’ğ• ğ•„ğ•’ğ•£ğ•œğ•–ğ•¥ ğ”¾ğ•£ğ• ğ•¨ğ•šğ•Ÿğ•˜ ğ•šğ•Ÿ ğ”¼ğ•„ğ•¤; ğ”½ğ•£ğ•’ğ•˜ğ•ğ•–ğ•Ÿğ•¥ğ•–ğ•• ğ•’ğ•Ÿğ•• ğ”½ğ•’ğ•”ğ•šğ•Ÿğ•˜ ğ•ğ• ğ•ğ•’ğ•¥ğ•šğ•ğ•šğ•¥ğ•ª Gulf Cooperation Council (GCC) countries contributed over 35% of all emerging-market (EM) US dollar debt issued in 1Q25 (excluding China)  up from around 25% in 2024  and this is likely to continue growing during 2025â€“2026  Fitch Ratings says. GCC debt capital markets (DCMs) are likely to collectively expand on the back of funding diversification  project financing  budget deficits  maturities  and regulatory moves. However  the region is not shielded from global macroeconomic and financial market uncertainty. Primary market dollar issuance since 2 April has been quiet  but some activity has occurred more recently  with a healthy pipeline building up. Regional and Islamic investor liquidity remains intact. The GCC DCM continues to be fragmented among its six member countries in its maturity  depth  and credit profile  with Saudi Arabia and the UAE the most mature. In Kuwait  Qatar  Bahrain  and Oman  the lack of a link with international central securities depositories such as Euroclear or Clearstream partly hinders foreign-investor participation in the local-currency DCMs. In Saudi Arabia  foreign investors account for a growing share of government local issuances  at 7.7% of the investor base at end-1Q25 (2024: 4.5%). US tariff-related volatility and faster-than-anticipated OPEC+ production cuts have put pressure on oil prices (2025F and 2026F: USD65/barrel)  which could affect fiscal revenue in the GCC and increase borrowing  including through the DCM. While public finances in Bahrain and Saudi Arabia have more exposure to lower oil prices  Oman is better positioned  and Qatar  Abu Dhabi and Kuwait have large assets to buffer against sustained oil price declines. Fitch projects that US Federal Reserve interest rates will drop to 4.25% by end-2025  with GCC central banks likely to mirror this trend. The size of the GCC DCM passed USD1 trillion outstanding (all currencies) at end-1Q25  up 10% year on year (yoy). Sukuk has around a 40% share of the GCC DCM at end-1Q25  with the rest in bonds. About 83.5% of the GCC US dollar sukuk publicly rated by Fitch are investment-grade as of end-1Q25 (outstanding  including multilaterals)... In Kuwait  the Council of Ministers approved the long-delayed financing and liquidity law  which should improve fiscal financing flexibility and clears the way for government debt to increase from its very low level. In the UAE  the government continues to implement the Dirham Monetary Framework. The dirhamâ€™s share in the UAE DCM expanded to 24.9% at end-1Q25 (2020: 0.5%). The UAE Central Bank also started development of a Sustainable Islamic M-Bills programme  while the Qatar Central Bank issued a Sustainable Finance Framework. https://lnkd.in/dCwF8c2y,neutral,0.05,0.93,0.02,negative,0.0,0.4,0.6,True,English,"['emerging-market debt', 'GCC', 'US Federal Reserve interest rates', 'emerging-market (EM) US dollar debt', 'Primary market dollar issuance', 'international central securities depositories', 'Sustainable Islamic M-Bills programme', 'GCC debt capital markets', 'GCC US dollar sukuk', 'The UAE Central Bank', 'US tariff-related volatility', 'financial market uncertainty', 'Sustainable Finance Framework', 'GCC central banks', 'OPEC+ production cuts', 'Qatar Central Bank', 'oil price declines', 'Islamic investor liquidity', 'six member countries', 'lower oil prices', 'The GCC DCM', 'ğ”½ğ•’ğ•”ğ•šğ•Ÿğ•˜ ğ•ğ• ğ•ğ•’ğ•¥ğ•šğ•ğ•šğ•¥ğ•ª Gulf Cooperation Council', 'government local issuances', 'Dirham Monetary Framework', 'fiscal financing flexibility', 'government debt', 'GCC) countries', 'investor base', 'fiscal revenue', 'liquidity law', 'funding diversification', 'project financing', 'budget deficits', 'regulatory moves', 'global macroeconomic', 'healthy pipeline', 'credit profile', 'Saudi Arabia', 'foreign-investor participation', 'foreign investors', 'public finances', 'Abu Dhabi', 'large assets', 'low level', 'UAE DCM', 'local-currency DCMs', 'Fitch Ratings', 'growing share', '40% share', '1Q25', 'China', 'back', 'maturities', 'region', '2 April', 'activity', 'maturity', 'depth', 'Kuwait', 'Bahrain', 'Oman', 'lack', 'link', 'Euroclear', 'Clearstream', 'pressure', 'borrowing', 'exposure', 'end', 'size', 'USD1', 'currencies', 'year', 'bonds', 'multilaterals', 'Ministers', 'way', 'development', 'lnkd', 'dCwF8c2y', 'ğ”¾â„‚â„‚ ğ”»ğ•–ğ•“ğ•¥ â„‚ğ•’ğ•¡ğ•šğ•¥ğ•’ğ• ğ•„ğ•’ğ•£ğ•œğ•–ğ•¥', 'ğ”¼ğ•„ğ•¤']",2025-05-01,2025-05-01,linkedin.com
50401,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070977/0/en/Quadient-11-Increase-in-Software-Sales-to-Mail-Clients-in-2024-Reflects-Rising-Demand-for-Smarter-Multichannel-Communications.html,Quadient: 11% Increase in Software Sales to Mail Clients in 2024 Reflects Rising Demand for Smarter  Multichannel Communications,Quadient (Euronext Paris: QDT)  a global automation platform powering secure and sustainable business connections  shared today that businesses are increasingly turning to digital solutions to meet rising customer expectations for modern  multichannel communiâ€¦,Quadient (Euronext Paris: QDT)  a global automation platform powering secure and sustainable business connections  shared today that businesses are increasingly turning to digital solutions to meet rising customer expectations for modern  multichannel communication. This shift is driving tangible growth: in fiscal year 2024  Quadient recorded a record 11% increase in cross-sales of its Digital automation solutions within its Mail customer base.This growth highlights a broader shift in customer engagement strategies  driven by evolving consumer expectations. Independent research commissioned by Quadient in fall 2024  which surveyed 6 000 consumers across the United States  United Kingdom  and France  revealed a clear demand for more modern  multichannel communication experiences. While physical mail remains relevant  a majority of respondents in each country want companies to communicate through multiple channels  including email  mail  text  mobile apps  and social media. This includes 73 percent in the USA  66 percent in France  and 62 percent in the UK. The findings send a critical message to businesses: organizations that align their strategies with these changing preferences are better positioned to improve customer satisfaction  foster loyalty  and remain competitive in an increasingly digital marketplace.â€œWeâ€™re meeting our customers where they are and helping them go further â€ said Alain Fairise  Chief Solution Officer  Mail Automation at Quadient. â€œThis isnâ€™t just about adopting new technology  itâ€™s about enabling smarter  more agile ways to connect. Consumers are not only ready for smarter digital communications  they now expect it. To stay competitive  businesses need trusted partners who can guide them through digital transformation with confidence and minimal disruption. Our growth in Digital cross-sales reflects that trust. By combining intelligent automation with proven expertise in physical communications  weâ€™re helping organizations reduce complexity  unlock growth opportunities  and build more resilient  future-ready customer relationships.â€With more than 350 000 business customers worldwide  Quadient is helping organizations across industries modernize how they communicate. Through its intelligent automation platform  including Quadient Impress and Quadient Inspire  companies are leveraging both physical and digital channels to improve efficiency  consistency  and responsiveness. In 2024  Quadient recorded its highest level of Digital solution sales into its Mail customer base  while its Mail business continued to outperform the market. Looking ahead  Quadient will continue investing in intelligent hybrid communication solutions to support businesses in delivering meaningful  future-ready customer communications. To know more about Quadientâ€™s smart mail solutions  go to https://mail.quadient.com/en/mailroom-software.About QuadientQuadient is a global automation platform powering secure and sustainable business connections through digital and physical channels. Quadient supports businesses of all sizes in their digital transformation and growth journey  unlocking operational efficiency and creating meaningful customer experiences. Listed in compartment B of Euronext Paris (QDT) and part of the CACÂ® Mid & Small and EnterNextÂ® Tech 40 indices  Quadient shares are eligible for PEA-PME investing. For more information about Quadient  visit www.quadient.com.ContactsJoe Scolaro  Quadient Sandy Armstrong  Sterling Kilgore Global Press Relations Manager VP of Media & Communications +1 203-301-3673 +1-630-699-8979 j.scolaro@quadient.com sarmstrong@sterlingkilgore.comAttachment,neutral,0.03,0.97,0.0,neutral,0.06,0.92,0.02,True,English,"['Software Sales', 'Mail Clients', 'Rising Demand', 'Multichannel Communications', 'Quadient', '11% Increase', 'Sterling Kilgore Global Press Relations Manager', 'resilient, future-ready customer relationships', 'modern, multichannel communication experiences', 'intelligent hybrid communication solutions', 'meaningful, future-ready customer communications', 'meaningful customer experiences', 'global automation platform', 'Chief Solution Officer', 'EnterNextÂ® Tech 40 indices', 'intelligent automation platform', 'rising customer expectations', 'sustainable business connections', 'Mail customer base', 'Digital solution sales', 'customer engagement strategies', 'smart mail solutions', 'Contacts Joe Scolaro', 'Digital automation solutions', 'smarter digital communications', 'Quadient Sandy Armstrong', 'digital solutions', 'customer satisfaction', 'Mail Automation', 'Mail business', 'consumer expectations', 'physical communications', 'digital marketplace', 'digital transformation', 'digital channels', 'Euronext Paris', 'fiscal year', 'record 11% increase', 'Independent research', 'United States', 'United Kingdom', 'clear demand', 'multiple channels', 'mobile apps', 'critical message', 'changing preferences', 'Alain Fairise', 'new technology', 'agile ways', 'trusted partners', 'minimal disruption', 'proven expertise', '350,000 business customers', 'highest level', 'compartment B', 'CACÂ® Mid', 'PEA-PME investing', 'physical mail', 'physical channels', 'Digital cross-sales', 'tangible growth', 'growth opportunities', 'growth journey', 'broader shift', 'social media', 'operational efficiency', 'Quadient Impress', 'Quadient Inspire', 'Quadient shares', 'QDT', 'secure', 'businesses', 'fall', '6,000 consumers', 'France', 'majority', 'respondents', 'country', 'companies', 'email', 'text', '73 percent', 'USA', '66 percent', '62 percent', 'UK', 'findings', 'organizations', 'loyalty', 'confidence', 'complexity', 'industries', 'consistency', 'responsiveness', 'mailroom', 'software', 'sizes', 'Small', 'information', 'VP', 'sterlingkilgore', 'Attachment']",2025-04-30,2025-05-01,globenewswire.com
50402,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071685/0/en/AMG-Schedule-for-First-Quarter-2025-Earnings-Release.html,AMG Schedule for First Quarter 2025 Earnings Release,"Amsterdam  30 April 2025 --- AMG Critical Materials N.V. (""AMG""  EURONEXT AMSTERDAM: ""AMG"") will release its first quarter 2025 financial results on Wednesday  May 7  2025  at approximately 18:00 CEST. AMG will host a conference call to discuss its financial â€¦","Amsterdam  30 April 2025 --- AMG Critical Materials N.V. (""AMG""  EURONEXT AMSTERDAM: ""AMG"") will release its first quarter 2025 financial results on Wednesday  May 7  2025  at approximately 18:00 CEST. AMG will host a conference call to discuss its financial results for the first quarter of 2025 at 09:00 CEST (08:00 BST / 3:00AM EDT) on Thursday  May 8  2025.Please connect approximately 10 minutes prior to the beginning of the call to ensure participation. The call-in information is as follows:Toll-free number: 1-800-830-9649Alternate (toll) number: 1-213-992-4624United Kingdom: 44 0800 524 4760Netherlands: 31 20 795 2687When prompted for the conference ID  tell the operator AMGQ12025 and you will be directed onto the call. The conference call will be available on the website www.amg-nv.com within twenty-four hours following completion of the call.About AMGAMG's mission is to provide critical materials and related process technologies to advance a less carbon-intensive world. To this end  AMG is focused on the production and development of energy storage materials such as lithium  vanadium  and tantalum. In addition  AMG's products include highly engineered systems to reduce CO 2 in aerospace engines  as well as critical materials addressing CO 2 reduction in a variety of other end use markets.AMGâ€™s Lithium segment spans the lithium value chain  reducing the CO 2 footprint of both suppliers and customers. AMGâ€™s Vanadium segment is the worldâ€™s market leader in recycling vanadium from oil refining residues  spanning the Companyâ€™s vanadium  titanium  and chrome businesses. AMGâ€™s Technologies segment is the established world market leader in advanced metallurgy and provides equipment engineering to the aerospace engine sector globally. It serves as the engineering home for the Companyâ€™s fast-growing LIVA batteries  NewMOX SAS formed to span the nuclear fuel market  and spans AMGâ€™s mineral processing operations in graphite  antimony  and silicon metal.With approximately 3 600 employees  AMG operates globally with production facilities in Germany  the United Kingdom  France  the United States  China  Mexico  Brazil  India  and Sri Lanka  and has sales and customer service offices in Japan (www.amg-nv.com).For further information  please contact:AMG Critical Materials N.V. +1 610 975 4979Michele Fischermfischer@amg-nv.comDisclaimerCertain statements in this press release are not historical facts and are â€œforward lookingâ€. Forward looking statements include statements concerning AMGâ€™s plans  expectations  projections  objectives  targets  goals  strategies  future events  future revenues or performance  capital expenditures  financing needs  plans and intentions relating to acquisitions  AMGâ€™s competitive strengths and weaknesses  plans or goals relating to forecasted production  reserves  financial position and future operations and development  AMGâ€™s business strategy and the trends AMG anticipates in the industries and the political and legal environment in which it operates and other information that is not historical information. When used in this press release  the words â€œexpects â€ â€œbelieves â€ â€œanticipates â€ â€œplans â€ â€œmay â€ â€œwill â€ â€œshould â€ and similar expressions  and the negatives thereof  are intended to identify forward looking statements. By their very nature  forward looking statements involve inherent risks and uncertainties  both general and specific  and risks exist that the predictions  forecasts  projections and other forward looking statements will not be achieved. These forward looking statements speak only as of the date of this press release. AMG expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statement contained herein to reflect any change in AMG's expectations with regard thereto or any change in events  conditions  or circumstances on which any forward looking statement is based.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.12,0.87,True,English,"['First Quarter 2025 Earnings Release', 'AMG Schedule', 'AMG Critical Materials N.V.', 'other end use markets', 'other forward looking statements', 'first quarter 2025 financial results', 'energy storage materials', 'oil refining residues', 'growing LIVA batteries', 'customer service offices', 'nuclear fuel market', 'related process technologies', 'aerospace engine sector', 'mineral processing operations', 'less carbon-intensive world', 'lithium value chain', 'world market leader', 'other information', 'financial position', 'aerospace engines', 'Technologies segment', 'future operations', 'Toll-free number', 'toll) number', 'United Kingdom', 'conference ID', 'twenty-four hours', 'engineered systems', 'Lithium segment', 'chrome businesses', 'advanced metallurgy', 'equipment engineering', 'engineering home', 'NewMOX SAS', 'silicon metal', 'United States', 'Sri Lanka', 'Michele Fischer', 'press release', 'historical facts', 'future revenues', 'capital expenditures', 'financing needs', 'competitive strengths', 'business strategy', 'legal environment', 'similar expressions', 'CO 2 reduction', 'CO 2 footprint', 'EURONEXT AMSTERDAM', 'future events', 'historical information', 'inherent risks', 'conference call', 'production facilities', 'Vanadium segment', '30 April', 'Wednesday', 'May', '09:00 CEST', '3:00AM', 'Thursday', 'beginning', 'participation', 'Alternate', 'Netherlands', 'operator', 'website', 'completion', 'mission', 'development', 'tantalum', 'addition', 'products', 'variety', 'suppliers', 'customers', 'Company', 'titanium', 'graphite', 'antimony', '3,600 employees', 'Germany', 'France', 'China', 'Mexico', 'Brazil', 'India', 'sales', 'Japan', 'mfischer', 'Disclaimer', 'plans', 'expectations', 'projections', 'objectives', 'targets', 'goals', 'strategies', 'performance', 'intentions', 'acquisitions', 'weaknesses', 'reserves', 'trends', 'industries', 'political', 'words', 'expects', 'believes', 'negatives', 'nature', 'uncertainties', 'predictions', 'forecasts', 'date', 'obligation', 'undertaking', 'revisions', 'change', 'regard', 'conditions', 'circumstances', 'Attachment', '18:00']",2025-04-30,2025-05-01,globenewswire.com
50403,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070999/0/en/CMB-TECH-BUSINESS-UPDATE.html,CMB.TECH BUSINESS UPDATE,Antwerp  April 30  2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (â€œCMBTâ€  â€œCMB.TECHâ€ or â€œthe Companyâ€) (NYSE: CMBT & Euronext: CMBT)Â provides a business update following the recent announcements. The company held two Capital Markets Days together with Golden Ocean  soâ€¦,Antwerp  April 30  2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (â€œCMBTâ€  â€œCMB.TECHâ€ or â€œthe Companyâ€) (NYSE: CMBT & Euronext: CMBT) provides a business update following the recent announcements. The company held two Capital Markets Days together with Golden Ocean  sold three VLCCs as part of its fleet rejuvenation and will align dates for announcing first and second quarter 2025 results due to the consolidation of Golden Ocean's financial results.Capital Markets DaysFollowing the announcement on 22 April of the signed term sheet for a stock-for-stock merger with Golden Ocean  with CMB.TECH as surviving entity  both companies have hosted Capital Markets Days in Antwerp  Belgium on 24 April 2025 and in Oslo  Norway on 29 April 2025 together. The presentations  recordings and transcripts of these Capital Markets Days are available on the CMB.TECH website.Vessel updateFurthermore  CMB.TECH has sold three VLCCs  Iris (2012  314 000 dwt)  Hakata (2010  302 550 dwt) & Hakone (2010  302 624 dwt) as part of its fleet rejuvenation. The sales generated a total capital gain of 96.7 million USD. The vessels will be delivered to their new owners in the course of this year.Change in publication date earnings releasesAs the company will consolidate the financial results of Golden Ocean in our upcoming earnings  CMB.TECH has decided to align the dates of the announcements of its first and second quarter 2025 earnings press releases and accompanying conference calls. The Q1 2025 earnings will be announced on 21 May 2025 and the Q2 2025 earnings will be announced on 28 August 2025.Announcement Q1 2025 results â€“ 21 May 2025About CMB.TECHCMB.TECH is a diversified and future-proof maritime group. We own and operate more than 150 seagoing vessels: crude oil tankers  dry bulk vessels  container ships  chemical tankers  offshore wind vessels & workboats. We also offer hydrogen and ammonia fuel to customers  through own production or third-party producers.The company is headquartered in Antwerp  Belgium  and has offices across Europe  Asia  United States and Africa.CMB.TECH is listed on Euronext Brussels and the NYSE under the ticker symbol CMBT.More information can be found at https://cmb.techForward-Looking StatementsMatters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbour protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans  objectives  goals  strategies  future events or performance  and underlying assumptions and other statements  which are other than statements of historical facts. The Company desires to take advantage of the safe harbour provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbour legislation. The words â€œbelieveâ€  â€œanticipateâ€  â€œintendsâ€  â€œestimateâ€  â€œforecastâ€  â€œprojectâ€  â€œplanâ€  â€œpotentialâ€  â€œmayâ€  â€œshouldâ€  â€œexpectâ€  â€œpendingâ€ and similar expressions identify forward-looking statements.The forward-looking statements in this press release are based upon various assumptions  many of which are based  in turn  upon further assumptions  including without limitation  our management's examination of historical operating trends  data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made  because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control  we cannot assure you that we will achieve or accomplish these expectations  beliefs or projections.In addition to these important factors  other important factors that  in our view  could cause actual results to differ materially from those discussed in the forward-looking statements include potential legal actions by other parties relating to the Market Courtâ€™s decision  the outcome of the proceedings pending before the Enterprise Court in Antwerp  the failure of counterparties to fully perform their contracts with us  the strength of world economies and currencies  general market conditions  including fluctuations in charter rates and vessel values  changes in demand for tanker vessel capacity  changes in our operating expenses  including bunker prices  dry-docking and insurance costs  the market for our vessels  availability of financing and refinancing  charter counterparty performance  ability to obtain financing and comply with covenants in such financing arrangements  changes in governmental rules and regulations or actions taken by regulatory authorities  potential liability from pending or future litigation  general domestic and international political conditions  potential disruption of shipping routes due to accidents or political events  vessels breakdowns and instances of off-hires and other factors. Please see our filings with the United States Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties.Attachment,negative,0.02,0.24,0.74,negative,0.0,0.01,0.99,True,English,"['TECH BUSINESS UPDATE', 'CMB', 'The Private Securities Litigation Reform Act', 'second quarter 2025 earnings press releases', 'publication date earnings releases', 'two Capital Markets Days', 'The Q1 2025 earnings', 'total capital gain', 'accompanying conference calls', 'future-proof maritime group', 'safe harbour protections', 'safe harbour provisions', 'safe harbour legislation', 'crude oil tankers', 'international political conditions', 'tanker vessel capacity', 'dry bulk vessels', 'offshore wind vessels', 'historical operating trends', 'general market conditions', 'charter counterparty performance', 'potential legal actions', 'other important factors', 'Announcement Q1 2025 results', 'future litigation', 'upcoming earnings', 'Q2 2025 earnings', 'other factors', 'chemical tankers', 'historical facts', 'charter rates', 'operating expenses', 'general domestic', 'political events', 'Vessel update', 'vessel values', 'potential liability', 'potential disruption', 'other parties', 'GLOBE NEWSWIRE', 'Golden Ocean', 'three VLCCs', 'fleet rejuvenation', 'financial results', 'term sheet', 'stock merger', 'surviving entity', 'new owners', '150 seagoing vessels', 'container ships', 'ammonia fuel', 'third-party producers', 'United States', 'ticker symbol', 'More information', 'prospective information', 'future events', 'other statements', 'cautionary statement', 'similar expressions', 'third parties', 'significant uncertainties', 'actual results', 'Market Court', 'Enterprise Court', 'world economies', 'bunker prices', 'insurance costs', 'governmental rules', 'regulatory authorities', 'shipping routes', 'vessels breakdowns', 'Forward-Looking Statements', 'other data', 'business update', 'recent announcements', 'Euronext Brussels', 'underlying assumptions', 'various assumptions', 'financing arrangements', 'TECH NV', 'TECH website', 'Antwerp', 'April', 'CMB', 'NYSE', 'dates', 'first', 'consolidation', 'companies', 'Belgium', 'Oslo', 'Norway', 'presentations', 'recordings', 'transcripts', 'Iris', 'Hakata', 'Hakone', '302,624 dwt', 'sales', 'course', 'year', 'Change', '21 May', '28 August', 'diversified', 'workboats', 'hydrogen', 'customers', 'production', 'offices', 'Europe', 'Asia', 'Africa', 'Matters', 'order', 'plans', 'objectives', 'goals', 'strategies', 'advantage', 'connection', 'words', 'forecast', 'project', 'turn', 'limitation', 'management', 'examination', 'records', 'contingencies', 'control', 'expectations', 'beliefs', 'addition', 'view', 'decision', 'outcome', 'proceedings', 'failure', 'counterparties', 'contracts', 'strength', 'currencies', 'fluctuations', 'demand', 'dry-docking', 'availability', 'refinancing', 'covenants', 'regulations', 'pending', 'accidents', 'instances', 'hires', 'filings', '4,000', '302,550', '96.7']",2025-04-30,2025-05-01,globenewswire.com
50404,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071593/0/en/Pharming-Group-announces-the-2025-Annual-General-Meeting-of-Shareholders-and-the-nomination-of-a-new-Non-Executive-Director.html,Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director,Leiden  the Netherlands  April 30  2025:Â Pharming Group N.V. (â€œPharmingâ€ or â€œthe Companyâ€) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Companyâ€™s 2025 Annual General Meeting of Shareholders (the â€œAGMâ€) will be held on Wednesday June 11  2025 â€¦,Leiden  the Netherlands  April 30  2025: Pharming Group N.V. (â€œPharmingâ€ or â€œthe Companyâ€) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Companyâ€™s 2025 Annual General Meeting of Shareholders (the â€œAGMâ€) will be held on Wednesday June 11  2025  at 14:00 CEST. The Notice to Convene  Explanatory Notes  Proxy and other meeting documents for the AGM can be found on the Companyâ€™s website under Investors/Shareholder Meetings.The Board of Directors has decided to nominate Dr. Elaine Sullivan at the AGM for the appointment as a new Non-Executive Director for a term of four years. The terms of Mrs. Deborah Jorn and Mr. Steven Baert are scheduled to expire at the AGM and they are not available for reappointment.The agenda of the AGM also includes the reappointments of Mrs. Jabine van der Meijs and Mr. Leonard Kruimer as Non-Executive Directors  the proposal to reappoint Deloitte Accountants B.V. as the external auditor of the Company for the financial year 2025  and the renewal of the authorizations for the Board of Directors to issue shares (including rights to acquire shares)  and to repurchase shares.The AGM will be held at the Corpus Congress Centre  Willem Einthovenstraat 1  2342 BH in Oegstgeest  the Netherlands  and will be webcast live.ProfileDr. Elaine Sullivan (date of birth: February 6  1961  British and Irish citizen) is a senior executive  with a successful track record in developing novel medicines  business development  fund investments and start-ups. Dr. Sullivan has international experience in the pharmaceutical and biotech industry  having lived and worked in Ireland  UK  Switzerland  and the US  delivering novel drug projects  commercial partnerships and implementing breakthrough technologies.Dr. Sullivan has served as Non-Executive Director at Zealand Pharma A/S (listed on NASDAQ Copenhagen  â€œZEALâ€)  a biotechnology company focused on the discovery and development of peptide-based medicines  since 2024. She has also served as Senior Non-Executive Director at hVIVO  previously known as Open Orphan plc  listed on the London Stock Exchange AIM market (â€œHVOâ€) since 2020. hVIVO is a contract research organization which is a world leader in human challenge clinical trials.Prior thereto  Dr. Sullivan gained global leadership experience  including membership of the senior global R&D management teams at Eli Lilly and Company (US) and AstraZeneca (UK)  and also served as Non-Executive Director at various public companies  including IP Group plc  Evotec AG  Active Biotech AB and Nykode Therapeutics ASA  including membership in audit  remuneration  ESG and nomination committees.Dr. Sullivan holds a PhD in Molecular Virology (University of Edinburgh) and a BSc (Hons) in Molecular Biology (University of Glasgow  UK).The resume of Dr. Sullivan has been uploaded as part of the meeting documents for the AGM. Dr. Sullivan will introduce herself to our shareholders during the AGM.About Pharming Group N.V.Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare  debilitating  and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines  including small molecules and biologics. Pharming is headquartered in Leiden  the Netherlands  and has employees around the globe who serve patients in over 30 markets in North America  Europe  the Middle East  Africa  and Asia-Pacific.For more information  visit www.pharming.com and find us on LinkedIn.Inside InformationThis press release relates to the disclosure of information that qualifies  or may have qualified  as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.For further public information  contact:Pharming Group  Leiden  the NetherlandsMichael Levitan  VP Investor Relations & Corporate CommunicationsT: +1 (908) 705 1696E: investor@pharming.comFTI Consulting  London  UKSimon Conway/Alex ShawithAmy ByrneT: +44 203 727 1000LifeSpring Life Sciences Communication  Amsterdam  the NetherlandsLeon MelensT: +31 6 53 81 64 27E: pharming@lifespring.nlAttachment,neutral,0.01,0.99,0.0,negative,0.0,0.13,0.87,True,English,"['2025 Annual General Meeting', 'new Non-Executive Director', 'Pharming Group', 'Shareholders', 'nomination', 'senior global R&D management teams', 'Mrs. Jabine van der Meijs', 'London Stock Exchange AIM market', 'EU Market Abuse Regulation', 'Deloitte Accountants B.V.', 'human challenge clinical trials', 'LifeSpring Life Sciences Communication', 'Pharming Group N.V.', 'Mrs. Deborah Jorn', 'global leadership experience', 'IP Group plc', 'Mr. Steven Baert', 'Mr. Leonard Kruimer', 'Corpus Congress Centre', 'successful track record', 'Zealand Pharma A/S', 'Open Orphan plc', 'contract research organization', 'Nykode Therapeutics ASA', 'Corporate Communications T', 'Leon Melens T', '2025 Annual General Meeting', 'Senior Non-Executive Director', 'novel drug projects', 'various public companies', 'Active Biotech AB', 'global biopharmaceutical company', 'other meeting documents', 'VP Investor Relations', 'new Non-Executive Director', 'Dr. Elaine Sullivan', 'senior executive', 'novel medicines', 'Dr. Sullivan', 'international experience', 'biotech industry', 'Wednesday June', 'Explanatory Notes', 'Investors/Shareholder Meetings', 'four years', 'external auditor', 'financial year', 'Willem Einthovenstraat', 'Irish citizen', 'fund investments', 'commercial partnerships', 'breakthrough technologies', 'peptide-based medicines', 'world leader', 'Eli Lilly', 'Evotec AG', 'nomination committees', 'Molecular Virology', 'Molecular Biology', 'life-threatening diseases', 'innovative medicines', 'small molecules', 'North America', 'Middle East', 'press release', 'Michael Levitan', 'FTI Consulting', 'Simon Conway', 'Alex Shaw', 'Amy Byrne', 'nl Attachment', 'public information', 'Non-Executive Directors', 'Euronext Amsterdam', 'business development', 'NASDAQ Copenhagen', 'biotechnology company', 'The AGM', 'Inside Information', 'Leiden', 'Netherlands', 'Shareholders', '14:00 CEST', 'Notice', 'Proxy', 'website', 'Board', 'appointment', 'term', 'agenda', 'proposal', 'renewal', 'authorizations', 'shares', 'rights', 'BH', 'Oegstgeest', 'Profile', 'date', 'birth', 'February', 'British', 'start-ups', 'Ireland', 'UK', 'Switzerland', 'discovery', 'hVIVO', 'HVO', 'membership', 'AstraZeneca', 'remuneration', 'ESG', 'PhD', 'University', 'Edinburgh', 'BSc', 'Hons', 'Glasgow', 'resume', 'PHARM/Nasdaq', 'lives', 'patients', 'portfolio', 'biologics', 'employees', 'globe', '30 markets', 'Europe', 'Africa', 'Asia-Pacific', 'LinkedIn', 'disclosure', 'meaning', 'Article']",2025-04-30,2025-05-01,globenewswire.com
50405,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071728/0/en/Marie-Brizard-Wine-Spirits-Availability-of-the-2024-Universal-Registration-Document-including-the-2024-Annual-Financial-Report.html,Marie Brizard Wine & Spirits: Availability of the 2024 Universal Registration Document including the 2024 Annual Financial Report,Charenton-le-Pont  30 April 2025   Availability of the 2024 Universal Registration...,"Charenton-le-Pont  30 April 2025Availability of the 2024 Universal Registration Documentincluding the 2024 Annual Financial ReportMarie Brizard Wine & Spirits (Euronext: MBWS) announces that it has filed its Universal Registration Document for the year 2024 with the AutoritÃ© des MarchÃ©s Financiers (AMF) on 30 April 2025.This document includes  in particular  the following items:- the 2024 annual financial report - the Board of Directors report on corporate governance  and- the auditors' reports relating thereto.The Universal Registration Document is made available under the conditions stipulated by the prevailing regulations. It can be consulted on the MBWS website (http://www.mbws.com/) under the heading ""Regulatory Information"" as well as on the website of the AutoritÃ© des MarchÃ©s Financiers (www.amf-france.org).It is also available at the Company's head office :10-12 avenue du GÃ©nÃ©ral de Gaulle - 94220 CHARENTON-LE-PONT.Investor and shareholder relations contactMBWS GroupEmilie Drexlerrelations.actionnaires@mbws.comTel.: +33 1 43 91 62 21 Press contactImage SeptClaire Doligez - Laurent Poinsotcdoligez@image7.fr â€“ lpoinsot@image7.frTel.: +33 1 53 70 74 70About Marie Brizard Wine & SpiritsMarie Brizard Wine & Spirits is a wine and spirits group based in Europe and the United States. Marie Brizard Wine & Spirits stands out for its expertise  a combination of brands with a long tradition and a resolutely innovative spirit. Since the birth of the Maison Marie Brizard in 1755  the Marie Brizard Wine & Spirits Group has developed its brands in a spirit of modernity while respecting their origins. Marie Brizard Wine & Spirits is committed to offering its customers bold and trusted brands full of flavour and experiences. The Group now has a rich portfolio of leading brands in their market segments  including William Peel  Sobieski  Marie Brizard and Cognac Gautier.Marie Brizard Wine & Spirits is listed on Compartment B of Euronext Paris (FR0000060873 - MBWS) and is part of the EnterNextÂ© PEA-PME 150 index.Attachment",neutral,0.0,1.0,0.0,neutral,0.03,0.97,0.0,True,English,"['Marie Brizard Wine', '2024 Universal Registration Document', '2024 Annual Financial Report', 'Spirits', 'Availability', 'AutoritÃ© des MarchÃ©s Financiers', 'GÃ©nÃ©ral de Gaulle', 'The Universal Registration Document', '2024 Universal Registration Document', '2024 Annual Financial Report', 'Emilie Drexler relations', 'Laurent Poinsot cdoligez', 'EnterNextÂ© PEA-PME 150 index', 'Maison Marie Brizard', 'Marie Brizard Wine', 'shareholder relations contact', 'The Group', 'Press contact', 'following items', 'corporate governance', ""auditors' reports"", 'prevailing regulations', 'Regulatory Information', 'head office', '10-12 avenue', 'Claire Doligez', 'United States', 'long tradition', 'rich portfolio', 'market segments', 'William Peel', 'Cognac Gautier', 'Compartment B', 'innovative spirit', 'trusted brands', 'leading brands', 'Euronext Paris', 'MBWS Group', 'Image Sept', 'spirits group', 'MBWS website', 'Charenton-le-Pont', '30 April', 'Availability', 'year', 'AMF', 'Board', 'Directors', 'conditions', 'heading', 'org', 'Company', 'Investor', 'actionnaires', 'Tel.', 'lpoinsot', 'Europe', 'expertise', 'combination', 'birth', 'modernity', 'origins', 'customers', 'bold', 'flavour', 'experiences', 'Sobieski', 'Attachment', '53']",2025-04-30,2025-05-01,globenewswire.com
50406,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070969/0/en/Cabka-Receives-B-Score-in-Second-CDP-Climate-Assessment.html,Cabka Receives B Score in Second CDP Climate Assessment,PRESS RELEASE  Amsterdam April 30  2025. Cabka N.V. (together with its subsidiaries â€œCabkaâ€  or the â€œCompanyâ€)  a company specialized in transforming......,"PRESS RELEASEAmsterdam April 30  2025. Cabka N.V. (together with its subsidiaries â€œCabkaâ€  or the â€œCompanyâ€)  a company specialized in transforming hard-to-recycle plastic waste into innovative Reusable Transport Packaging (RTP)  listed at Euronext Amsterdam  announces its achievement of a B score in the 2024 CDP climate assessment for the second consecutive year.The CDP  a globally recognized non-profit organization  facilitates companies in reporting their utilization of natural resources and capital  aiding them in measuring and managing risks and opportunities related to climate change  water security  and deforestation. In 2024  over 22 000 companies  representing two-thirds of the global market capitalization  were scored by CDP on their climate management. CDP's climate assessment serves as the gold standard for measuring corporate climate performance  offering valuable insights to investors  businesses  and policymakers worldwide.""We are proud to maintain our B score in the CDP climate assessment "" said Katrin Poirier  Sustainability Director at Cabka. ""This recognition reaffirms our commitment to climate change management and sustainability in general and also motivates us to continue driving our industry towards a circular economy.""Cabka's commitment to low-carbon circular economy principles is evident in its product designs and material management strategies. By utilizing recycled materials and designing products for reuse and recyclability  Cabka minimizes waste and resource consumption throughout its product lifecycle. Our ongoing decarbonization efforts  including the transition to renewable energy together with our circularity actions  are expected to continue to strengthen our performance in future disclosures.The result of the assessment is available on the CDP website https://www.cdp.net/en/scores.Financial Calendar 2025May 29 Annual General Meeting of Shareholders August 12 Half-Year Results and Half-Year Report 2025 October 21 Trading Update Q3 2025For more information  please contact:Nadia Lubbe  Investor & Press contactIR@cabka.com  or n.lubbe@cabka.com;+31 6 21 51 54 52www.investors.cabka.comCommercial contact: info@cabka.comwww.cabka.comAbout CabkaCabka is in the business of recycling plastics from post-consumer and post-industrial waste into innovative reusable transport packaging (RTP)  like pallets- and large container solutions enhancing logistics chain sustainability. ECO product are mainly construction and road safety products produced exclusively out of post-consumer waste.Cabka is leading the industry in its integrated approach closing the loop from waste  to recycling  to manufacturing. Backed by its own innovation center it has the rare industry knowledge  capability  and capacity of making maximum use bringing recycled plastics back in the production loop at attractive returns. Cabka is fully equipped to exploit the full value chain from waste to end-products.Cabka is listed at Euronext Amsterdam as of 1 March 2022 under the CABKA ticker with international securities identification number NL00150000S7.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.16,0.83,True,English,"['Second CDP Climate Assessment', 'B Score', 'Cabka', 'innovative Reusable Transport Packaging', 'international securities identification number', 'May 29 Annual General Meeting', 'low-carbon circular economy principles', 'second consecutive year', 'global market capitalization', 'ongoing decarbonization efforts', 'large container solutions', 'full value chain', 'material management strategies', 'logistics chain sustainability', 'road safety products', 'climate change management', 'rare industry knowledge', 'corporate climate performance', 'Cabka N.V.', '2024 CDP climate assessment', 'climate management', 'PRESS RELEASE', 'B score', 'non-profit organization', 'natural resources', 'water security', 'gold standard', 'valuable insights', 'Katrin Poirier', 'Sustainability Director', 'product designs', 'recycled materials', 'resource consumption', 'product lifecycle', 'renewable energy', 'circularity actions', 'future disclosures', 'Financial Calendar', 'Half-Year Results', 'Half-Year Report', 'Trading Update', 'Press contact', 'Commercial contact', 'ECO product', 'integrated approach', 'innovation center', 'maximum use', 'attractive returns', 'The CDP', 'CDP website', 'Euronext Amsterdam', 'plastic waste', 'Nadia Lubbe', 'post-industrial waste', 'recycled plastics', 'production loop', 'CABKA ticker', 'post-consumer waste', 'subsidiaries', 'Company', 'hard-to', 'RTP', 'achievement', 'companies', 'utilization', 'risks', 'opportunities', 'deforestation', 'two-thirds', 'investors', 'businesses', 'policymakers', 'recognition', 'commitment', 'reuse', 'recyclability', 'transition', 'scores', 'Shareholders', 'October', 'information', 'construction', 'recycling', 'manufacturing', 'capability', 'capacity', 'end-products', '1 March', 'Attachment']",2025-04-30,2025-05-01,globenewswire.com
50407,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071597/0/en/AKWEL-TURNOVER-FOR-THE-FIRST-QUARTER-OF-2025.html,AKWEL: TURNOVER FOR THE FIRST QUARTER OF 2025,Champfromier  Wednesday  April 30  2025  TURNOVER FOR THE FIRST QUARTER OF 2025  AKWEL (FR0000053027  AKW  PEA-eligible)  parts and systems......,Champfromier  Wednesday  April 30  2025TURNOVER FOR THE FIRST QUARTER OF 2025AKWEL (FR0000053027  AKW  PEA-eligible)  parts and systems manufacturer for the automotive and heavy-vehicle industry  specialist in fluid management  mechanisms and structural parts for electric vehicles  has recorded  over the first quarter of 2025  a consolidated turnover of â‚¬255.6M.Consolidated turnover for the first quarter of 2025 (from January 1 to March 31)in â‚¬m â€” unaudited 2025 2024 Variation PCC variation (*) 1st quarter 255.6 263.5 -3.0% -4.0%(*) At constant scope and exchange ratesIn the first quarter of 2025  global automotive production fell in most of the key automotive manufacturing countries  excluding China and Japan. The decline was also less severe in Germany  India and Mexico. Against this backdrop  AKWEL recorded a reported decline in revenue of -4.0% at constant scope and exchange rates.This turnover is distributed by geographic production area:EMEA (Europe  Middle East  Africa): â‚¬170.7M (-3.8%)America: â‚¬76.4M (-1.9%)Asia: â‚¬8.5M (+2.8%)Turnover for Products and Functions amounted to â‚¬247.8M  down -3.3%. The Decontamination (+10.4%) and Cooling (+4.5%) product lines recorded growth  while other lines  including Air (-27.1%)  Mechanisms (-8.7%) and Fuel (-2.7%)  exhibited a downward trend. Tools was relatively stable  with a turnover of â‚¬5.6M.Consolidated net cash excluding the impact of lease liabilities reached â‚¬149.6M at the end of March 2025  an increase of â‚¬4.6M compared to December 31  2024  with â‚¬8.6M of investments made compared to â‚¬20.2M in the first quarter of 2024.Given the very limited visibility of the automotive market and despite a moderate decline in activity this quarter compared to the two previous quarters  AKWEL confirms that it anticipates a decrease in 2025 revenue comparable to that recorded last year.An independent family business  trading on Euronext Paris  AKWEL is a parts and systems manufacturer for the automotive and heavy-vehicle industry  and a specialist in fluid management  mechanisms and structural parts for electric vehicles. The Group achieves this with their first-rate industrial and technological know-how in mastering the application and processing of materials (plastic  rubber  metal) and mechatronic integration.Operating in 20 countries across 5 continents  AKWEL employs 8 600 people worldwide.Euronext Paris â€” Sub-fund B â€” ISIN: FR0000053027 â€” Reuters: AKW.PA â€” Bloomberg: AKW:FPAttachment,neutral,0.0,0.99,0.0,mixed,0.43,0.28,0.29,True,English,"['FIRST QUARTER', 'AKWEL', 'TURNOVER', 'THE', '2025', 'key automotive manufacturing countries', '2024 Variation PCC variation', 'geographic production area', 'two previous quarters', 'independent family business', 'Consolidated net cash', 'global automotive production', 'automotive market', 'FIRST QUARTER', 'systems manufacturer', 'heavy-vehicle industry', 'fluid management', 'electric vehicles', '1st quarter', 'constant scope', 'exchange rates', 'Middle East', 'product lines', 'other lines', 'downward trend', 'lease liabilities', 'limited visibility', 'Euronext Paris', 'first-rate industrial', 'technological know-how', 'mechatronic integration', 'Sub-fund B', 'consolidated turnover', 'The Decontamination', 'The Group', 'structural parts', 'moderate decline', '20 countries', 'Champfromier', 'Wednesday', 'April', 'AKWEL', 'PEA', 'specialist', 'mechanisms', 'January', 'March', 'China', 'Japan', 'Germany', 'India', 'Mexico', 'backdrop', 'revenue', 'EMEA', 'Europe', 'Africa', 'America', 'Asia', 'Products', 'Functions', 'Cooling', 'growth', 'Air', 'Fuel', 'Tools', 'impact', 'increase', 'December', 'investments', 'activity', 'decrease', 'application', 'processing', 'materials', 'rubber', 'metal', '5 continents', '8,600 people', 'ISIN', 'Reuters', 'AKW.', 'Bloomberg', 'Attachment', '2025']",2025-04-30,2025-05-01,globenewswire.com
50408,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071736/0/en/Planisware-Availability-of-the-2024-Universal-Registration-Document.html,Planisware - Availability of the 2024 Universal Registration Document,Availability of the 2024Universal Registration Document  Paris  France  April 30  2025 â€“ Planisware  a leading B2B provider of SaaS in the rapidly...,Availability of the 2024Universal Registration DocumentParis  France  April 30  2025 â€“ Planisware  a leading B2B provider of SaaS in the rapidly growing Project Economy market  announces the approval of its 2024 Universal Registration Document by the AutoritÃ© des marchÃ©s financiers (AMF) on April 30  2025 under the approval number nÂ° R.25-002.The Universal Registration Document notably includes:The annual financial report for the year ended December 31  2024;The management report ;The corporate governance report;The sustainability reportThe description of the share buyback program;The Statutory Auditors' reports;The information on fees paid to the Statutory Auditors.This Universal Registration Document can be consulted or downloaded from the Planisware website  planisware.com  in the investors section.ContactInvestor Relations Media Benoit dâ€™AmÃ©court Brunswick GroupHugues BoÃ«ton / Tristan Roquet MontÃ©gon benoit.damecourt@planisware.com planisware@brunswickgroup.com +33 6 75 51 41 47 +33 6 79 99 27 15 / +33 6 37 00 52 57About PlaniswarePlanisware is a leading business-to-business (â€œB2Bâ€) provider of Software-as-a-Service (â€œSaaSâ€) in the rapidly growing Project Economy. Planiswareâ€™s mission is to provide solutions that help organizations transform how they strategize  plan and deliver their projects  project portfolios  programs and products.With circa 750 employees across 16 offices  Planisware operates at significant scale serving around 600 organizational clients in a wide range of verticals and functions across more than 30 countries worldwide. Planiswareâ€™s clients include large international companies  medium-sized businesses and public sector entities.Planisware is listed on the regulated market of Euronext Paris (Compartment A  ISIN code FR001400PFU4  ticker symbol â€œPLNWâ€).For more information  visit: https://planisware.com/ and connect with Planisware on LinkedIn .Attachment,neutral,0.0,1.0,0.0,neutral,0.01,0.98,0.0,True,English,"['2024 Universal Registration Document', 'Planisware', 'Availability', 'AutoritÃ© des marchÃ©s financiers', 'Tristan Roquet MontÃ©gon benoit', 'Investor Relations Media Benoit', 'AmÃ©court Brunswick Group', 'growing Project Economy market', ""The Statutory Auditors' reports"", 'The Universal Registration Document', '2024 Universal Registration Document', 'share buyback program', 'Hugues BoÃ«ton', 'large international companies', 'public sector entities', 'ISIN code FR001400PFU', 'annual financial report', 'corporate governance report', 'leading B2B provider', 'project portfolios', 'regulated market', 'management report', 'sustainability report', 'investors section', 'leading business', 'significant scale', 'wide range', 'medium-sized businesses', 'Compartment A', 'ticker symbol', 'approval number', '600 organizational clients', 'Euronext Paris', 'Planisware website', 'Availability', 'France', 'April', 'SaaS', 'AMF', 'year', 'description', 'information', 'fees', 'Contact', 'damecourt', 'brunswickgroup', 'Software', 'Service', 'mission', 'solutions', 'organizations', 'projects', 'programs', 'products', '750 employees', '16 offices', 'verticals', 'functions', '30 countries', 'PLNW', 'LinkedIn', 'Attachment']",2025-04-30,2025-05-01,globenewswire.com
50409,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071618/0/en/Ipsen-S-A-Formalities-for-making-available-and-consulting-preparatory-documents-to-the-2025-Annual-General-Meeting.html,Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting,Information relating to the holding of the Combined Shareholdersâ€™ Meeting of 21 May 2025 of Ipsen S.A.  Formalities for making available and...,Information relating to the holding of the Combined Shareholdersâ€™ Meeting of 21 May 2025 of Ipsen S.A.Formalities for making available and consulting preparatory documents to the MeetingPARIS  FRANCE  30 April 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Shareholders of the Company are invited to participate in the Combined Shareholdersâ€™ Meeting of Ipsen (Euronext: IPN; ADR: IPSEY) to be held on Wednesday 21 May 2025 at 3:00 p.m. (Paris time) at the Salons de l'HÃ´tel des Arts et MÃ©tiers  9 bis avenue d'IÃ©na  75116 Paris.The preliminary notice of the Meeting (â€œavis de rÃ©unionâ€) was published in the Bulletin des Annonces LÃ©gales Obligatoires (BALO) of 11 April 2025 and the notice of Meeting (â€œavis de convocationâ€) was published in the BALO on 30 April 2025. These documents  as well as the Convening notice (including the agenda  the draft resolutions and the conditions regarding attendance and vote)  are also available on Ipsenâ€™s website at the following address: www.ipsen.com   under the Investors / Regulated Information / Shareholders Meeting section. Documents and information relating to this Meeting are made available to shareholders under the legal and regulatory conditions in force.The Shareholders will be asked to approve in particular the following resolutions:The payment of a dividend of â‚¬1.40 per share for the 2024 financial year  the ex-date being set on 4 June 2025 and the dividend payment on 6 June 2025;The renewals of the terms of office of Mr. David LOEW  Mr. Antoine FLOCHEL  Mrs. Margaret LIU and Mrs. Karen WITTS as Directors for a term of 4 years  maintaining the independence Directorsâ€™ rate within the Board of Directors at a third in accordance with the Afep-Medef Code and each genderâ€™s proportion at more than 40% in accordance with the law (Directors representing the employees being not taken into account in these rates).In accordance with applicable regulatory provisions:Registered shareholders may  up to the fifth day (inclusive) before the Meeting  request from the Company to send these documents  where appropriate at his/her express request by electronic means. For holders of bearer shares  the exercise of this right is subject to the presentation of a shareholding certificate (attestation de participation) in the bearer securities accounts managed by the authorized intermediary.Any shareholder may consult these documents at the Companyâ€™s headquarters.ENDSAbout IpsenWe are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology  Rare Disease and Neuroscience.Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S.  France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 80 countries.Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information  visit ipsen.com.Ipsen contactsInvestorsKhalid DEOJEE | + 33 6 66 01 95 26 | khalid.deojee@ipsen.comMediaSally BAIN | + 1 857 320 0517 | sally.bain@ipsen.comAnne LIONTAS | + 33 7 67 34 72 96 | anne.liontas.ext@ipsen.comDisclaimers and/or Forward-Looking StatementsThe forward-looking statements  objectives and targets contained herein are based on Ipsenâ€™s management strategy  current views and assumptions. Such statements involve known and unknown risks and uncertainties that may cause actual results  performance or events to differ materially from those anticipated herein. All of the above risks could affect Ipsenâ€™s future ability to achieve its financial targets  which were set assuming reasonable macroeconomic conditions based on the information available today. Use of the words â€˜believesâ€™  â€˜anticipatesâ€™ and â€˜expectsâ€™ and similar expressions are intended to identify forward-looking statements  including Ipsenâ€™s expectations regarding future events  including regulatory filings and determinations. Moreover  the targets described in this document were prepared without taking into account external-growth assumptions and potential future acquisitions  which may alter these parameters. These objectives are based on data and assumptions regarded as reasonable by Ipsen. These targets depend on conditions or facts likely to happen in the future  and not exclusively on historical data. Actual results may depart significantly from these targets given the occurrence of certain risks and uncertainties  notably the fact that a promising medicine in early development phase or clinical trial may end up never being launched on the market or reaching its commercial targets  notably for regulatory or competition reasons. Ipsen must face or might face competition from generic medicine that might translate into a loss of market share. Furthermore  the research and development process involves several stages each of which involves the substantial risk that Ipsen may fail to achieve its objectives and be forced to abandon its efforts with regards to a medicine in which it has invested significant sums. Therefore  Ipsen cannot be certain that favorable results obtained during preclinical trials will be confirmed subsequently during clinical trials  or that the results of clinical trials will be sufficient to demonstrate the safe and effective nature of the medicine concerned. There can be no guarantees a medicine will receive the necessary regulatory approvals or that the medicine will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize  actual results may differ materially from those set forth in the forward-looking statements. Other risks and uncertainties include but are not limited to  general industry conditions and competition; general economic factors  including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation; global trends toward healthcare cost containment; technological advances  new medicine and patents attained by competitors; challenges inherent in new-medicine development  including obtaining regulatory approval; Ipsenâ€™s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Ipsenâ€™s patents and other protections for innovative medicines; and the exposure to litigation  including patent litigation  and/or regulatory actions. Ipsen also depends on third parties to develop and market some of its medicines which could potentially generate substantial royalties; these partners could behave in such ways which could cause damage to Ipsenâ€™s activities and financial results. Ipsen cannot be certain that its partners will fulfil their obligations. It might be unable to obtain any benefit from those agreements. A default by any of Ipsenâ€™s partners could generate lower revenues than expected. Such situations could have a negative impact on Ipsenâ€™s business  financial position or performance. Ipsen expressly disclaims any obligation or undertaking to update or revise any forward-looking statements  targets or estimates contained in this press release to reflect any change in events  conditions  assumptions or circumstances on which any such statements are based  unless so required by applicable law. Ipsenâ€™s business is subject to the risk factors outlined in its registration documents filed with the French AutoritÃ© des MarchÃ©s Financiers. The risks and uncertainties set out are not exhaustive and the reader is advised to refer to Ipsenâ€™s latest Universal Registration Document  available on ipsen.com.Attachment,neutral,0.0,1.0,0.0,negative,0.0,0.22,0.78,True,English,"['Ipsen S.A.', '2025 Annual General Meeting', 'preparatory documents', 'Formalities', 'Sponsored Level I American Depositary Receipt program', 'Bulletin des Annonces LÃ©gales Obligatoires', 'avis de rÃ©union', 'Investors / Regulated Information', 'HÃ´tel des', 'Mr. David LOEW', 'Mr. Antoine FLOCHEL', 'Mrs. Margaret LIU', 'Mrs. Karen WITTS', 'attestation de participation', 'three therapeutic areas', 'bearer securities accounts', 'early development phase', 'applicable regulatory provisions', 'potential future acquisitions', 'reasonable macroeconomic conditions', 'independence Directorsâ€™ rate', 'global biopharmaceutical company', 'Combined Shareholdersâ€™ Meeting', 'Shareholders Meeting section', 'Ipsen S.A.', 'IÃ©na', 'bearer shares', 'global hubs', 'development experience', 'U.S.', 'development process', 'The Shareholders', 'Registered shareholders', 'MÃ©tiers', '9 bis avenue', 'draft resolutions', 'following address', 'following resolutions', '2024 financial year', 'Afep-Medef Code', 'fifth day', 'express request', 'electronic means', 'shareholding certificate', 'authorized intermediary', 'Rare Disease', 'external innovation', 'U.K.', 'Forward-Looking Statements', 'management strategy', 'current views', 'Such statements', 'actual results', 'future ability', 'similar expressions', 'regulatory filings', 'promising medicine', 'clinical trial', 'generic medicine', 'several stages', 'substantial risk', 'regulatory conditions', 'preliminary notice', 'Convening notice', 'Wednesday 21 May', 'transformative medicines', 'future events', 'historical data', 'competition reasons', 'unknown risks', 'financial targets', 'external-growth assumptions', 'commercial targets', 'Paris time', 'preparatory documents', 'Ipsen contacts', 'dividend payment', 'Khalid DEOJEE', 'Sally BAIN', 'Anne LIONTAS', 'market share', '75116 Paris', 'Formalities', 'FRANCE', '30 April', 'Euronext', 'IPN', 'ADR', 'IPSEY', 'Salons', 'Arts', 'BALO', '11 April', 'convocation', 'agenda', 'attendance', 'vote', 'website', 'legal', 'force', 'ex-date', '4 June', '6 June', 'renewals', 'terms', 'office', '4 years', 'Board', 'accordance', 'gender', 'proportion', 'law', 'employees', 'rates', 'exercise', 'right', 'presentation', 'headquarters', 'ENDS', 'focus', 'patients', 'Oncology', 'Neuroscience', 'pipeline', '100 years', 'teams', '40 countries', 'partnerships', 'world', '80 countries', 'Disclaimers', 'objectives', 'uncertainties', 'performance', 'Use', 'words', 'expects', 'expectations', 'determinations', 'parameters', 'facts', 'occurrence', 'loss', 'research', '3:00']",2025-04-30,2025-05-01,globenewswire.com
50410,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070972/0/en/Nanobiotix-Announces-Presentation-of-Full-Results-From-Completed-Phase-1-Study-Evaluating-JNJ-1900-NBTXR3-in-Pancreatic-Cancer-Followed-by-a-Conference-Call.html,Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call,PARIS andÂ CAMBRIDGE  Mass.  April 30  2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO â€“â€“ NASDAQ: NBTX â€“ the â€˜â€˜Companyâ€™â€™)  a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand treatment possibilities foâ€¦,Full results from the completed dose escalation part and dose expansion parts of a Phase 1 study evaluating JNJ-1900 (NBTXR3) after induction chemotherapy for patients with locally advanced or borderline resectable pancreatic cancer to be presented by Principal Investigator Eugene Koay  MD  at ESTRO 2025 on Sunday  May 4 th at 11:00 AM EDT / 5:00 PM CESTat 11:00 AM EDT / 5:00 PM CEST Nanobiotix will host an event on Monday  May 5th at 8:00 AM EDT / 2:00 PM CEST to review the presented resultsPARIS and CAMBRIDGE  Mass.  April 30  2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO â€“â€“ NASDAQ: NBTX â€“ the â€˜â€˜Companyâ€™â€™)  a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases  today announced the presentation of full results from the completed dose escalation and dose expansion parts of a Phase 1 study evaluating JNJ-1900 (NBTXR3) in patients with locally advanced or borderline resectable pancreatic cancer. The study  conducted by The University of Texas MD Anderson Cancer Center  will be presented by principal investigator Dr. Eugene Koay on Sunday  May 4th at 11:00 AM EDT / 5:00 PM CEST during the 2025 Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO 2025).PRESENTATION #E25-2265: NANORAY Pancreas: A Phase 1 Study of NBTXR3 (JNJ-1900) Activated by Radiotherapy for Locally Advanced or Borderline Resectable Pancreatic Cancer (LAPC or BRPC)Koay EJ  Liu S  Guerrero P  Stokes E  Katz MHG  Ikoma N  Snyder RA  Tzeng CD  Overman MJ  Pant S  Wolff RA  Javle M  Holliday EB  Ludmir EB  Das P  Noticewala S  Koong AC  Tamm EP  Bhutani MNanobiotix ConferenceCallNanobiotix will host a conference call and webcast featuring Nanobiotix chief executive officer and chairman of the executive board  Laurent Levy  to discuss the data on Monday May 5th  2025  at 8:00 AM EDT / 2:00 PM CEST.Details for the call are as follows :Webcast link: click hereAudio-only dial-in link: click hereParticipants can use the audio-only link above to register and obtain dial-in instructions to listen to the presentation via phone and ask questions during the Q&A session  or participants can use the webcast link to register and listen and watch the slide presentation online; the replay version will be available under the same webcast link shortly after the presentation and will be archived on the Companyâ€™s website at www.nanobiotix.com. It is recommended to join 10 minutes prior to the event start. Participants are invited to email their questions in advance to investors@nanobiotix.com .About JNJ-1900 (NBTXR3)NBTXR3 is a novel  potentially first-in-class oncology product composed of functionalized hafnium oxide nanoparticles that is administered via one-time intratumoral injection and activated by radiotherapy. Its proof-of-concept was achieved in soft tissue sarcomas for which the product received a European CE mark in 2019. The product candidateâ€™s physical mechanism of action (MoA) is designed to induce significant tumor cell death in the injected tumor when activated by radiotherapy  subsequently triggering adaptive immune response and long-term anti-cancer memory. Given the physical MoA  Nanobiotix believes that NBTXR3 could be scalable across any solid tumor that can be treated with radiotherapy and across any therapeutic combination  particularly immune checkpoint inhibitors.Radiotherapy-activated NBTXR3 is being evaluated across multiple solid tumor indications as a single agent or in combination with anti-PD-1 immune checkpoint inhibitors  including in NANORAY-312â€”a global  randomized Phase 3 study in locally advanced head and neck squamous cell cancers. In February 2020  the United States Food and Drug Administration granted regulatory Fast Track designation for the investigation of NBTXR3 activated by radiation therapy  with or without cetuximab  for the treatment of patients with locally advanced HNSCC who are not eligible for platinum-based chemotherapyâ€”the same population being evaluated in the Phase 3 study.Given the Companyâ€™s focus areas  and balanced against the scalable potential of NBTXR3  Nanobiotix has engaged in a collaboration strategy to expand development of the product candidate in parallel with its priority development pathways. Pursuant to this strategy  in 2019 Nanobiotix entered into a broad  comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center to sponsor several Phase 1 and Phase 2 studies evaluating NBTXR3 across tumor types and therapeutic combinations. In 2023  Nanobiotix announced a license agreement for the global co-development and commercialization of NBTXR3 with Janssen Pharmaceutica NV  a Johnson & Johnson company.About NANOBIOTIXNanobiotix is a late-stage clinical biotechnology company pioneering disruptive  physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Companyâ€™s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.Incorporated in 2003  Nanobiotix is headquartered in Paris  France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge  Massachusetts (United States) amongst other locations.Nanobiotix is the owner of more than 25 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.For more information about Nanobiotix  visit us at www.nanobiotix.com or follow us on LinkedIn and TwitterDisclaimerThis press release contains â€œforward-lookingâ€ statements within the meaning of the â€œsafe harborâ€ provisions of the Private Securities Litigation Reform Act of 1995  including  but not limited to  statements regarding the use of proceed therefrom  and the period of time through which the Companyâ€™s anticipates its financial resources will be adequate to support operations. Words such as â€œexpectsâ€  â€œintendsâ€  â€œcanâ€  â€œcouldâ€  â€œmayâ€  â€œmightâ€  â€œplanâ€  â€œpotentialâ€  â€œshouldâ€ and â€œwillâ€ or the negative of these and similar expressions are intended to identify forward-looking statements. These forward-looking statements which are based on the Companyâ€™ managementâ€™s current expectations and assumptions and on information currently available to management. These forward-looking statements involve known and unknown risks  uncertainties and other factors that could cause actual results to differ materially from those implied by the forward-looking statements  including risks related to Nanobiotixâ€™s business and financial performance  which include the risk that assumptions underlying the Companyâ€™s cash runway projections are not realized. Further information on the risk factors that may affect company business and financial performance is included in Nanobiotixâ€™s Annual Report on Form 20-F filed with the SEC on April 02  2025 under â€œItem 3.D. Risk Factorsâ€  in Nanobiotixâ€™s 2024 universal registration document filed with the AMF on April 02  2025   and subsequent filings Nanobiotix makes with the SEC from time to time which are available on the SECâ€™s website at www.sec.gov. The forward-looking statements included in this press release speak only as of the date of this press release  and except as required by law  Nanobiotix assumes no obligation to update these forward-looking statements publicly.ContactsNanobiotixCommunications DepartmentBrandon OwensVP  Communications+1 (617) 852-4835contact@nanobiotix.comInvestor Relations DepartmentRicky BhajunDirector  Investor Relations+33 (0)6 42 05 34 15investors@nanobiotix.comMedia RelationsFrance â€“ HARDYCaroline Hardy+33 06 70 33 49 50carolinehardy@outlook.frGlobal â€“ uncapped Communicationsnanobiotixteam@uncappedcommunications.comAttachment,neutral,0.0,0.99,0.0,negative,0.01,0.3,0.69,True,English,"['Full Results', 'Phase 1 Study', 'Pancreatic Cancer', 'Conference Call', 'Nanobiotix', 'Presentation', 'JNJ-1900', 'NBTXR', 'broad, comprehensive clinical research collaboration', 'Texas MD Anderson Cancer Center', 'functionalized hafnium oxide nanoparticles', 'neck squamous cell cancers', 'regulatory Fast Track designation', 'borderline resectable pancreatic cancer', 'late-stage clinical biotechnology company', 'significant tumor cell death', 'anti-PD-1 immune checkpoint inhibitors', 'disruptive, physics-based therapeutic approaches', 'late-clinical stage biotechnology company', 'multiple solid tumor indications', 'Principal Investigator Eugene Koay', 'Nanobiotix chief executive officer', 'global, randomized Phase 3 study', 'Dr. Eugene Koay', 'adaptive immune response', 'nanoparticle-based therapeutic approaches', 'other major diseases', 'Q&A session', 'one-time intratumoral injection', 'soft tissue sarcomas', 'long-term anti-cancer memory', 'United States Food', 'Janssen Pharmaceutica NV', 'dose expansion parts', 'European CE mark', 'dose escalation part', 'priority development pathways', 'class oncology product', 'Monday May 5th', 'same webcast link', 'Koay EJ', 'executive board', 'collaboration strategy', 'global co', 'therapeutic combinations', 'tumor types', 'European Society', 'same population', 'Phase 1 study', 'several Phase 1', 'Phase 2 studies', 'The Company', 'induction chemotherapy', 'GLOBE NEWSWIRE', 'The University', 'May 4th', '2025 Annual Meeting', 'NANORAY Pancreas', 'Liu S', 'Guerrero P', 'Stokes E', 'Katz MHG', 'Ikoma N', 'Snyder RA', 'Tzeng CD', 'Overman MJ', 'Pant S', 'Wolff RA', 'Javle M', 'Holliday EB', 'Ludmir EB', 'Das P', 'Noticewala S', 'Koong AC', 'Tamm EP', 'Bhutani M', 'Laurent Levy', 'replay version', 'product candidate', 'physical mechanism', 'single agent', 'Drug Administration', 'radiation therapy', 'advanced HNSCC', 'platinum-based chemotherapy', 'focus areas', 'scalable potential', 'license agreement', 'Full results', 'treatment possibilities', 'treatment outcomes', 'Johnson company', 'conference call', 'event start', 'physical MoA', 'Nanobiotix ConferenceCall', '11:00 AM EDT', 'Radiotherapy-activated NBTXR3', 'slide presentation', 'CEST Nanobiotix', 'NBTXR3, Nanobiotix', 'JNJ-1900 (NBTXR', '8:00 AM', 'patients', 'ESTRO', 'Sunday', '2:00 PM', 'PARIS', 'CAMBRIDGE', 'Mass.', 'Euronext', 'NASDAQ', 'Locally', 'LAPC', 'BRPC', 'chairman', 'data', 'Details', 'Participants', 'dial', 'instructions', 'phone', 'questions', 'website', 'investors', 'proof', 'concept', 'action', 'NANORAY-3', 'head', 'February', 'investigation', 'cetuximab', 'parallel', 'commercialization', 'millions', 'people', 'difference', 'humanity', 'philosophy', '5:00', '2019']",2025-04-30,2025-05-01,globenewswire.com
50411,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071673/0/en/Press-Release-Annual-General-Meeting-of-April-30-2025.html,Press Release: Annual General Meeting of April 30  2025,Annual General Meeting of April 30  2025  Approval of the financial statements for the fiscal year 2024Distribution of a cash dividend of â‚¬3.92 per...,Annual General Meeting of April 30  2025Approval of the financial statements for the fiscal year 2024Distribution of a cash dividend of â‚¬3.92 per share  with payment as of May 14  2025Board composition: renewal of four Directors and ratification of the cooptation of Jean-Paul KressParis  April 30  2025. The Combined General Shareholdersâ€™ Meeting of Sanofi was held on April 30  2025  under the chairmanship of FrÃ©dÃ©ric OudÃ©a. All resolutions submitted to the vote were adopted by the shareholders.The General Meeting approved the individual Company and consolidated financial statements for the fiscal year 2024 and decided on the distribution of an ordinary annual dividend of â‚¬3.92 per share. The payment of the dividend will be made on May 14  2025.The General Meeting also renewed Carole Ferrand  Barbara Lavernos  Emile Voest and Antoine Yver as Directors  and ratified the cooptation of Jean-Paul Kress.The Board of Directors is now composed of 16 Directors  including two directors representing employees. It has an independence rate of 78% and a gender diversity rate of 43%. It also has 8 directors of foreign nationality  i.e. a rate of 50 %.On the proposal of the Appointments  Governance and CSR Committee  the Board of Directors has appointed Clotilde Delbos  independent Director  as Chairwoman of the Compensation Committee.The voting results and the videocast of the Annual General Meeting are available here.About SanofiWe are an innovative global healthcare company  driven by one purpose: we chase the miracles of science to improve peopleâ€™s lives. Our team  across the world  is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally  while putting sustainability and social responsibility at the center of our ambitions.Sanofi is listed on EURONEXT: SAN and NASDAQ: SNYMedia RelationsSandrine Guendoul | + 33 6 25 09 14 25 | sandrine.guendoul@sanofi.comVictor Rouault | + 33 6 70 93 71 40 | victor.rouault@sanofi.comNicolas Obrist | + 33 6 77 21 27 55 | nicolas.obrist@sanofi.comLÃ©o Le Bourhis | + 33 6 75 06 43 81 | leo.lebourhis@sanofi.comLÃ©a Ubaldi | +33 (0)6 30 19 66 46 | lea.ubaldi@sanofi.comEvan Berland | +1 215 432 0234 | evan.berland@sanofi.comTimothy Gilbert | + 1 516 521 2929 | timothy.gilbert@sanofi.comInvestor RelationsThomas Kudsk Larsen |+ 44 7545 513 693 | thomas.larsen@sanofi.comAlizÃ© Kaisserian | + 33 6 47 04 12 11 | alize.kaisserian@sanofi.comFelix Lauscher | + 1 908 612 7239 | felix.lauscher@sanofi.comKeita Browne | + 1 781 249 1766 | keita.browne@sanofi.comNathalie Pham | + 33 7 85 93 30 17 | nathalie.pham@sanofi.comTarik Elgoutni | + 1 617 710 3587 | tarik.elgoutni@sanofi.comThibaud ChÃ¢telet | + 33 6 80 80 89 90 | thibaud.chatelet@sanofi.comAttachment,neutral,0.0,1.0,0.0,neutral,0.02,0.98,0.0,True,English,"['Annual General Meeting', 'Press Release', 'April', 'FrÃ©dÃ©ric OudÃ©a', 'The Combined General Shareholdersâ€™ Meeting', 'LÃ©o Le Bourhis', 'innovative global healthcare company', 'The General Meeting', 'Annual General Meeting', 'LÃ©a Ubaldi', 'life-changing treatment options', 'life-saving vaccine protection', 'SNY Media Relations', 'ordinary annual dividend', 'gender diversity rate', 'Thibaud ChÃ¢telet', 'Thomas Kudsk Larsen', 'individual Company', 'Investor Relations', 'financial statements', 'fiscal year', 'cash dividend', 'Jean-Paul Kress', 'Carole Ferrand', 'Barbara Lavernos', 'Emile Voest', 'Antoine Yver', 'independence rate', 'foreign nationality', 'CSR Committee', 'Clotilde Delbos', 'independent Director', 'Compensation Committee', 'voting results', 'one purpose', 'social responsibility', 'AlizÃ© Kaisserian', 'Board composition', 'four Directors', 'two directors', 'Sandrine Guendoul', 'Victor Rouault', 'Nicolas Obrist', 'Evan Berland', 'Timothy Gilbert', 'Felix Lauscher', 'Keita Browne', 'Nathalie Pham', 'Tarik Elgoutni', '16 Directors', '8 directors', 'April', 'Approval', 'Distribution', 'payment', 'May', 'renewal', 'ratification', 'cooptation', 'Paris', 'Sanofi', 'chairmanship', 'resolutions', 'vote', 'employees', 'proposal', 'Appointments', 'Governance', 'Chairwoman', 'videocast', 'miracles', 'science', 'people', 'lives', 'team', 'world', 'practice', 'medicine', 'millions', 'sustainability', 'center', 'ambitions', 'EURONEXT', 'NASDAQ', 'leo', 'lebourhis', 'lea', 'alize', 'chatelet', 'Attachment', '50 %.']",2025-04-30,2025-05-01,globenewswire.com
50412,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071012/0/en/Combined-General-Shareholders-Meeting-of-May-22-2025-availability-of-preliminary-documents.html,Combined General Shareholders' Meeting of May 22  2025: availability of preliminary documents,Press ReleaseVELIZY-VILLACOUBLAY  France â€” April 30  2025  COMBINED GENERAL SHAREHOLDERSâ€™ MEETING OF MAY 22  2025  Availability of preliminary documents...,Press ReleaseVELIZY-VILLACOUBLAY  France â€” April 30  2025COMBINED GENERAL SHAREHOLDERSâ€™ MEETINGOF MAY 22  2025Availability of preliminary documentsDassault SystÃ¨mes (Euronext Paris: FR0014003TT8  DSY.PA) informs its shareholders that its Combined Shareholdersâ€™ Meeting will be held on Thursday  May 22  2025 at 3:00 pm at Dassault SystÃ¨mesâ€™ headquarters  10 rue Marcel Dassault â€“ 78140 VÃ©lizy-Villacoublay.The preliminary notification stating the agenda and the draft resolutions was published in the Bulletin des Annonces LÃ©gales Obligatoires (BALO) on April 14  2025  and is available on Dassault SystÃ¨mesâ€™ website at the following address: https://investor.3ds.com/shareholders-meeting/home.The convening notice stating the agenda will be published on May 2  2025 in the BALO and will be made available at the foregoing address.Documents and information relating to this meeting and especially information provided by the article R.22-10-23 of the French Commercial code  are available to the shareholders at the foregoing internet address. They will also be available at Dassault SystÃ¨mesâ€™ headquarters.Shareholders are invited to consult the Dassault SystÃ¨mesâ€™ 2024 Universal Registration Document  filed on March 18  2025 with the AutoritÃ© des marchÃ©s financiers (AMF) and available on Dassault SystÃ¨mesâ€™ website at the forgoing internet address. It provides a major part of information mentioned in the article R.225-83 of the French Commercial code.###ABOUT DASSAULT SYSTÃˆMESDassault SystÃ¨mes is a catalyst for human progress. Since 1981  the company has pioneered virtual worlds to improve real life for consumers  patients and citizens. With Dassault SystÃ¨mesâ€™ 3DEXPERIENCE platform  370 000 customers of all sizes  in all industries  can collaborate  imagine and create sustainable innovations that drive meaningful impact. For more information  visit www.3ds.comDassault SystÃ¨mes Investor Relations Team FTI ConsultingBÃ©atrix Martinez : Arnaud de Cheffontaines: +33 1 47 03 69 48+33 1 61 62 40 73 Jamie Ricketts : +44 20 3727 1600investors@3ds.comDassault SystÃ¨mes Press ContactsCorporate / FranceArnaud Malherbe: +33 1 61 62 87 73arnaud.malherbe@3ds.comÂ© Dassault SystÃ¨mes. All rights reserved. 3DEXPERIENCE  the 3DS logo  the Compass icon  IFWE  3DEXCITE  3DVIA  BIOVIA  CATIA  CENTRIC PLM  DELMIA  ENOVIA  GEOVIA  MEDIDATA  NETVIBES  OUTSCALE  SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault SystÃ¨mes  a European company (Societas Europaea) incorporated under French law  and registered with the Versailles trade and companies registry under number 322 306 440  or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault SystÃ¨mes or its subsidiaries trademarks is subject to their express written approval.Attachment,neutral,0.0,1.0,0.0,neutral,0.03,0.96,0.01,True,English,"[""Combined General Shareholders' Meeting"", 'preliminary documents', 'May', 'availability', 'Dassault SystÃ¨mesâ€™ 2024 Universal Registration Document', 'Dassault SystÃ¨mes Press Contacts Corporate', 'Dassault SystÃ¨mes Investor Relations Team', 'AutoritÃ© des marchÃ©s financiers', 'Dassault SystÃ¨mesâ€™ 3DEXPERIENCE platform', 'Dassault SystÃ¨mesâ€™ headquarters', 'Annonces LÃ©gales Obligatoires', 'Dassault SystÃ¨mesâ€™ website', 'COMBINED GENERAL SHAREHOLDERSâ€™ MEETING', '10 rue Marcel Dassault', 'BÃ©atrix Martinez', 'express written approval', 'French Commercial code', 'Combined Shareholdersâ€™ Meeting', 'Arnaud de Cheffontaines', 'foregoing internet address', 'Press Release', 'foregoing address', 'commercial trademarks', 'French law', 'following address', 'Euronext Paris', 'VÃ©lizy-Villacoublay', 'preliminary notification', 'draft resolutions', 'convening notice', 'major part', 'human progress', 'virtual worlds', 'real life', 'sustainable innovations', 'meaningful impact', 'FTI Consulting', 'Jamie Ricketts', 'Compass icon', 'CENTRIC PLM', 'registered trademarks', 'Societas Europaea', 'Versailles trade', 'companies registry', 'United States', 'other countries', 'other trademarks', 'respective owners', 'preliminary documents', 'Arnaud Malherbe', 'European company', 'subsidiaries trademarks', '3DS logo', 'VELIZY-VILLACOUBLAY', 'France', 'April', 'MAY', 'Availability', 'DSY', 'Thursday', 'agenda', 'Bulletin', 'BALO', 'information', 'article', 'AMF', 'catalyst', 'consumers', 'patients', 'citizens', '370 000 customers', 'sizes', 'industries', 'rights', 'IFWE', '3DEXCITE', '3DVIA', 'BIOVIA', 'CATIA', 'DELMIA', 'ENOVIA', 'GEOVIA', 'MEDIDATA', 'NETVIBES', 'OUTSCALE', 'SIMULIA', 'SOLIDWORKS', 'number', 'Use', 'Attachment', '3:00', 'Â©']",2025-04-30,2025-05-01,globenewswire.com
50413,EuroNext,NewsApi.org,https://www.hospitalitynet.org/news/4126956.html,Accor Continues to Elevate Its Guest Experience with Key Hotel Renovations across Europe,Accor  a global leader in hospitality  continues to elevate its hotel portfolio in Europe through a number of key renovation projects across its premium  midscale and economy properties in the region.,Accor  a global leader in hospitality  continues to elevate its hotel portfolio in Europe through a number of key renovation projects across its premium  midscale and economy properties in the region.In 2023  Accor launched a brand rejuvenation and modernisation strategy to ensure guests can continue to experience the same level of quality in all its hotels  everywhere they travel around the region. Since its launch  over 70 hotels have already been renovated  with approximately 60 projects in the plan or underway. The momentum of Accorâ€™s strategy demonstrates the engagement of its hotel partners across the region who have been the driving force behind the renovations projects.Keeping our brands fresh  relevant and true to their promise is vital to meeting todayâ€™s consumer demands. Our modernisation strategy in Europe  the historic home of Accor  underscores our commitment to innovation to ensure we continue to excite and delight our guests  while also strengthening brand loyalty and long-term profitability. Julie White  Chief Commercial Officer Europe & North Africa  Premium  Midscale & Economy  AccorAmong a wide range of key hotel renovations around the region  some of the recent projects include:Mercure Wien City (Austria) â€“ Located in Viennaâ€™s vibrant second district  the hotel offers guests easy access to many the cityâ€™s attractions including St. Stephen's Cathedral  the Hofburg and the State Opera House. Following an extensive modernisation of the hotelâ€™s 123 guest rooms and communal areas  including its reception  lounge and bar  the hotel seamlessly combines the refined elegance of the Viennese Art Nouveau with modern comforts and interiors that are inspired by Wiener WerkstÃ¤tte  one of the longest-lived design movements of the twentieth century.Novotel Warsaw Centrum (Poland) â€“ To mark its 50th anniversary  this hotel recently finalised an extensive renovation project  which repositioned 364 guest rooms and corridors spanning over 12 floors  in addition to a conference space  a restaurant and office space. Led by the renowned Sundukovy Sisters Design & Architecture Studio  the project lasted 18 months and incorporated sustainable materials and advanced energy-saving systems  all aimed at enhancing the hotelâ€™s standards. Novotel Warsaw Centrum is situated in the heart of the capital city  and itâ€™s the perfect base to explore its bustling city centre and many attractions.Mercure Bologna Centro (Italy) â€“ This centrally located hotel  which is a stoneâ€™s throw away from Bolognaâ€™s historic centre  has been fully renovated and features 244 modern rooms  three versatile meetings and events spaces and even a private garden. The hotel boasts an outstanding restaurant with panoramic views of the nearby park  as well as the â€˜Binomioâ€™ lounge bar  a perfect spot to relax after a day out in the city.Mercure Napoli Centro Angioino (Italy) â€“ Located right in Naplesâ€™ historical old town  close to the port and with panoramic view of the majestic Maschio Angioino and the Mediterranean Sea  this hotel has recently renovated several key spaces  including an expanded reception area  99 upgraded guest rooms as well as a modern fitness centre  further enhancing the hotel's offering to guests. The renovation also included new elegant flooring throughout and an upgraded cocktail bar.ibis Styles Barcelona Sant Joan Despi (Spain) â€“ Following a full renovation and rebranding  this hotel has been completely redesigned to highlight ibis Styleâ€™s passion for inspiring and original spaces. With 161 rooms distributed over seven floors  an outdoor pool  fitness centre and co-working area amongst other amenities  the hotelâ€™s new design is a nod to Catalan modernism with communal areas inspired to Casa Lana and featuring sustainable and functional spaces.ibis London Blackfriars (UK) â€“ Right on the doorsteps of some of Londonâ€™s most famous sights and attractions  this hotel boasts 297 fully renovated guest rooms  equipped with state-of-the-art technology and thoughtful amenities that blend functionality with comfort. The redesigned rooms are spacious and modern and include versatile and sustainable furniture  in line with the Green Key environmentalstandards.ibis Bayeux Port-en-Bessin (France) â€“ Ideally located near the D-Day landing beaches  close to Bayeux and renowned medieval streets  cathedral and tapestry  the hotel has been recently refurnished and showcases a new design that celebrates the charm of the fishing village of Port-en-Bessin. The brand-new communal areas also feature a spacious breakfast space and a stylish bar. The hotel offers secure bike storage and a bike repair station  making it an ideal stop for cyclists.Mercure AngoulÃªme - HÃ´tel de France (France) â€“ Located in an historical building  this hotel celebrates its strong local roots with themed guest rooms  modern design elements and warm decor for a home away from home feel. The hotel also offers the â€˜Bistro Bardyâ€™  a cozy lounge perfect to dine and wine in relaxed settings. The hotel completed its renovation early this year.Pullman Riga Old Town (Latvia) â€“ Set in a magnificent 1789 building  this hotel is undergoing a full renovation. Expected to be completed by the summer  the refurbishment will enhance the hotelâ€™s communal areas  including the lobby  restaurant and bar  as well as its wellness and fitness facilities  ensuring an exceptional lifestyle experience for all guests. The hotel's six meeting rooms and 154 guest rooms and suites will also be upgraded  making it an ideal choice for both business and leisure travellers. Designed by the Tremend design studio  the new interiors will seamlessly blend natural elements with modern aesthetics  creating a sophisticated yet welcoming atmosphere.About Accor  a world-leading hospitality groupAccor is a world-leading hospitality group offering stays and experiences across more than 110 countries with over 5 600 hotels and resorts  10 000 bars & restaurants  wellness facilities and flexible workspaces. The Group has one of the industry's most diverse hospitality ecosystems  encompassing around 45 hotel brands from luxury to economy  as well as Lifestyle with Ennismore. ALL  the booking platform and loyalty program embodies the Accor promise during and beyond the hotel stay and gives its members access to unique experiences. Accor is focused on driving positive action through business ethics  responsible tourism  environmental sustainability  community engagement  diversity  and inclusivity. Accor's mission is reflected in the Group's purpose: Pioneering the art of responsible hospitality  connecting cultures  with heartfelt care. Founded in 1967  Accor SA is headquartered in France. Included in the CAC 40 index  the Group is publicly listed on the Euronext Paris Stock Exchange (ISIN code: FR0000120404) and on the OTC Market (Ticker: ACCYY) in the United States. For more information  please visit group.accor.com or follow us on X  Facebook  LinkedIn  Instagram and TikTok.View source,neutral,0.01,0.99,0.0,positive,0.87,0.13,0.0,True,English,"['Key Hotel Renovations', 'Guest Experience', 'Accor', 'Europe', 'ibis Styles Barcelona Sant Joan Despi', 'Pullman Riga Old Town', 'Naplesâ€™ historical old town', 'renowned Sundukovy Sisters Design', 'Mercure Napoli Centro Angioino', 'Chief Commercial Officer Europe', 'HÃ´tel de France', 'Green Key environmental standards', '297 fully renovated guest rooms', 'majestic Maschio Angioino', 'renowned medieval streets', 'Mercure AngoulÃªme', 'vibrant second district', 'Wiener WerkstÃ¤tte', 'Novotel Warsaw Centrum', 'D-Day landing beaches', 'secure bike storage', 'bike repair station', 'strong local roots', 'lived design movements', 'Mercure Bologna Centro', 'ibis London Blackfriars', 'several key spaces', 'new elegant flooring', 'spacious breakfast space', 'modern design elements', 'Mercure Wien City', 'State Opera House', 'Viennese Art Nouveau', 'three versatile meetings', '99 upgraded guest rooms', 'brand-new communal areas', 'bustling city centre', 'modern fitness centre', 'key renovation projects', 'Binomioâ€™ lounge bar', 'key hotel renovations', 'extensive renovation project', 'new design', 'historical building', '123 guest rooms', '364 guest rooms', '244 modern rooms', 'renovations projects', 'extensive modernisation', 'modern comforts', 'historic centre', 'conference space', 'office space', 'events spaces', 'original spaces', 'functional spaces', 'redesigned rooms', 'global leader', 'brand rejuvenation', 'same level', 'driving force', 'consumer demands', 'brand loyalty', 'long-term profitability', 'Julie White', 'North Africa', 'wide range', 'recent projects', 'easy access', 'St. Stephen', 'refined elegance', 'twentieth century', '50th anniversary', 'Architecture Studio', 'energy-saving systems', 'capital city', 'perfect base', 'private garden', 'panoramic views', 'nearby park', 'perfect spot', 'Mediterranean Sea', 'cocktail bar', 'full renovation', 'outdoor pool', 'working area', 'other amenities', 'Catalan modernism', 'Casa Lana', 'famous sights', 'thoughtful amenities', 'fishing village', 'stylish bar', 'warm decor', 'Bistro Bardy', 'cozy lounge', 'relaxed settings', 'modernisation strategy', 'historic home', 'sustainable materials', 'sustainable furniture', 'home feel', 'economy properties', 'outstanding restaurant', 'reception area', 'seven floors', 'many attractions', 'hotel portfolio', 'hotel partners', '161 rooms', '60 projects', '12 floors', 'Accor', 'hospitality', 'number', 'midscale', 'region', 'guests', 'quality', 'hotels', 'launch', 'plan', 'momentum', 'engagement', 'brands', 'promise', 'today', 'commitment', 'innovation', 'Premium', 'Austria', 'Vienna', 'Cathedral', 'Hofburg', 'interiors', 'Poland', 'corridors', 'addition', '18 months', 'advanced', 'heart', 'Italy', 'offering', 'Spain', 'rebranding', 'passion', 'inspiring', 'nod', 'doorsteps', 'technology', 'functionality', 'line', 'Bessin', 'Bayeux', 'tapestry', 'charm', 'stop', 'cyclists', 'themed', 'Latvia']",2025-04-30,2025-05-01,hospitalitynet.org
50414,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071686/0/en/Edf-EDF-announces-the-success-of-its-senior-green-multi-tranche-bond-issue-for-a-nominal-amount-of-2-25-billion-euros.html,Edf: EDF announces the success of its senior green multi tranche bond issue for a nominal amount of 2.25 billion euros,EDF announces the success of its senior green multi tranche bond issue for a nominal amount of 2.25 billion euros  On 30 April 2025: EDF (BBB positive......,EDF announces the success of its senior green multi tranche bond issue for a nominal amount of 2.25 billion eurosOn 30 April 2025: EDF (BBB positive S&P / Baa1 stable Moodyâ€™s / BBB+ negative Fitch) successfully priced a senior green bond issuance in 3 tranches for a nominal amount of â‚¬2.25 billion (the â€œBondsâ€):â‚¬750 million Bond  with a 7-year maturity and a 3.250% fixed coupon;â‚¬1 billion Bond  with a 12-year maturity and a 4.000% fixed coupon;â‚¬500 million Bond  with a 20-year maturity and a 4.625% fixed coupon.An amount equal to the net proceeds of the Bonds will be used to finance and/or refinance the following investments:The 7-year maturity tranche in relation to the lifetime extension of the existing French nuclear reactors The 12-year maturity tranche to renewable energy and hydro power projects The 20-year maturity tranche to Hinkley Point C project  a pair of EPR nuclear reactors in construction in the United Kingdom.These investments correspond to the categories of eligible projects defined in EDF's Green Financing Framework updated on 28 April 2025  which was the subject of a second party opinion by S&P Global Ratings  which awarded it a medium green rating (1).This transaction enables EDF to finance its strategy and objective to contribute to achieving carbon neutrality by 2050.Settlement and delivery will take place on 7 May 2025  the date on which the Bonds are expected to be admitted to trading on the regulated market of Euronext Paris.The expected rating for the Bonds is BBB / Baa1 / BBB+ (S&P / Moody's / Fitch).EDF is an active issuer of debt and other types of securities. EDF regularly assesses its financing requirements and monitors national and international financial markets for opportunities to conduct additional issuances of senior debt  hybrids and/or other types of securities.About EDFThe EDF Group is a key player in the energy transition  as an integrated energy operator engaged in all aspects of the energy business: power generation  distribution  trading  energy sales and energy services. The Group is a world leader in low-carbon energy  with a output of 520TWh 94% decarbonised and a carbon intensity of 30gCO2/kWh  a diverse generation mix based mainly on nuclear and renewable energy (including hydropower). It is also investing in new technologies to support the energy transition. EDFâ€™s raison dâ€™Ãªtre is to build a net zero energy future with electricity and innovative solutions and services  to help save the planet and drive well-being and economic development. The Group supplies energy and services to approximately 41.5 million customers(1) and generated consolidated sales of â‚¬118.7 billion in 2024.(1) The customer portfolio consists of electricity  gas and recurring service contracts(1) The Green Financing Framework and the Second Party Opinion are available on the EDF website in the Sustainable Finance section.Attachment,neutral,0.08,0.91,0.0,neutral,0.02,0.97,0.01,True,English,"['senior green multi tranche bond issue', 'nominal amount', '2.25 billion euros', 'Edf', 'success', 'senior green multi tranche bond issue', 'Hinkley Point C project', 'senior green bond issuance', 'S&P Global Ratings', 'existing French nuclear reactors', 'The Green Financing Framework', 'net zero energy future', 'BBB positive S&P', 'medium green rating', 'EPR nuclear reactors', 'second party opinion', 'international financial markets', 'recurring service contracts', 'Sustainable Finance section', '7-year maturity tranche', '12-year maturity tranche', '20-year maturity tranche', 'diverse generation mix', 'integrated energy operator', 'BBB+ negative Fitch', 'hydro power projects', 'Baa1 stable Moody', 'The EDF Group', 'senior debt', 'â‚¬750 million Bond', 'â‚¬1 billion Bond', 'â‚¬500 million Bond', 'The Group', 'net proceeds', 'financing requirements', 'power generation', 'eligible projects', 'expected rating', 'renewable energy', 'energy transition', 'energy business', 'energy sales', 'low-carbon energy', '2.25 billion euros', '3.250% fixed coupon', '4.000% fixed coupon', '4.625% fixed coupon', 'lifetime extension', 'United Kingdom', 'carbon neutrality', 'regulated market', 'Euronext Paris', 'active issuer', 'other types', 'additional issuances', 'key player', 'world leader', 'carbon intensity', 'new technologies', 'innovative solutions', 'economic development', 'consolidated sales', 'customer portfolio', 'nominal amount', 'energy services', 'following investments', 'EDF website', 'success', '30 April', '3 tranches', 'Bonds', 'relation', 'pair', 'construction', 'categories', '28 April', 'subject', 'transaction', 'strategy', 'objective', 'Settlement', 'delivery', 'place', '7 May', 'securities', 'opportunities', 'hybrids', 'aspects', 'distribution', 'trading', 'output', '30gCO', 'hydropower', 'raison', 'electricity', 'planet', 'being', 'gas', 'Attachment']",2025-04-30,2025-05-01,globenewswire.com
50415,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071706/0/en/Societe-Generale-Availability-of-the-first-amendment-to-2025-Universal-Registration-Document.html,Societe Generale: Availability of the first amendment to 2025 Universal Registration Document,AVAILABILITY OF THE FIRST AMENDMENT TO 2025 UNIVERSAL REGISTRATION DOCUMENT  Regulated Information  Paris  30 April 2025  Societe Generale hereby...,AVAILABILITY OF THE FIRST AMENDMENT TO 2025 UNIVERSAL REGISTRATION DOCUMENTRegulated InformationParis  30 April 2025Societe Generale hereby informs the public that the first amendment to the 2025 Universal Registration Document filed on 12th March 2025 under number D.25-0088  has been filed with the French Financial Markets Authority (AMF) on 30th April 2025 under number D-25-0088-A01.This document is made available to the public  free of charge  in accordance with the conditions provided for by the regulations in force and may be consulted in the â€œRegulated informationâ€ section ofthe Companyâ€™s website (https://investors.societegenerale.com/en/financial-and-non-financial-information/regulated-information) and on the AMFâ€™s website.Press contacts:Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.comFanny Rouby_+33 1 57 29 11 12_ fanny.rouby@socgen.comSociete GeneraleSociete Generale is a top tier European Bank with around 119 000 employees serving more than 26 million clients in 62 countries across the world. We have been supporting the development of our economies for 160 years  providing our corporate  institutional  and individual clients with a wide array of value-added advisory and financial solutions. Our long-lasting and trusted relationships with the clients  our cutting-edge expertise  our unique innovation  our ESG capabilities and leading franchises are part of our DNA and serve our most essential objective - to deliver sustainable value creation for all our stakeholders.The Group runs three complementary sets of businesses  embedding ESG offerings for all its clients:French Retail  Private Banking and Insurance   with leading retail bank SG and insurance franchise  premium private banking services  and the leading digital bank BoursoBank.  with leading retail bank SG and insurance franchise  premium private banking services  and the leading digital bank BoursoBank. Global Banking and Investor Solutions   a top tier wholesale bank offering tailored-made solutions with distinctive global leadership in equity derivatives  structured finance and ESG.  a top tier wholesale bank offering tailored-made solutions with distinctive global leadership in equity derivatives  structured finance and ESG. Mobility  International Retail Banking and Financial Services  comprising well-established universal banks (in Czech Republic  Romania and several African countries)  Ayvens (the new ALD I LeasePlan brand)  a global player in sustainable mobility  as well as specialized financing activities.Committed to building together with its clients a better and sustainable future  Societe Generale aims to be a leading partner in the environmental transition and sustainability overall. The Group is included in the principal socially responsible investment indices: DJSI (Europe)  FTSE4Good (Global and Europe)  Bloomberg Gender-Equality Index  Refinitiv Diversity and Inclusion Index  Euronext Vigeo (Europe and Eurozone)  STOXX Global ESG Leaders indexes  and the MSCI Low Carbon Leaders Index (World and Europe).In case of doubt regarding the authenticity of this press release  please go to the end of the Group News page on societegenerale.com website where official Press Releases sent by Societe Generale can be certified using blockchain technology. A link will allow you to check the documentâ€™s legitimacy directly on the web page.For more information  you can follow us on Twitter/X @societegenerale or visit our website societegenerale.com .Attachment,neutral,0.0,1.0,0.0,neutral,0.02,0.98,0.0,True,English,"['2025 Universal Registration Document', 'Societe Generale', 'first amendment', 'Availability', 'new ALD I LeasePlan brand', 'MSCI Low Carbon Leaders Index', 'STOXX Global ESG Leaders indexes', '2025 UNIVERSAL REGISTRATION DOCUMENT Regulated Information', 'socially responsible investment indices', 'top tier European Bank', 'top tier wholesale bank', 'leading retail bank SG', 'premium private banking services', 'French Financial Markets Authority', 'Regulated informationâ€ section', 'leading digital bank', 'Bloomberg Gender-Equality Index', 'International Retail Banking', 'three complementary sets', 'specialized financing activities', 'distinctive global leadership', 'sustainable value creation', 'official Press Releases', 'several African countries', 'Group News page', 'societegenerale.com website', 'French Retail', 'Global Banking', 'Financial Services', 'universal banks', 'Inclusion Index', 'leading franchises', 'leading partner', 'global player', 'web page', 'Press contacts', 'sustainable future', 'financial solutions', 'ESG capabilities', 'ESG offerings', 'FIRST AMENDMENT', 'Societe Generale', '12th March', 'investors.societegenerale', 'corporate, institutional', 'wide array', 'value-added advisory', 'trusted relationships', 'cutting-edge expertise', 'unique innovation', 'essential objective', 'The Group', 'Investor Solutions', 'tailored-made solutions', 'equity derivatives', 'Czech Republic', 'environmental transition', 'Refinitiv Diversity', 'Euronext Vigeo', 'blockchain technology', 'sustainable mobility', 'website societegenerale', '30th April', 'Jean-Baptiste Froville', 'Fanny Rouby', 'structured finance', '26 million clients', 'individual clients', 'insurance franchise', '62 countries', '30 April', 'AVAILABILITY', 'Paris', 'number', 'AMF', 'charge', 'accordance', 'conditions', 'regulations', 'force', 'Company', 'financial-information', 'regulated-information', 'socgen', '119,000 employees', 'world', 'development', 'economies', '160 years', 'long-lasting', 'DNA', 'stakeholders', 'businesses', 'BoursoBank', 'Romania', 'Ayvens', 'sustainability', 'DJSI', 'FTSE4Good', 'Eurozone', 'case', 'doubt', 'authenticity', 'link', 'legitimacy', 'Twitter/X', 'Attachment']",2025-04-30,2025-05-01,globenewswire.com
50416,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070960/0/en/Nicox-Provides-Full-Year-2024-Financial-Results.html,Nicox Provides Full Year 2024 Financial Results,Press Release Nicox Provides Full Year 2024 Financial Results  Nicox SA revenue of â‚¬7.9 million for full year 2024Â Exceptional income of â‚¬13.7 million......,Nicox SA revenue of â‚¬7.9 million for full year 2024Exceptional income of â‚¬13.7 million following the transfer of VYZULTAâ€™s future revenue stream to Soleus CapitalNicox SA cash of â‚¬10.5 million on 31 December 2024 and the Company estimates it is currently financed into the fourth quarter of 2025Topline results from NCX 470 second Phase 3 clinical trial  Denali  expected in the third quarter of 2025Ongoing discussions and business development outreach underway for NCX 470 U.S. partnership April 30  2025 â€“ release at 7:30 am CETSophia Antipolis  FranceNicox SA (Euronext Growth Paris: FR0013018124  ALCOX)  an international ophthalmology company  today provided its financial results for the full year of 2024  as approved by the Board of Directors on 28 April 2025  and provided an update on key future milestones. Following the sale of the VYZULTA royalty in October 2024  the Company will no longer be providing quarterly revenue reports.â€œThe achievements of 2024 by the Nicox team and our partners have allowed us to keep our product development on track and prepared to deliver two clinical readouts on NCX 470 in 2025. Our focus is now on ensuring that the Company is in the optimal position to exploit those results through ongoing partnership  business and corporate development discussions.â€ said Gavin Spencer  Chief Executive Officer of Nicox.Key Future MilestonesWhistler Phase 3b clinical trial investigating NCX 470â€™s dual mechanism of action (nitric oxide and prostaglandin analog) in intraocular pressure lowering: Results are expected in May 2025.Results are expected in May 2025. Denali Phase 3 clinical trial evaluating NCX 470 in patients with open-angle glaucoma or ocular hypertension: Topline results are expected in the third quarter of 2025. Full Year 2024 Financial Results for Nicox SARevenue for the full year of 2024 was â‚¬7.9 million versus â‚¬6.9 million for the full year of 2023  including â‚¬3.0 million of VYZULTA royalties  recognized up to 30 June 2024 prior to the sale of the royalties to Soleus Capital  versus â‚¬6.6 million  consisting principally of royalty payments  for the full year of 2023. The revenue for 2024 also includes the upfront payment of â‚¬3.0 million from Kowa for the Japanese rights to NCX 470 and a non-cash amount of â‚¬1.5 million previously recognized as prepaid income. The revenue for 2024 also includes â‚¬0.2 million of internal rebilling compared to â‚¬0.3 million for 2023.Operating expenses for the full year of 2024 were â‚¬18.7 million compared to â‚¬24.2 million for the full year of 2023.Exceptional income in 2024 was â‚¬13.7 million compared to â‚¬0.1 million in 2023. In 2024 this revenue corresponds to the sale of the future milestones and royalty of VYZULTA to Soleus Capital.Nicox SA recorded a net loss of â‚¬22.4 million for year ended 31 December 2024  compared to a net loss of â‚¬20.9 million for the same period in 2023. The 2024 loss includes a non-cash amount of â‚¬27.1 million due to the impairment of an intercompany receivable held by Nicox SA on its U.S. affiliate Nicox Ophthalmics  Inc. The recoverability of this receivable depends on the future royalties the subsidiary is expected to receive from the commercialization of ZERVIATE. In accordance with French GAAP  the Company has adopted a prudent approach based on the most conservative sales forecast amongst other  more favorable scenarios. This led to a downward revaluation of the value of ZERVIATE following a new analysis for the Chinese market. This analysis highlighted developments that reduce the probability of achieving the initially anticipated annual peak sales target of US$100M. Since ZERVIATE is the sole revenue-generating asset in Nicox Ophthalmics  Inc.  the intercompany receivable has consequently been impaired. The details concerning this impairment are given in Note 2.4.1 of the statutory accounts of the Company which are available on the Companyâ€™s website on the page â€œFinancial and Regulatory Informationâ€.As of 31 December 2024  Nicox SA had cash and cash equivalents of â‚¬10.5 million compared to â‚¬11.3 million as of 31 December 2023. The Company is currently funded until at least into the fourth quarter of 2025  based on focusing exclusively on the development of NCX 470.As of 31 December 2024  Nicox SA had financial debt of â‚¬15.1 million  consisting of â‚¬14.2 million in the form of a bond financing agreement with Kreos Capital (an affiliate of BlackRock)  and a â‚¬0.9 million credit agreement guaranteed by the French State  and granted in the context of the COVID-19 pandemic.The Company is pursuing business development discussions  including the sale or license of certain assets  and exploring multiple other strategic options which could further extend the cash runway. The Company is evaluating all options for financing and will use the most appropriate at the time.,neutral,0.0,1.0,0.0,negative,0.0,0.26,0.74,True,English,"['Full Year 2024 Financial Results', 'Nicox', 'Whistler Phase 3b clinical trial', 'NCX 470 second Phase 3 clinical trial', 'Denali Phase 3 clinical trial', 'annual peak sales target', 'multiple other strategic options', 'NCX 470 U.S. partnership', 'two clinical readouts', 'conservative sales forecast', 'Euronext Growth Paris', 'Chief Executive Officer', 'intraocular pressure lowering', 'U.S. affiliate', 'sole revenue-generating asset', 'â‚¬0.9 million credit agreement', 'Full Year 2024 Financial Results', 'key future milestones', 'corporate development discussions', 'bond financing agreement', 'quarterly revenue reports', 'business development outreach', 'future revenue stream', 'international ophthalmology company', 'business development discussions', 'Nicox SA cash', 'Nicox SA revenue', 'ongoing partnership', 'Ongoing discussions', 'product development', 'future royalties', 'financial debt', 'Nicox team', 'Nicox Ophthalmics', 'Exceptional income', 'Soleus Capital', 'fourth quarter', 'third quarter', 'Sophia Antipolis', 'optimal position', 'Gavin Spencer', 'dual mechanism', 'nitric oxide', 'prostaglandin analog', 'open-angle glaucoma', 'ocular hypertension', 'upfront payment', 'Japanese rights', 'cash amount', 'prepaid income', 'internal rebilling', 'Operating expenses', 'same period', 'French GAAP', 'prudent approach', 'favorable scenarios', 'downward revaluation', 'Chinese market', 'statutory accounts', 'Regulatory Information', 'cash equivalents', 'Kreos Capital', 'French State', 'COVID-19 pandemic', 'cash runway', 'Topline results', 'royalty payments', 'net loss', 'intercompany receivable', 'new analysis', 'The Company', 'VYZULTA royalty', 'VYZULTA royalties', '2024 loss', 'transfer', '31 December', 'release', 'CET', 'France', 'ALCOX', 'Board', 'Directors', '28 April', 'update', 'October', 'achievements', 'track', 'focus', 'action', 'May', 'patients', '30 June', 'Kowa', 'impairment', 'recoverability', 'subsidiary', 'commercialization', 'ZERVIATE', 'accordance', 'value', 'developments', 'probability', 'details', 'Note', 'website', 'page', 'BlackRock', 'context', 'license', 'assets', 'time', '7:30']",2025-04-30,2025-05-01,globenewswire.com
50417,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071643/0/en/Viridien-Combined-General-Meeting-and-Board-of-Directors-Meeting-of-April-30-2025.html,Viridien: Combined General Meeting and Board of Directors Meeting of April 30  2025,Combined General Meeting and Board of Directors Meeting  of April 30  2025   Paris  France â€“ April 30  2025  The Combined General Meeting of...,Combined General Meeting and Board of Directors Meetingof April 30  2025Paris  France â€“ April 30  2025The Combined General Meeting of Viridien  chaired by Mr. Philippe SALLE was held on April 30  2025 in Paris. The voting results and video replay of the event will be available on the Companyâ€™s website at the following address: https://www.viridiengroup.com/investors/shareholders/general-meetings.The General Meeting approved all resolutions that were submitted to it and notably:The statutory financial statements and consolidated financial statements for the financial year 2024;Appointment of DELOITTE & ASSOCIES  in replacement of ERNST & YOUNG et Autres  as statutory auditor in charge of certifying financial statements;Appointment of BDO PARIS  in replacement of MAZARS  as statutory auditor in charge of certifying financial statements;The Appointment of BDO PARIS as statutory auditors in charge of certifying the sustainability information;The Say on Pay resolutions on the remuneration of corporate officers;The renewals of Mr. Philippe SALLE  Mrs. Anne-France LACLIDE-DROUIN and Mr. Michael DALYâ€™s term as Director for a period of four years and the co-optation of Mrs. AmÃ©lie OYARZABAL as Director.The Board of Directors  at its meeting following the General Meeting  appointed:Mrs. Sophie ZURQUIYAH as Chairperson and Chief Executive Officer until the end of her term of office as director at the latest  i.e. until the Annual General Meeting of 2026 Mr. Philippe SALLE as Vice-Chairman and Lead Independent Director.The Board also noted the end of Patrick CHOUPINâ€™s term of office as Director representing the employees. As the Company no longer exceeds the headcount thresholds requiring the appointment of a director representing the employees  no new director representing the employees will be appointed. The Board thanks Patrick CHOUPIN for his valuable insights  bringing the employeesâ€™ view to the Board room.The Board of Directors therefore comprises 8 directors  of whom 87.5% are independent and 50% are women. The Board is composed of:Sophie ZURQUIYAH  Chairperson and Chief Executive OfficerPhilippe SALLE*  Vice-Chairman and Lead Independent DirectorMichael DALY*Olivier JOUVE*Anne-France LACLIDE-DROUIN*Colette LEWINER*AmÃ©lie OYARZABAL*Mario RUSCEV*The Board also modified the composition of its committees as follows:Audit and Risk Management CommitteeAnne-France LACLIDE-DROUIN*  ChairwomanColette LEWINER *AmÃ©lie OYARZABAL*Appointment  Remuneration and Governance CommitteeColette LEWINER*  ChairwomanOlivier JOUVE*Mario RUSCEV*New Businesses and M&A CommitteeMichael DALY*  ChairmanOlivier JOUVE*AmÃ©lie OYARZABAL*Mario RUSCEV*Sustainability CommitteePhilippe SALLE*  ChairmanMichael DALY*Anne-France LACLIDE-DROUIN*Mario RUSCEV*Sophie Zurquiyah  Chairperson and Chief Executive Officer of Viridien:â€œOn behalf of the Board of Directors  I extend our heartfelt gratitude to Philippe SALLE for his exceptional leadership and vision. His guidance has empowered the Group to undertake a bold and pivotal transformation  laying the foundation for a sustainable future. We are fortunate to have his continued presence on the Board as Vice-Chair and Lead Independent Director  which will be a precious assurance of continuity and stability.I would like to express my sincere gratitude to the Board of Directors for the trust they have placed in me by appointing me as Chairperson of the Board  in addition to my current role as Chief Executive Officer. This responsibility is a true honor  and I am committed to fulfilling it with determination  while awaiting the Board's definition of a new governance structure for Viridien starting in 2026.â€* Independent directorAbout Viridien :Viridien (www.viridiengroup.com) is an advanced technology  digital and Earth data company that pushes the boundaries of science for a more prosperous and sustainable future. With our ingenuity  drive and deep curiosity we discover new insights  innovations  and solutions that efficiently and responsibly resolve complex natural resource  digital  energy transition and infrastructure challenges. Viridien employs around 3 400 people worldwide and is listed as VIRI on the Euronext Paris SA (ISIN: FR001400PVN6).Contact:Group General Secretarygeneral.secretary@viridiengroup.comAttachment,neutral,0.0,1.0,0.0,positive,0.74,0.25,0.0,True,English,"['Combined General Meeting', 'Directors Meeting', 'Viridien', 'Board', 'April', 'Mrs. AmÃ©lie OYARZABAL', 'The Combined General Meeting', 'Chief Executive Officer', 'complex natural resource', 'Annual General Meeting', 'Mr. Philippe SALLE', 'Risk Management Committee', 'M&A Committee', 'Mrs. Anne-France LACLIDE-DROUIN', 'Mrs. Sophie ZURQUIYAH', 'advanced technology, digital', 'The General Meeting', 'Euronext Paris SA', 'new governance structure', 'Mr. Michael DALY', 'Earth data company', 'Lead Independent Director', 'Group General Secretary', 'statutory financial statements', 'Governance Committee', 'Sustainability Committee', 'The Say', 'statutory auditor', 'New Businesses', 'new insights', 'financial year', 'new director', 'voting results', 'video replay', 'following address', 'sustainability information', 'corporate officers', 'four years', 'Patrick CHOUPIN', 'headcount thresholds', 'valuable insights', 'Olivier JOUVE', 'Colette LEWINER', 'Mario RUSCEV', 'heartfelt gratitude', 'exceptional leadership', 'pivotal transformation', 'sustainable future', 'continued presence', 'precious assurance', 'sincere gratitude', 'current role', 'true honor', 'deep curiosity', 'energy transition', 'infrastructure challenges', 'BDO PARIS', 'Directors Meeting', 'The Board', 'Pay resolutions', 'Board room', 'employeesâ€™ view', '8 directors', 'April', 'Viridien', 'event', 'website', 'investors/shareholders', 'Appointment', 'DELOITTE', 'ASSOCIES', 'replacement', 'ERNST', 'YOUNG', 'Autres', 'charge', 'MAZARS', 'remuneration', 'renewals', 'term', 'period', 'optation', 'Chairperson', 'Vice-Chairman', 'women', 'composition', 'committees', 'Chairwoman', 'behalf', 'vision', 'guidance', 'bold', 'foundation', 'continuity', 'stability', 'trust', 'addition', 'responsibility', 'definition', 'boundaries', 'science', 'prosperous', 'ingenuity', 'drive', 'innovations', '3,400 people', 'ISIN', 'Contact', 'Attachment']",2025-04-30,2025-05-01,globenewswire.com
50418,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070957/0/en/Immuno-Oncology-Results-from-Research-Collaboration-with-L%C3%A9on-B%C3%A9rard-Cancer-Center-Presented-at-AACR-Annual-Meeting-2025.html,Immuno-Oncology Results from Research Collaboration with LÃ©on BÃ©rard Cancer Center Presented at AACR Annual Meeting 2025,Immuno-Oncology Results from Research Collaboration with LÃ©on BÃ©rard Cancer Center Presented at AACR Annual Meeting 2025   New gene expression...,Immuno-Oncology Results from Research Collaboration withLÃ©on BÃ©rard Cancer Center Presentedat AACR Annual Meeting 2025New gene expression signature for cancer patients to predict clinical response toimmune checkpoint.Potential of signature to enhance personalized treatment for patients  regardless of cancer type.NANTES  France â€“ April 30  2025  7:30 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)  a biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation  today reported on an oral presentation from a research collaboration with the renowned LÃ©on BÃ©rard Cancer Center in Lyon at the American Association for Cancer Research (AACR) Annual Meeting held April 25 â€“ 30  2025  in Chicago.Immune checkpoint blockade (ICB) therapies  targeting PD-1  PD-L1  and CTLA-4  have revolutionized cancer treatment by helping the immune system recognize and attack cancer cells more effectively. These therapies offer lasting responses and significant survival benefits across various cancers. However  current biomarkers like PD-L1 expression and tumor mutational burden (TMB) are not always reliable. PD-L1 expression can vary within tumors and between patients  making predictions inconsistent. Therefore  more universally applicable biomarkers are needed to predict patient responses and guide treatment decisions. While RNA sequencing has created detailed gene expression signatures (GES) that describe the tumor environment  their use in everyday clinical practice is limited due to their specificity and lack of widespread adoption.The presentation  entitled â€œA tumor agnostic composite gene expression signature identifies three groups of patients treated with immune checkpoint blockade with distinct clinical outcomeâ€  reported on the development and validation of a robust and tumor-agnostic composite gene expression signature (cGES) that can predict overall survival and progression free survival in cancer patients treated with immune checkpoint blockers (e.g. Anti PD-L1  Anti PD-1 and Anti CTLA-4). This signature could be useful in clinical practice to better stratify patients on risk and potentially guide treatment decisions of multiple cancer types.Professor Pierre Saintigny of UniversitÃ© Claude Bernard Lyon 1  Centre LÃ©on BÃ©rard Comprehensive Cancer Center and Team leader Inserm/Inria at Cancer Research Centre of Lyon stated: â€œOur collaborative research program validated a composite gene expression signature with a strong potential for stratifying and predicting clinical outcomes more accurately  which could significantly improve personalized treatment in clinical practice for ICB-treated patients  regardless of cancer type. We were very pleased to present the results of our translational research at the AACR conference on this cutting-edge program conducted in collaboration with OSE Immunotherapeuticsâ€™ teams.â€ABOUT THE LÃ‰ON BÃ‰RARD CENTERThe Centre LÃ©on BÃ©rard (CLB) is part of the twenty French Comprehensive Cancer Centres in France  providing a global management of cancer patients on a unique area  from diagnosis to treatment and beyond. The Centre is a regional  national and international recognized reference cancer Centre assigned with three essential missions: Care  Research and Education and is willing to continuously improve the quality and accessibility of care for cancer patients.ABOUT OSE IMMUNOTHERAPEUTICSOSE Immunotherapeutics is a biotech company dedicated to developing first-in-class assets in immuno-oncology (IO) and immuno-inflammation (I&I) that address the unmet patient needs of today and tomorrow. We partner with leading academic institutions and biopharmaceutical companies in our efforts to develop and bring to the market transformative medicines for people with serious diseases. OSE Immunotherapeutics is based between Nantes and Paris and is quoted on Euronext.Additional information about OSE Immunotherapeutics assets is available on the Companyâ€™s website: www.ose-immuno.com. Follow us on LinkedIn.ContactsFiona Olivierfiona.olivier@ose-immuno.comSylvie DÃ©trysylvie.detry@ose-immuno.comFrench Media ContactFP2COMFlorence Portejoiefportejoie@fp2com.fr+33 6 07 768 283U.S. Media ContactRooney Partners LLCKate Barrettekbarrette@rooneypartners.com+1 212 223 0561Forward-looking statementsThis press release contains express or implied information and statements that might be deemed forward-looking information and statements in respect of OSE Immunotherapeutics. They do not constitute historical facts. These information and statements include financial projections that are based upon certain assumptions and assessments made by OSE Immunotherapeuticsâ€™ management considering its experience and its perception of historical trends  current economic and industry conditions  expected future developments and other factors they believe to be appropriate.These forward-looking statements include statements typically using conditional and containing verbs such as â€œexpectâ€  â€œanticipateâ€  â€œbelieveâ€  â€œtargetâ€  â€œplanâ€  or â€œestimateâ€  their declensions and conjugations and words of similar import. Although the OSE Immunotherapeutics management believes that the forward-looking statements and information are reasonable  the OSE Immunotherapeuticsâ€™ shareholders and other investors are cautioned that the completion of such expectations is by nature subject to various risks  known or not  and uncertainties which are difficult to predict and generally beyond the control of OSE Immunotherapeutics. These risks could cause actual results and developments to differ materially from those expressed in or implied or projected by the forward-looking statements. These risks include those discussed or identified in the public filings made by OSE Immunotherapeutics with the AMF. Such forward-looking statements are not guarantees of future performance. This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on April 30  2024  including the annual financial report for the fiscal year 2023  available on the OSE Immunotherapeuticsâ€™ website. Other than as required by applicable law  OSE Immunotherapeutics issues this press release at the date hereof and does not undertake any obligation to update or revise the forward-looking information or statements.Attachment,neutral,0.0,1.0,0.0,mixed,0.25,0.14,0.6,True,English,"['LÃ©on BÃ©rard Cancer Center', 'AACR Annual Meeting', 'Immuno-Oncology Results', 'Research Collaboration', 'Centre LÃ©on BÃ©rard Comprehensive Cancer Center', 'renowned LÃ©on BÃ©rard Cancer Center', 'The Centre LÃ©on BÃ©rard', 'LÃ‰ON BÃ‰RARD CENTER', 'tumor agnostic composite gene expression signature', 'twenty French Comprehensive Cancer Centres', 'international recognized reference cancer Centre', 'tumor-agnostic composite gene expression signature', 'detailed gene expression signatures', 'Sylvie DÃ©try sylvie', 'FP2COM Florence Portejoie fportejoie', 'New gene expression signature', 'U.S. Media Contact', 'UniversitÃ© Claude Bernard Lyon', 'French Media Contact', 'Cancer Research Centre', 'tumor mutational burden', 'multiple cancer types', 'Professor Pierre Saintigny', 'leading academic institutions', 'Rooney Partners LLC', 'AACR Annual Meeting 2025', 'AACR) Annual Meeting', 'three essential missions', 'unmet patient needs', 'Immune checkpoint blockade', 'immune checkpoint blockers', 'significant survival benefits', 'distinct clinical outcome', 'OSE Immunotherapeutics SA', 'OSE Immunotherapeuticsâ€™ teams', 'everyday clinical practice', 'collaborative research program', 'OSE Immunotherapeutics assets', 'OSE Immunotherapeuticsâ€™ management', 'PD-L1 expression', 'tumor environment', 'cancer cells', 'cancer treatment', 'cancer patients', 'AACR conference', 'immune system', 'patient responses', 'three groups', 'cutting-edge program', 'global management', 'class assets', 'clinical response', 'overall survival', 'free survival', 'clinical outcomes', 'translational research', 'American Association', 'lasting responses', 'various cancers', 'RNA sequencing', 'widespread adoption', 'Anti CTLA', 'Team leader', 'unique area', 'regional, national', 'I&I', 'biopharmaceutical companies', 'transformative medicines', 'serious diseases', 'Kate Barrette', 'press release', 'historical facts', 'financial projections', 'historical trends', 'current economic', 'industry conditions', 'future developments', 'other factors', 'personalized treatment', 'treatment decisions', 'Research Collaboration', 'biotech company', 'class therapies', 'ICB) therapies', 'ICB-treated patients', 'oral presentation', 'current biomarkers', 'Anti PD-L', 'Anti PD-1', 'strong potential', 'Additional information', 'implied information', 'Forward-looking statements', 'Fiona Olivier', 'Immuno-Oncology Results', 'NANTES', 'France', 'April', '7:30 a', 'CET', 'ISIN', 'Mnemo', 'first', 'immuno-inflammation', 'Chicago', 'CTLA-4', 'TMB', 'tumors', 'predictions', 'GES', 'use', 'specificity', 'lack', 'validation', 'robust', 'progression', 'risk', 'Inserm/Inria', 'CLB', 'diagnosis', 'Care', 'Education', 'quality', 'accessibility', 'today', 'tomorrow', 'efforts', 'market', 'people', 'Paris', 'Euronext', 'website', 'LinkedIn', 'Contacts', 'kbarrette', 'rooneypartners', 'respect', 'assumptions', 'assessments', 'experience', 'perception', 'conditional', 'verbs']",2025-04-30,2025-05-01,globenewswire.com
50419,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070998/0/en/Orange-Orange-Business-and-Shiftmove-enter-exclusive-negotiations-for-the-acquisition-of-Oc%C3%A9an-by-Shiftmove.html,Orange: Orange Business and Shiftmove enter exclusive negotiations for the acquisition of OcÃ©an by Shiftmove,Press ReleaseParis  April 30th 2025  Orange Business and Shiftmove enter exclusive negotiations for the acquisition of OcÃ©an by Shiftmove  Orange...,"Press ReleaseParis  April 30th 2025Orange Business and Shiftmove enter exclusive negotiations for the acquisition of OcÃ©an by ShiftmoveOrange Business and Shiftmove announce that they have signed an exclusivity agreement for the acquisition of the OcÃ©an business by Shiftmove.OcÃ©an is the Fleet Management activity of Orange Business  currently supporting thousands of corporate clients and public organizations in the efficient management of their vehicle fleets  machinery and trucks. Fleets operated by OcÃ©anâ€™s clients account for nearly 170 000 vehicles across France.Through their Software-as-a-Service platform and tailored services  OcÃ©an enables companies to make informed decisions allowing them to optimize costs  enhance employee safety and meet their environmental commitments regarding their fleets.This proposed transaction comes as part of Orange Businessâ€™s continued execution of its strategy of refocusing its business portfolio and optimizing its investments on key strategic priorities. The proposed acquisition by Shiftmove  a pure player that is committed to consolidating the market  will benefit OcÃ©an and help maximize its growth potential.In 2023  OcÃ©an celebrated 20 years of expertise  during which the company successfully anticipated and supported market developments â€” from the early days of geolocation to the adoption of embedded telematics (i.e. connected solutions). OcÃ©an aims to become one of the leading fleet management providers in France.""In a telematics market undergoing profound transformation  marked by accelerated innovation and increasingly complex customer expectations  our ambition is to build strong and lasting synergies that anticipate future technological and industry developments. By relying on a growth strategy focused on innovation and operational excellence  OcÃ©an aims to establish itself as a key player in the sector. The company intends to respond agilely to the growing functional needs of businesses  enhance the user experience  accelerate the creation of high-value strategic partnerships  and strengthen its international presence â€ said StÃ©phane Peycelon  CEO of OcÃ©an.With a clear ambition to become the European leader in digital fleet solutions by 2027  Shiftmove is continuing its strategic development with the goal of optimizing the management of more than one million vehicles. Its recent establishment in France represents a major milestone in this journey  while further strengthening its presence across Europe. The acquisition of OcÃ©an marks yet another significant step for Shiftmove  reinforcing its strategic vision and shaping a strong leadership position based on the digital transformation of fleet management.""Shiftmove is actively pursuing its European development with a clear strategic vision for forging partnerships and making acquisitions  particularly in France. This next step with OcÃ©an fits perfectly within this dynamic: it marks a key milestone in building a strong ecosystem  where the combination of our respective expertise will create an increasingly innovative and recognized group in the fleet management market "" said Taco van der Leij  Managing Director  Shiftmove France.Employee representative bodies of OBS S.A. will be consulted with a view to a possible completion of the transaction by the end of 2025.About OrangeOrange is one of the worldâ€™s leading telecommunications operators with revenues of 40.3 billion euros in 2024 and 125 800 employees worldwide at 31 March 2025  including 69 700 employees in France. The Group has a total customer base of294 million customers worldwide at 31 March 2025  including 256 million mobile customers and 22 million fixed broadband customers. These figures account for the deconsolidation of certain activities in Spain following the creation of MASORANGE. The Group is present in 26 countries (including non-consolidated countries).Orange is also a leading provider of global IT and telecommunication services to multinational companies under the brand Orange Business. In February 2023  the Group presented its strategic plan ""Lead the Future""  built on a new business model and guided by responsibility and efficiency. ""Lead the Future"" capitalizes on network excellence to reinforce Orange's leadership in service quality.Orange is listed on Euronext Paris (symbol ORA).For more information on the internet and on your mobile: www.orange.com  www.orange-business.com and the Orange News app or to follow us on X: @orangegrouppr.Orange and any other Orange product or service names included in this material are trademarks of Orange or Orange Brand Services Limited.Contacts presse OrangeTom Wright : tom.wright@orange.comFatima Rahil : fatima.rahil@orange.comAbout ShiftmoveShiftmove's software transforms the way companies manage the mobility operations of their employees  goods  and services. Created in January 2023 from the merger of industry leaders Avrios (est. 2015) and Vimcar (est. 2013)  Shiftmove has the clear goal: becoming Europe's leading provider of digital fleet solutions by 2027. With AI-supported software and intelligent connected solutions  the company aims to optimize the efficiency of over one million fleet vehicles. This will make fleets more profitable and actively promote climate policy goals such as electrification and decarbonisation. In October 2024  Shiftmove acquired the French fleet management company Optimum Automotive. This created a group with 340 employees serving 17 000 corporate customers with more than 500 000 vehicles. Shiftmove is headquartered in Berlin  with offices in Zurich  Wroclaw  Milan and Aix-en-Provence. Shiftmove's main investor is Battery Ventures. www.shiftmove.comPress Contacts Shiftmove  FranceAgence Sergeant Paper Astrid Sergeant 07 77 70 71 73 asergeant@agence-sergeantpaper.frAngela Zippelius +49 173 522 9813 press@shiftmove.comAttachment",neutral,0.0,1.0,0.0,positive,0.8,0.2,0.0,True,English,"['exclusive negotiations', 'OcÃ©an', 'Orange Business', 'Shiftmove', 'acquisition', 'Taco van der Leij', '22 million fixed broadband customers', 'leading fleet management providers', 'Orange Brand Services Limited', 'complex customer expectations', 'growing functional needs', 'StÃ©phane Peycelon', 'OBS S.A.', 'total customer base', 'leading telecommunications operators', 'Fleet Management activity', 'Employee representative bodies', 'new business model', 'digital fleet solutions', 'one million vehicles', '256 million mobile customers', 'key strategic priorities', 'Orange News app', 'other Orange product', 'Contacts presse Orange', 'high-value strategic partnerships', 'fleet management market', 'clear strategic vision', 'strong leadership position', 'OcÃ©an business', '294 million customers', 'leading provider', 'digital transformation', 'efficient management', 'employee safety', 'strategic development', 'strategic plan', 'key player', 'key milestone', 'tailored services', 'telecommunication services', 'business portfolio', 'Press Release', 'April 30th', 'exclusive negotiations', 'exclusivity agreement', 'public organizations', 'Service platform', 'informed decisions', 'environmental commitments', 'continued execution', 'pure player', 'growth potential', 'market developments', 'early days', 'embedded telematics', 'telematics market', 'profound transformation', 'lasting synergies', 'industry developments', 'operational excellence', 'user experience', 'European leader', 'recent establishment', 'major milestone', 'significant step', 'European development', 'next step', 'strong ecosystem', 'Managing Director', 'possible completion', '40.3 billion euros', 'global IT', 'network excellence', 'service quality', 'symbol ORA', 'service names', 'Tom Wright', 'mobility operations', 'industry leaders', 'Orange Business', 'clear ambition', 'clear goal', 'recognized group', 'The Group', 'corporate clients', 'accelerated innovation', 'growth strategy', 'international presence', 'respective expertise', 'consolidated countries', 'Euronext Paris', 'Fatima Rahil', 'vehicle fleets', 'future technological', 'multinational companies', 'Shiftmove France', '170,000 vehicles', '26 countries', 'acquisition', 'thousands', 'machinery', 'trucks', 'Software', 'costs', 'transaction', 'investments', '20 years', 'company', 'geolocation', 'adoption', 'connected', 'sector', 'businesses', 'creation', 'CEO', 'journey', 'dynamic', 'combination', 'innovative', 'view', 'end', 'world', 'revenues', '125,800 employees', '31 March', '69,700 employees', 'figures', 'deconsolidation', 'activities', 'Spain', 'MASORANGE', 'February', 'responsibility', 'efficiency', 'information', 'internet', 'material', 'trademarks', 'way', 'goods', 'January', 'merger', 'Avrios', 'Vimcar', 'supported', '2024', '2027']",2025-04-30,2025-05-01,globenewswire.com
50420,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071702/0/en/Weekly-share-repurchase-program-transaction-details.html,Weekly share repurchase program transaction details,April 30  2025    SBM Offshore reports the transaction details related to its EUR141 million (c. US$150 million1) share repurchase program for the...,"April 30  2025SBM Offshore reports the transaction details related to its EUR141 million (c. US$150 million1) share repurchase program for the period April 24  2025 through April 30  2025.The repurchases were made under the EUR141 million share repurchase program announced on February 20  2025 and effective from April 24  2025. The objective of the program is to reduce share capital and  in addition  to provide shares for regular management and employee share programs. Information regarding the progress of the share repurchase program and the aggregate of the transactions (calculated on a daily basis) for the period April 24  2025 through April 30  2025 can be found in the top half of the table below. Further detailed information regarding both the progress of the share repurchase program and all individual transactions can be accessed via the Investors section of the Companyâ€™s website.Share Repurchase Program Overall progress Share Repurchase Program:Total Repurchase Amount EUR 141 189 019Cumulative Repurchase Amount EUR 3 553 327Cumulative Quantity Repurchased 197 000Cumulative Average Repurchase Price EUR 18.04Start Date April 24  2025Percentage of program completed as of April 30  2025 2.52%Overview of details of last 5 trading days:Trade Date Quantity Repurchased Average Purchase Price Settlement AmountApril 24  2025 41 500 EUR 17.62 EUR 731 159April 25  2025 41 500 EUR 17.83 EUR 739 800April 28  2025 41 500 EUR 18.12 EUR 751 889April 29  2025 38 500 EUR 18.34 EUR 706 059April 30  2025 34 000 EUR 18.37 EUR 624 420Total 197 000 EUR 18.04 EUR 3 553 327All shares purchased via Euronext Amsterdam  CBOE DXE and or TurquoiseThis press release contains information which is to be made publicly available under the Market Abuse Regulation (nr. 596/2014). The information concerns a regular update of the transactions conducted under SBM Offshoreâ€™s current share repurchase program  as announced by the Company on February 20  2025  details of which are available on its website.Corporate ProfileSBM Offshore is the worldâ€™s deepwater ocean-infrastructure expert. Through the design  construction  installation  and operation of offshore floating facilities  we play a pivotal role in a just transition. By advancing our core  we deliver cleaner  more efficient energy production. By pioneering more  we unlock new markets within the blue economy.More than 7 800 SBMers collaborate worldwide to deliver innovative solutions as a responsible partner towards a sustainable future  balancing ocean protection with progress.For further information  please visit our website at www.sbmoffshore.com.Financial Calendar Date Year First Quarter 2025 Trading UpdateMay 15 2025 Half Year 2025 EarningsAugust 7 2025 Third Quarter 2025 Trading UpdateNovember 13 2025 Full Year 2025 EarningsFebruary 26 2026 Annual General MeetingApril 15 2026For further information  please contact:Investor RelationsWouter HoltiesCorporate Finance & Investor Relations ManagerMobile: +31 (0) 2 02 36 32 36 E-mail: wouter.holties@sbmoffshore.com Website: www.sbmoffshore.comMedia RelationsGiampaolo ArghittuHead of External RelationsPhone: +31 (0) 6 212 62 333 / +39 33 494 79 584 E-mail: giampaolo.arghittu@sbmoffshore.com Website: www.sbmoffshore.comMarket Abuse RegulationThis press release may contain inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.DisclaimerSome of the statements contained in this release that are not historical facts are statements of future expectations and other forward-looking statements based on managementâ€™s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results  performance  or events to differ materially from those in such statements. These statements may be identified by words such as â€˜expectâ€™  â€˜shouldâ€™  â€˜couldâ€™  â€˜shallâ€™ and similar expressions. Such forward-looking statements are subject to various risks and uncertainties. The principal risks which could affect the future operations of SBM Offshore N.V. are described in the â€˜Impact  Risk and Opportunity Managementâ€™ section of the 2023 Annual Report.Should one or more of these risks or uncertainties materialize  or should underlying assumptions prove incorrect  actual results and performance of the Companyâ€™s business may vary materially and adversely from the forward-looking statements described in this release. SBM Offshore does not intend and does not assume any obligation to update any industry information or forward-looking statements set forth in this release to reflect new information  subsequent events or otherwise.This release contains certain alternative performance measures (APMs) as defined by the ESMA guidelines which are not defined under IFRS. Further information on these APMs is included in the Half-Year Management Report accompanying the Half Year Earnings 2024 report  available on our website https://www.sbmoffshore.com/investors/financial-disclosures.Nothing in this release shall be deemed an offer to sell  or a solicitation of an offer to buy  any securities. The companies in which SBM Offshore N.V. directly and indirectly owns investments are separate legal entities. In this release â€œSBM Offshoreâ€ and â€œSBMâ€ are sometimes used for convenience where references are made to SBM Offshore N.V. and its subsidiaries in general. These expressions are also used where no useful purpose is served by identifying the particular company or companies.""SBM OffshoreÂ®""  the SBM logomark  â€œFast4WardÂ®â€  â€œemissionZEROÂ®â€ and â€œF4WÂ®â€ are proprietary marks owned by SBM Offshore.1 Based on the foreign exchange rate on February 20  2025Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.04,0.95,True,English,"['repurchase program transaction details', 'Weekly share', 'Average Purchase Price Settlement Amount', 'EUR141 million share repurchase program', 'Overall progress Share Repurchase Program', 'Cumulative Average Repurchase Price', 'First Quarter 2025 Trading Update', 'Third Quarter 2025 Trading Update', 'EU Market Abuse Regulation', 'Financial Calendar Date Year', 'Investor Relations Manager Mobile', 'current share repurchase program', 'SBM Offshore N.V.', 'Half Year Earnings 2024 report', 'Cumulative Repurchase Amount', 'Total Repurchase Amount', '1) share repurchase program', 'last 5 trading days', 'employee share programs', 'Cumulative Quantity Repurchased', 'Trade Date Quantity', 'deepwater ocean-infrastructure expert', 'efficient energy production', 'offshore floating facilities', '2026 Annual General Meeting', 'Half-Year Management Report', 'Opportunity Managementâ€™ section', 'alternative performance measures', 'other forward-looking statements', 'Such forward-looking statements', '2023 Annual Report', 'share capital', 'regular update', 'Start Date', 'Full Year', 'current views', 'top half', 'Media Relations', 'External Relations', 'regular management', 'daily basis', 'Investors section', 'Euronext Amsterdam', 'CBOE DXE', 'Corporate Profile', 'pivotal role', 'new markets', 'blue economy', 'innovative solutions', 'responsible partner', 'sustainable future', 'ocean protection', 'Corporate Finance', 'historical facts', 'future expectations', 'actual results', 'similar expressions', 'future operations', 'ESMA guidelines', 'unknown risks', 'various risks', 'principal risks', 'underlying assumptions', 'subsequent events', 'detailed information', 'industry information', 'new information', 'transaction details', 'individual transactions', 'press release', 'Wouter Holties', 'Giampaolo Arghittu', 'Further information', '2025 Earnings', 'April', 'period', 'repurchases', 'February', 'objective', 'addition', 'shares', 'aggregate', 'table', 'Company', 'website', 'Percentage', 'Overview', 'Turquoise', 'nr', 'world', 'design', 'construction', 'installation', 'transition', 'core', 'More', '7,800 SBMers', 'sbmoffshore', 'May', 'November', 'mail', 'Head', 'Phone', 'inside', 'meaning', 'Article', 'Disclaimer', 'uncertainties', 'words', 'business', 'obligation', 'APMs', 'IFRS', 'financial-disclosures', 'Nothing', 'offer', '31']",2025-04-30,2025-05-01,globenewswire.com
50421,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071167/0/en/Press-Release-Sanofi-and-CD-R-close-Opella-transaction-create-global-consumer-healthcare-leader.html,Press Release: Sanofi and CD&R close Opella transaction  create global consumer healthcare leader,Sanofi and CD&R close Opella transaction  create global consumer healthcare leader  Paris  April 30  2025. Opella today becomes an independent...,Sanofi and CD&R close Opella transaction  create global consumer healthcare leaderParis  April 30  2025. Opella today becomes an independent global leader in consumer healthcare  marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R of a 50.0% controlling stake of its consumer healthcare business Opella. Sanofi retains a significant shareholding of Opella with a 48.2% stake. Bpifrance will own a 1.8% stake in Opella and will join the Board. The transaction was completed on the terms previously disclosed. Sanofi has received total net cash proceeds of around â‚¬10 billion.Sanofi is now a pure-play biopharma  strategically focused on pushing the boundaries of science and leveraging cutting-edge research to deliver breakthrough medicines and vaccines.Paul HudsonChief Executive Officer  Sanofiâ€œWe have full confidence in Opellaâ€™s future as a new independent champion. Built on the strength of its talented teams  deep consumer understanding  and international reach  Opella is perfectly positioned for long-term success. With the support of CD&Râ€”renowned for its expertise in the consumer and healthcare sectors and its commitment to people  communities  and sustainability  Opella is ready to grow and thrive. This new chapter marks the beginning of a promising journey for a company we believe in deeply.â€Eric RouzierPartner and Head of European Healthcare  CD&Râ€œThis is an exciting opportunity for CD&R to support Opella in building a French headquartered  global consumer health champion. Opella stands out through the strength of its brands and the expertise of its people. CD&R brings complementary experience in the consumer health sector  along with operational insight and long-term capital  to help accelerate Opellaâ€™s growth. We are committed to supporting Opellaâ€™s continued development  both in France and abroad and to better serving employees  consumers  and patients alike.â€Julie Van OngevallePresident and Chief Executive Officer  Opellaâ€œReaching this milestone is an exciting moment in Opella's journey. Through significant transformations  we have become one of the largest global players in our sector  bringing innovation to over half a billion consumers worldwide. We are ready to unlock Opellaâ€™s full potential  drive value creation  and leverage our teams' exceptional talent to become a leader in the fast-moving consumer healthcare space.â€Headquartered in France  Opella employs over 11 000 talented and passionate people  operates in 100 countries with 13 best-in-class and strategic manufacturing sites and four science and innovation development centers. With a portfolio of iconic brands  such as Allegra  Doliprane  and Dulcolax  Opella is already the third-largest business worldwide in the over-the-counter and vitamins  minerals & supplements market (OTC & VMS)  serving more than half a billion consumers worldwide. Opella operates in a fast-growing industry driven by sustainable long-term trends  such as an aging population  rising income levels  and greater health and well-being awareness.About SanofiWe are an innovative global healthcare company  driven by one purpose: we chase the miracles of science to improve peopleâ€™s lives. Our team  across the world  is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally  while putting sustainability and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.Media RelationsSandrine Guendoul | +33 6 25 09 14 25 | sandrine.guendoul@sanofi.comVictor Rouault | +33 6 70 93 71 40 | victor.rouault@sanofi.comLÃ©o Le Bourhis | +33 6 75 06 43 81 | leo.lebourhis@sanofi.comLÃ©a Ubaldi | +33 6 30 19 66 46 | lea.ubaldi@sanofi.comEvan Berland | +1 215 432 0234 | evan.berland@sanofi.comTimothy Gilbert | +1 516 521 2929 | timothy.gilbert@sanofi.comInvestor RelationsThomas Kudsk Larsen | +44 7545 513 693 | thomas.larsen@sanofi.comAlizÃ© Kaisserian | +33 6 47 04 12 11 | alize.kaisserian@sanofi.comFelix Lauscher | +1 908 612 7239 | felix.lauscher@sanofi.comKeita Browne | +1 781 249 1766 | keita.browne@sanofi.comNathalie Pham | +33 7 85 93 30 17 | nathalie.pham@sanofi.comTarik Elgoutni | +1 617 710 3587 | tarik.elgoutni@sanofi.comThibaud ChÃ¢telet | +33 6 80 80 89 90 | thibaud.chatelet@sanofi.comYun Li | +33 6 84 00 90 72 | yun.li3@sanofi.comForward-looking statementsThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995  as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions  statements regarding plans  business transformations  objectives  intentions  and expectations with respect to future financial results  events  operations  services  product development and potential  and statements regarding future performance. Forward-looking statements are generally identified by the words â€œexpectsâ€  â€œanticipatesâ€  â€œbelievesâ€  â€œintendsâ€  â€œestimatesâ€  â€œplansâ€  â€œpotentialâ€  â€œoutlookâ€  â€œguidanceâ€ and similar expressions. Although Sanofiâ€™s management believes that the expectations reflected in such forward-looking statements are reasonable  investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties  many of which are difficult to predict and generally beyond the control of Sanofi  that could cause actual results and developments to differ materially from those expressed in  or implied or projected by  the forward-looking information and statements. These risks and uncertainties include among other things  those inherent in research and development  future clinical data and analysis  including post marketing  decisions by regulatory authorities  such as the FDA or the EMA  regarding whether and when to approve any drug  device or biological application as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates  the fact that product candidates if approved may not be commercially successful  the future approval and commercial success of therapeutic alternatives  Sanofiâ€™s ability to benefit from external growth opportunities  to complete related transactions and/or obtain regulatory clearances  risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation  trends in exchange rates and prevailing interest rates  volatile economic and market conditions  cost containment initiatives and subsequent changes thereto  and the impact that global crises may have on us  our customers  suppliers  vendors  and other business partners  and the financial condition of any one of them  as well as on our employees and on the global economy as a whole. More specifically regarding the transaction described above  these risks and uncertainties include among other things the possibility that the expected strategic benefits  synergies or opportunities from the transaction may not be realized  or may take longer to realize than expected  or potential adverse reactions to the proposed transaction by customers  suppliers  strategic partners or key Sanofi or Opella employees. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi  including those listed under â€œRisk Factorsâ€ and â€œCautionary Statement Regarding Forward-Looking Statementsâ€ in Sanofiâ€™s annual report on Form 20-F for the year ended December 31  2024. Other than as required by applicable law  Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.All trademarks mentioned in this press release are the property of the Opella group.Attachment,neutral,0.03,0.97,0.0,mixed,0.64,0.25,0.11,True,English,"['global consumer healthcare leader', 'Press Release', 'CD&R', 'Opella transaction', 'Sanofi', 'Private Securities Litigation Reform Act', 'Paul Hudson Chief Executive Officer', 'total net cash proceeds', 'Julie Van Ongevalle President', 'LÃ©o Le Bourhis', 'half a billion consumers', 'moving consumer healthcare space', 'global consumer health champion', 'innovative global healthcare company', 'global consumer healthcare leader', 'independent global leader', 'LÃ©a Ubaldi', 'largest global players', 'new independent champion', 'deep consumer understanding', 'Eric Rouzier Partner', 'strategic manufacturing sites', 'rising income levels', 'life-changing treatment options', 'life-saving vaccine protection', 'consumer healthcare business', 'sustainable long-term trends', 'consumer health sector', 'Thibaud ChÃ¢telet', 'future financial results', 'innovation development centers', 'Thomas Kudsk Larsen', 'healthcare sectors', 'European Healthcare', 'greater health', 'largest business', 'new chapter', 'long-term success', 'long-term capital', 'continued development', 'business transformations', 'product development', 'CD&R', 'pivotal step', 'significant shareholding', 'pure-play biopharma', 'cutting-edge research', 'breakthrough medicines', 'full confidence', 'international reach', 'exciting opportunity', 'French headquartered', 'complementary experience', 'operational insight', 'exciting moment', 'significant transformations', 'value creation', 'exceptional talent', 'supplements market', 'growing industry', 'aging population', 'well-being awareness', 'one purpose', 'social responsibility', 'Media Relations', 'Investor Relations', 'press release', 'historical facts', 'underlying assumptions', 'future perf', 'talented teams', 'promising journey', 'full potential', 'iconic brands', 'Evan Berland', 'AlizÃ© Kaisserian', 'Yun Li', 'Forward-looking statements', '50.0% controlling stake', 'four science', 'passionate people', 'Sandrine Guendoul', 'Victor Rouault', 'Timothy Gilbert', 'Felix Lauscher', 'Keita Browne', 'Nathalie Pham', 'Tarik Elgoutni', 'Opella transaction', '11,000 talented', '48.2% stake', '1.8% stake', 'Sanofi', 'Paris', 'April', 'strategy', 'closing', 'sale', 'Bpifrance', 'Board', 'terms', 'boundaries', 'vaccines', 'strength', 'support', 'expertise', 'commitment', 'communities', 'sustainability', 'beginning', 'growth', 'employees', 'patients', 'milestone', 'fast', '100 countries', 'class', 'portfolio', 'Allegra', 'Doliprane', 'Dulcolax', 'counter', 'vitamins', 'minerals', 'OTC', 'VMS', 'miracles', 'lives', 'world', 'practice', 'millions', 'ambitions', 'EURONEXT', 'NASDAQ', 'SNY', 'leo', 'lebourhis', 'alize', 'chatelet', 'projections', 'estimates', 'plans', 'objectives', 'intentions', 'expectations', 'respect', 'events', 'operations', 'services', '13']",2025-04-30,2025-05-01,globenewswire.com
50422,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071734/0/en/Tonner-Drones-publishes-its-Annual-Results-2024.html,Tonner Drones publishes its Annual Results 2024,Tonner Drones publishes its Annual Results 2024   Schiltigheim  April 30th  2025  20:00  Tonner Drones (â€™the Companyâ€™) publishes today its annual...,"Tonner Drones publishes its Annual Results 2024Schiltigheim  April 30th  2025  20:00  Tonner Drones (â€™the Companyâ€™) publishes today its annual results and annual report.2024 was marked by reorganization and refinancingMajority of losses caused by one-off costs and depreciationStrong reduced operational costsThe company was able to reduce and close the number of lawsuits and litigations. Tonner Drones finally says goodbye to the past.Tonner Drones was able to maintain its most valuable assets with stakes in French private drone companies Elistair and Donecle.The Companyâ€™s main focus is now to commercialize Countbot and InhibitorNegative equity caused by depreciations. Recovery plan to be installed.Q1 2025 already showed strong cash inflow and strengthened balance sheetThe company has obtained legal advice from a renowned firm on the new cash management and advisory strategy. The same firm is analyzing Tonner Drones' tax situation.The Company continues its discussions with various parties for collaboration within her stock-market-listing. Management will only enter into a partnership if it creates significant value for current shareholders.Full annual report can be consulted on the financial website of Tonner Drones.CEO to continue to support the company. He continued to invest in Q1 2025. He has waived its management fee for 2025 and is the reference shareholder of the company.2024 was an eventful year. Although the year (2024) was much better than the year before (2023)  turnover decreased to 119k euros (2023: 1 081k euro). Operational costs improved significantly to 3 281k euros (2023: 8 481k euro). Many of these costs were one-off costs and will not recur in 2025. The aim is to ultimately reduce operational costs to â‚¬20 000 - â‚¬25 000 per month in 2025. The one-off costs consisted of costs for the rights issue (April 2024)  legal costs and significant depreciation on investments and inventory. The total loss amounted to 5 639k euros (2023: 10 749k euro).The cash position was â‚¬341k (2023: â‚¬61k) on 31-12-2024 and increased to â‚¬1 655k on 31-03-2025 (unaudited). Negative Equity of 5.587k euro was caused by the strategy of high depreciation and low valued assets on the balance sheet. A recovery plan will be made to recover the negative equity situation. the company has 2 years to succeed in this. Equity has already improved in Q1 2025 because of the positive inflow of capital and therefore strong cash position. One of the possibilities could be to consider selling assets (such as Elistair and Donecle) in the next two years. This could bring the equity back in the positive.The company has good expectations for its â€˜Countbotâ€™ solution. Tonner Drones is currently outsourcing R&D and it is intensively working together with the â€˜fatherâ€™ of the product. The trend in the automation of warehouses continues. Tonner Drones is positively surprised about the interest in Countbot  even though the company has yet to advertise the product at all. The Countbot could generate revenue in 2025 for the Company. Because Tonner Drones does not want to develop the â€˜Inhibitorâ€™ itself  it is looking for partners who want to invest in the product or use the patents. Although the company cannot give any guarantees about the success of this  it notes that there is currently a strong dynamic in Europe in the field of defense and drones.Tonner Drones holdings in Elistair  Donecle and Diodon could also benefit from this trend. Tonner Drones therefore continues to have high expectations for the future performance and value of these companies. Tonner Drones holds between 5 and 12% stakes in the three companies. The value of these holdings on the company's balance sheet is low. When Tonner Drones is able to sell shares of these holdings  then the real value will become visible.Tonner Drones received a mandate from shareholders in October to expand its activities. After legal advice  Tonner Drones will  for now  mainly focus on actively managing its treasury. Because the company is actively looking at possible collaborations or RTOs in the future  the company is currently having its tax situation investigated. Given the many changes within the company in the last 2 years  the situation regarding the carry forward losses needs to be analyzed. Ultimately  it will be the tax authorities who determine whether past losses can be used.Finally  Tonner Drones believes it can create value for shareholders by entering partnerships with other companies. The company's stock exchange listing is a major asset. The measures taken in 2024 have made the company even more attractive. The increased cash position and market capitalization in Q1 also works in Tonner Drones' favor. Tonner Drones is currently analyzing various options  but a collaboration will only be started if significant value can be created for shareholders.For a comprehensive report of 2024  shareholders are advised to read the full annual report. This annual report can be found on the company's website.â€œGiven the developments in 2024  the results for last year cannot come as a surprise. â€œAlso for me  2024 wasnâ€™t always a pleasant year. There were intense periods  and we had to fight a lot of fires.â€ Diede van den Ouden  CEO  said. â€œBut since 2025 the situation has changed  we are looking forward to options to grow the business again. Also  thanks to the support provided by our shareholders  we have created the right conditions to start creating value. Iâ€™m enthousiastic about the future  and I will do whatever is in my power to bring success to the company. Not only because Iâ€™m heavily invested  but it has also become a matter of honour to build this company  to make a success of this company which previously had one of the worst reputations on the French stock exchange.â€End of Press-Release.About Tonner Drones : Tonner Drones develops technologies for the logistics sector. Tonner Drones holds valuable stakes in some promising French drone manufacturers like Elistair and Donecle. Tonner Dronesâ€™ strategy is to increase the value of its shareholdings in these companies through active asset management. Additional revenues can be achieved through royalties from patents held by Tonner Drones. Tonner Drones does not plan on owning a factory; however  it is determined to retain R&D for its products and systems in France. Tonner Drones uses an active strategy to manage its treasury.Tonner Dronesâ€™ shares are listed on Euronext Growth Paris (ISIN code: FR001400H2X4).More information at www.tonnerdrones.com / contact@tonnerdrones.comWarningRegarding the merits of any transaction or the making of any investment decision. It does not constitute or include any confirmation or commitment by Tonner Drones (or any other person) regarding the present or future value of Tonner Drones ' business  its securities  its subsidiaries or any other assets of Tonner Drones .This press release contains forward-looking statements based on current beliefs and expectations regarding future events. These forward-looking statements may include projections and estimates and their underlying assumptions  statements regarding plans  objectives  intentions and/or expectations regarding future financial results  events  operations and services. and product development  as well as statements regarding performance or events. These statements are generally identified by the terms ""expect""  ""anticipate""  ""believe""  ""intend""  ""estimate""  ""plan""  ""project""  ""may""  ""should"" or the negative form of these and other similar expressions. These statements are not guarantees of future performance and are subject to inherent risks  uncertainties and assumptions regarding Tonner Drones and its subsidiaries and investments  trends in their businesses  future capital expenditures and acquisitions  developments relating to contingent liabilities  changes in global economic conditions or Tonner Drones ' principal markets  competitive market conditions and regulatory factors. The realization of these events is uncertain; their outcome could turn out to be different from that envisaged today  which is likely to significantly affect the expected results. Actual results may differ materially from those anticipated or implied in these forward-looking statements. Any forward-looking statements contained in this press release are made as of the date of this press release. Except as required by applicable law  Tonner Drones undertakes no obligation to revise or update any forward-looking statements  taking into account new information or future events.Attachment",neutral,0.0,1.0,0.0,mixed,0.3,0.26,0.43,True,English,"['Tonner Drones', 'Annual Results', 'French private drone companies', 'Strong reduced operational costs', ""Tonner Drones' tax situation"", 'stock exchange listing', 'strong cash inflow', 'low valued assets', 'next two years', 'strong cash position', 'Full annual report', 'new cash management', ""Tonner Drones' favor"", 'negative equity situation', 'Tonner Drones holdings', 'strong dynamic', 'tax authorities', 'comprehensive report', 'three companies', 'other companies', 'Annual Results', 'valuable assets', 'main focus', 'Recovery plan', 'balance sheet', 'legal advice', 'renowned firm', 'same firm', 'various parties', 'management fee', 'reference shareholder', '119k euros', '3,281k euros', 'rights issue', 'total loss', '5,639k euros', '5.587k euro', 'positive inflow', 'good expectations', 'R&D', 'high expectations', 'possible collaborations', 'many changes', 'last 2 years', 'major asset', 'market capitalization', 'various options', 'one-off costs', 'legal costs', 'significant depreciation', 'high depreciation', 'April 30th', 'advisory strategy', 'significant value', 'financial website', 'eventful year', 'Countbotâ€™ solution', 'The Countbot', 'future performance', 'real value', 'last year', 'current shareholders', 'The Company', 'past losses', 'Schiltigheim', 'reorganization', 'refinancing', 'Majority', 'number', 'lawsuits', 'litigations', 'goodbye', 'stakes', 'Elistair', 'Donecle', 'Inhibitor', 'depreciations', 'Q1', 'discussions', 'stock-market-listing', 'partnership', 'CEO', 'turnover', '1,081k', '8,481k', 'aim', 'month', 'investments', 'inventory', '10,749k', 'possibilities', 'father', 'product', 'trend', 'automation', 'warehouses', 'interest', 'revenue', 'patents', 'guarantees', 'success', 'Europe', 'field', 'defense', 'Diodon', 'shares', 'mandate', 'October', 'activities', 'treasury', 'RTOs', 'carry', 'measures', 'developments', '2024']",2025-04-30,2025-05-01,globenewswire.com
50423,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070991/0/en/Stellantis-Reports-Q1-2025-Net-Revenues-and-Shipments.html,Stellantis Reports Q1 2025 Net Revenues and Shipments,Stellantis Reports Q1 2025 Net Revenues and Shipments  Net revenues of â‚¬35.8 billion  down 14% compared to Q1 2024 primarily due to lower shipment...,"Stellantis Reports Q1 2025 Net Revenues and ShipmentsNet revenues of â‚¬35.8 billion  down 14% compared to Q1 2024 primarily due to lower shipment volumes  as well as unfavorable mix and pricingConsolidated shipments (1) of 1 217 thousand units  down 9%   reflect lower North American production  a consequence of extended holiday downtime in January  product transition impacts and lower industry LCV volume s in Enlarged EuropeTotal new vehicle inventory of 1 210 thousand units (Company inventory of 333 thousand units) on March 31  2025  broadly in line with December 31  2024Commercial recovery actions included the launch of 3 all-new products and several updated nameplates in Q1 2025  contributing to increased EU30 market share compared to Q4 2024  and improvement in U.S. retail order volumesThe Company is suspending its 2025 financial guidance due to tariff-related uncertaintiesThe Company is highly engaged with policymakers on tariff policies  while taking action to reduce impactsOrdinary dividend of â‚¬0.68 per share was approved at AGM and will be distributed on May 5  2025The process to appoint the new permanent Chief Executive Officer is well underway and will be concluded within the first half of 2025""While Q1 2025 top-line results were below prior-year levels  other KPIs reflect early  initial progress on our commercial recovery efforts. North America is at a very early stage  with improvement in retail order intake  while we are seeing sequential improvement in EU30 market share. At the same time  the Company is benefiting from its diverse geographic footprint  as our ""Third Engine""(2) regions delivered in Q1 2025 positive year-on-year growth in aggregate.""Doug Ostermann  CFO Fiat Grande Panda HybridRESULTS FROM CONTINUING OPERATIONS SUSPENDING FY 2025 GUIDANCEDue to evolving tariff policies  as well as the difficulty predicting possible impacts on market volumes and the competitive landscape.Q1 2025Q1 2024ChangeCombined shipments (000 units) 1 233 1 371 (10)% Consolidated shipments (000 units) 1 217 1 335 (9)% Net revenues (â‚¬ billion) 35.8 41.7 (14)%____________________________________________________________________________________________________________________________________All reported data is unaudited. Reference should be made to the section â€œSafe Harbor Statementâ€ included elsewhere within this document.AMSTERDAM  April 30  2025 - Stellantis N.V. announced its Q1 2025 revenues and shipments today  reporting Net revenues of â‚¬35.8 billion  a 14% decrease compared to Q1 2024. This decline was primarily due to lower volume  adverse regional mix and price normalization. For the three months ending March 31  2025  consolidated shipments were 1 217 thousand units  a 9% decrease versus the same period in 2024. The reduction in shipments was mainly due to lower production in North America  resulting from an extended holiday downtime in January  as well as impacts of product transitions and decreased LCV volumes in Enlarged Europe.Update on Commercial Recovery ActionsDuring Q1 2025  the Company launched 3 all-new products planned for 2025: the all-new Fiat Grande Panda  Opel/Vauxhall Frontera and CitroÃ«n C3 Aircross. Additionally  the refreshed Opel/Vauxhall Mokka  Ram 2500 HD and Ram 3500 HD went on sale.the all-new Fiat Grande Panda  Opel/Vauxhall Frontera and CitroÃ«n C3 Aircross. Additionally  the refreshed Opel/Vauxhall Mokka  Ram 2500 HD and Ram 3500 HD went on sale. Market share in EU30 of 17.3% in Q1 2025  ro se by 1.9 percentage points compared to Q4 2024  benefiting from continued ramp-up and expanding availability of the CitroÃ«n C3/Ã«C3  Peugeot 5008 and Opel/Vauxhall Grandland  which launched in late 2024. The introduction of the CitroÃ«n C3 Aircross  Opel/Vauxhall Frontera and Fiat Grande Panda during Q1 2025 provides opportunities to increase shipments of B-segment vehicles in upcoming periods. Also  in Q1 2025  Stellantis became the leader in the hybrid segment and regained the second position in the BEV market with market shares of 15.5% and 13.0%  respectively.compared to Q4 2024  benefiting from continued ramp-up and expanding availability of the CitroÃ«n C3/Ã«C3  Peugeot 5008 and Opel/Vauxhall Grandland  which launched in late 2024. The introduction of the CitroÃ«n C3 Aircross  Opel/Vauxhall Frontera and Fiat Grande Panda during Q1 2025 provides opportunities to increase shipments of B-segment vehicles in upcoming periods. Also  in Q1 2025  Stellantis became the leader in the hybrid segment and regained the second position in the BEV market with market shares of 15.5% and 13.0%  respectively. In the U.S.  stabilization of retail share with a >10% y-o-y retail sales increase in the JeepÂ® Grand Cherokee and Compass  as well as the Ram 1500 and 2500. Further progress is expected from the expanded availability of specific light-duty truck trim levels  the successful launch of refreshed heavy-duty trucks  and enhanced sales and marketing efforts. In March 2025  new retail orders rose 82% compared to March 2024  hitting their highest monthly level since June 2023.Further progress is expected from the expanded availability of specific light-duty truck trim levels  the successful launch of refreshed heavy-duty trucks  and enhanced sales and marketing efforts. In March 2025  new retail orders rose 82% compared to March 2024  hitting their highest monthly level since June 2023. Continued strong revenue dynamics from the Third Engine(2). In South America  the Company maintained its leading position  with market share of 23.8%  an increase of 1.5 percentage points from Q4 2024  due to the improvement of Stellantis' brands performance in Brazil  Chile and especially Argentina where the market is recovering following the easing of import restrictions. The Middle East & Africa region  while facing import restrictions in some countries  continues to focus on its localization efforts that are expected to enable improved volumes in several markets in the mid-term.Responding to tariff actions to safeguard the CompanyProtecting the Company while engaging extensively with relevant governments to facilitate informed implementation and evolution of policies. At the same time  management is taking action to adjust production plans  and identifying opportunities for improved sourcing.Innovations driving the Company forwardIntroduction of STLA AutoDrive 1.0  Stellantis' proprietary automated driving system  delivers Hands-Free and Eyes-Off (SAE Level 3) functionality. AutoDrive supports automated driving at speeds up to 60 km/h (37 mph) and is a crucial component of Stellantisâ€™ technology strategy alongside STLA Brain and STLA SmartCockpit  advancing vehicle intelligence  automation and user experience.Stellantis' proprietary automated driving system  delivers Hands-Free and Eyes-Off (SAE Level 3) functionality. AutoDrive supports automated driving at speeds up to 60 km/h (37 mph) and is a crucial component of Stellantisâ€™ technology strategy alongside STLA Brain and STLA SmartCockpit  advancing vehicle intelligence  automation and user experience. Stellantis and Mistral AI strengthened their strategic partnership to enhance vehicle development and manufacturing and customers' in-car experience  including the development of an AI-powered in-car assistant that allows drivers to interact with their vehicles using natural language.UPCOMING EVENTS:First Half 2025 Results - July 24  2025; Third Quarter Shipments & Revenues - October 30  2025On April 30  2025  at 1:00 p.m. CEST / 7:00 a.m. EDT  a live webcast and conference call will be held to present Stellantis' First Quarter 2025 Shipments and Revenues  with the presentation expected to be posted at approximately 8:00 a.m. CEST / 2:00 a.m. EDT. The webcast and recorded replay will be accessible under the Investors section of the Stellantis corporate website ( www.stellantis.com ).About StellantisStellantis N.V. (NYSE: STLA / Euronext Milan: STLAM / Euronext Paris: STLAP) is a leading global automaker  dedicated to giving its customers the freedom to choose the way they move  embracing the latest technologies and creating value for all its stakeholders. Its unique portfolio of iconic and innovative brands includes Abarth  Alfa Romeo  Chrysler  CitroÃ«n  Dodge  DS Automobiles  FIAT  JeepÂ®  Lancia  Maserati  Opel  Peugeot  Ram  Vauxhall  Free2move and Leasys. For more information  visit www.stellantis.com .SEGMENT PERFORMANCENORTH AMERICA Q1 2025 Q1 2024 Change Shipments down 20%  reflecting lower Jan production  a consequence of extended holiday downtime  initial ramp up of updated 2025 Ram HD trucks and continued gaps from discontinued modelsdown 20%  reflecting lower Jan production  a consequence of extended holiday downtime  initial ramp up of updated 2025 Ram HD trucks and continued gaps from discontinued models Net revenues down 25%  primarily due to lower volumes and mix  as well as negative net pricing from increased incentivesShipments (000s) 325 407 (82) Net revenues (â‚¬ million) 14 416 19 291 (4 875)ENLARGED EUROPE Q1 2025 Q1 2024 Change Shipments down 8%  mostly due to transition gaps in certain A and B-segment vehicles replacing prior-generation products discontinued at the end of H1 2024  as well as a decline in LCV volumesdown 8%  mostly due to transition gaps in certain A and B-segment vehicles replacing prior-generation products discontinued at the end of H1 2024  as well as a decline in LCV volumes Net revenues down 3%  due to lower shipment volumes and increased incentives  partially offset by positive nameplate and energy mix impactsShipments (000s) 567 615 (48) Net revenues (â‚¬ million) 13 565 14 051 (486)MIDDLE EAST & AFRICA Q1 2025 Q1 2024 Change Consolidated shipments down 15%  mostly driven by the impact of import restrictions in some countriesdown 15%  mostly driven by the impact of import restrictions in some countries Net revenues down 15%  due to lower volumes and translation effects mainly related to the Turkish Lira  partially offset by positive pricing and market mix impactsCombined shipments (000s)(1) 116 154 (38) Consolidated shipments (000s)(1) 100 118 (18) Net revenues (â‚¬ million) 2 280 2 687 (407)SOUTH AMERICA Q1 2025 Q1 2024 Change Shipments up 19%  maintained >23% market share in South America while benefiting from higher industry volumes  especially in Brazil and Argentinaup 19%  maintained >23% market share in South America while benefiting from higher industry volumes  especially in Brazil and Argentina Net revenues up 6%  primarily due to increased volumes and positive mix  partially offset by negative translation effects from Brazilian Real and Argentine PesoShipments (000s) 211 177 +34 Net revenues (â‚¬ million) 3 678 3 466 +212CHINA AND INDIA & ASIA PACIFIC Q1 2025 Q1 2024 Change Consolidated shipments down 20%  driven by continued pressure in the region and an increased focus on reducing current inventory stock levels in Chinadown 20%  driven by continued pressure in the region and an increased focus on reducing current inventory stock levels in China Net revenues down 15%  due to lower shipment volumes  partially offset by higher market mix in Australia  New Zealand and South Korea.Combined shipments (000s)(1) 12 15 (3) Consolidated shipments (000s)(1) 12 15 (3) Net revenues (â‚¬ million) 447 525 (78)MASERATI Q1 2025 Q1 2024 Change Shipments down 48%  mainly due to reduced demand as well as significantly reduced product portfoliodown 48%  mainly due to reduced demand as well as significantly reduced product portfolio Net revenues down 50%  primarily due to lower volumes as well as pricing actions to help reduce and reposition North America inventoryShipments (000s) 1.7 3.3 (1.6) Net revenues (â‚¬ million) 157 313 (156)ReconciliationsNet revenues from external customers to Net revenues2025 (â‚¬ million) NORTH AMERICA ENLARGED EUROPE MIDDLE EAST & AFRICA SOUTH AMERICA CHINA AND INDIA & ASIA PACIFIC MASERATI OTHER(*) STELLANTIS Net revenues from external customers 14 416 13 522 2 274 3 667 446 157 1 331 35 813 Net revenues from transactions with other segments â€” 43 6 11 1 â€” (61) â€” Net revenues 14 416 13 565 2 280 3 678 447 157 1 270 35 813___________________________________________________________________________________________________________________(*) Other activities  unallocated items and eliminations2024 (â‚¬ million) NORTH AMERICA ENLARGED EUROPE MIDDLE EAST & AFRICA SOUTH AMERICA CHINA AND INDIA & ASIA PACIFIC MASERATI OTHER(*) STELLANTIS Net revenues from external customers 19 290 13 985 2 687 3 476 524 312 1 423 41 697 Net revenues from transactions with other segments 1 66 â€” (10) 1 1 (59) â€” Net revenues 19 291 14 051 2 687 3 466 525 313 1 364 41 697___________________________________________________________________________________________________________________(*) Other activities  unallocated items and eliminationsNOTES(1) Combined shipments include shipments by the Company's consolidated subsidiaries and unconsolidated joint ventures  whereas Consolidated shipments only include shipments by the Company's consolidated subsidiaries. This includes the vehicles produced by our joint ventures and associates (including Leapmotor) which are distributed by our consolidated subsidiaries. In addition to the volumes included in consolidated shipments  combined shipments also includes the vehicles distributed by our joint ventures (such as Tofas). Figures by segments may not add up due to rounding.(2) Refers to the aggregation of the South America  Middle East & Africa and China and India & Asia Pacific segments for presentation purposes only.Rankings  market share and other industry information are derived from third-party industry sources (e.g. Agence Nationale des Titres SÃ©curisÃ©s (ANTS)  AssociaÃ§Ã£o Nacional dos Fabricantes de VeÃ­culos Automotores (ANFAVEA)  Ministry of Infrastructure and Sustainable Mobility (MIMS)  S&P Global  Wardâ€™s Automotive) and internal information unless otherwise stated.For purposes of this document  and unless otherwise stated industry and market share information are for passenger cars (PC) plus light commercial vehicles (LCV)  except as noted below:Enlarged Europe excludes Russia and Belarus. From 2025  this includes Israel and Palestine (prior periods have not been restated);Middle East & Africa excludes Iran  Sudan and Syria. From 2025  this excludes Israel and Palestine (prior periods have not been restated);South America excludes Cuba;India & Asia Pacific reflects aggregate for major markets where Stellantis competes (Japan (PC)  India (PC)  South Korea (PC + Pickups)  Australia  New Zealand and South East Asia);China represents PC only and includes licensed sales from DPCA; andMaserati reflects aggregate for 17 major markets where Maserati competes and is derived from S&P Global data  Maserati competitive segment and internal information.Prior period figures have been updated to reflect current information provided by third-party industry sources.EU30 = EU 27 (excluding Malta)  Iceland  Norway  Switzerland and UK.Low emission vehicles (LEV) = battery electric (BEV)  plug-in hybrid (PHEV)  range-extender electric vehicle (REEV) and fuel cell electric (FCEV) vehicles.All Stellantis reported BEV and LEV sales include CitroÃ«n Ami  Opel Rocks-e and Fiat Topolino; in countries where these vehicles are classified as quadricycles  they are excluded from Stellantis reported combined sales  industry sales and market share figures.Adjusted operating income/(loss) excludes from Net profit/(loss) from continuing operations adjustments comprising restructuring and other termination costs  impairments  asset write-offs  disposals of investments and unusual operating income/(expense) that are considered rare or discrete events and are infrequent in nature  as inclusion of such items is not considered to be indicative of the Company's ongoing operating performance  and also excludes Net financial expenses/(income) and Tax expense/(benefit).Unusual operating income/(expense) are impacts from strategic decisions  as well as events considered rare or discrete and infrequent in nature  as inclusion of such items is not considered to be indicative of the Company's ongoing operating performance. Unusual operating income/(expense) includes  but may not be limited to: impacts from strategic decisions to rationalize Stellantis' core operations; facility-related costs stemming from Stellantis' plans to match production capacity and cost structure to market demand  and convergence and integration costs directly related to significant acquisitions or mergers.Adjusted operating income/(loss) margin is calculated as Adjusted operating income/(loss) divided by Net revenues.SAFE HARBOR STATEMENTThis document  in particular references to â€œFY 2025 Guidanceâ€  contains forward looking statements. Statements regarding future financial performance and the Companyâ€™s expectations as to the achievement of certain targeted metrics  including revenues  industrial free cash flows  vehicle shipments  capital investments  research and development costs and other expenses at any future date or for any future period are forward-looking statements. These statements may include terms such as â€œmayâ€  â€œwillâ€  â€œexpectâ€  â€œcouldâ€  â€œshouldâ€  â€œintendâ€  â€œestimateâ€  â€œanticipateâ€  â€œbelieveâ€  â€œremainâ€  â€œon trackâ€  â€œdesignâ€  â€œtargetâ€  â€œobjectiveâ€  â€œgoalâ€  â€œforecastâ€  â€œprojectionâ€  â€œoutlookâ€  â€œprospectsâ€  â€œplanâ€  or similar terms. Forward-looking statements are not guarantees of future performance. Rather  they are based on the Companyâ€™s current state of knowledge  future expectations and projections about future events and are by their nature  subject to inherent risks and uncertainties. They relate to events and depend on circumstances that may or may not occur or exist in the future and  as such  undue reliance should not be placed on them.Actual results may differ materially from those expressed in forward-looking statements as a result of a variety of factors  including: the Companyâ€™s ability to launch new products successfully and to maintain vehicle shipment volumes; the Companyâ€™s ability to attract and retain experienced management and employees; changes in trade policy  the imposition of global and regional tariffs or tariffs targeted to the automotive industry; changes in the global financial markets  general economic environment and changes in demand for automotive products  which is subject to cyclicality; the Companyâ€™s ability to successfully manage the industry-wide transition from internal combustion engines to full electrification and accurately predict the market demand for electrified vehicles; the Companyâ€™s ability to offer innovative  attractive products and to develop  manufacture and sell vehicles with advanced features including enhanced electrification  connectivity and autonomous-driving characteristics; the Companyâ€™s ability to produce or procure electric batteries with competitive performance  cost and at required volumes; the Companyâ€™s ability to successfully launch new businesses and integrate acquisitions; a significant malfunction  disruption or security breach compromising information technology systems or the electronic control systems contained in the Companyâ€™s vehicles; exchange rate fluctuations  interest rate changes  credit risk and other market risks; increases in costs  disruptions of supply or shortages of raw materials  parts  components and systems used in the Companyâ€™s vehicles; changes in local economic and political conditions; the enactment of tax reforms or other changes in tax laws and regulations; the level of governmental economic incentives available to support the adoption of battery electric vehicles; the impact of increasingly stringent regulations regarding fuel efficiency and greenhouse gas and tailpipe emissions; various types of claims  lawsuits  governmental investigations and other contingencies  including product liability and warranty claims and environmental claims  investigations and lawsuits; material operating expenditures in relation to compliance with environmental  health and safety regulations; the level of competition in the automotive industry  which may increase due to consolidation and new entrants; exposure to shortfalls in the funding of the Companyâ€™s defined benefit pension plans; the Companyâ€™s ability to provide or arrange for access to adequate financing for dealers and retail customers and associated risks related to the operations of financial services companies; the Companyâ€™s ability to access funding to execute its business plan; the Companyâ€™s ability to realize anticipated benefits from joint venture arrangements; disruptions arising from political  social and economic instability; risks associated with the Companyâ€™s relationships with employees  dealers and suppliers; the Companyâ€™s ability to maintain effective internal controls over financial reporting; developments in labor and industrial relations and developments in applicable labor laws; earthquakes or other disasters; and other risks and uncertainties.Any forward-looking statements contained in this document speak only as of the date of this document and the Company disclaims any obligation to update or revise publicly forward-looking statements. Further information concerning the Company and its businesses  including factors that could materially affect the Companyâ€™s financial results  is included in the Companyâ€™s reports and filings with the U.S. Securities and Exchange Commission and AFM.Attachment",neutral,0.0,1.0,0.0,mixed,0.28,0.22,0.5,True,English,"['Stellantis Reports Q1 2025 Net Revenues', 'Shipments', 'new permanent Chief Executive Officer', 'specific light-duty truck trim levels', 'CFO Fiat Grande Panda Hybrid', 'U.S. retail order volumes', 'CitroÃ«n C3 Aircross', 'CitroÃ«n C3/Ã«C', 'new Fiat Grande Panda', 'Total new vehicle inventory', 'Stellantis Reports Q1 2025 Net Revenues', 'lower industry LCV volume', 'lower North American production', 'retail order intake', 'new retail orders', 'Stellantis N.V.', 'lower shipment volumes', 'extended holiday downtime', 'Commercial recovery actions', 'diverse geographic footprint', 'Third Engine""(2) regions', 'Safe Harbor Statement', 'JeepÂ® Grand Cherokee', 'commercial recovery efforts', 'adverse regional mix', 'retail sales increase', 'early, initial progress', 'evolving tariff policies', 'product transition impacts', 'EU30 market share', 'Q1 2025 top-line results', 'lower volume', 'lower production', 'LCV volumes', 'prior-year levels', 'retail share', 'market volumes', 'hybrid segment', 'Company inventory', 'unfavorable mix', 'early stage', 'product transitions', 'Further progress', 'marketing efforts', 'BEV market', 'market shares', 'Q1 2025 revenues', 'Enlarged Europe', '2025 financial guidance', 'tariff-related uncertainties', 'Ordinary dividend', 'first half', 'other KPIs', 'same time', 'year growth', 'Doug Ostermann', 'CONTINUING OPERATIONS', 'FY 2025 GUIDANCE', 'competitive landscape', 'price normalization', 'three months', 'same period', 'Opel/Vauxhall Frontera', 'Opel/Vauxhall Mokka', '1.9 percentage points', 'expanding availability', 'Opel/Vauxhall Grandland', 'B-segment vehicles', 'upcoming periods', 'second position', 'expanded availability', 'heavy-duty trucks', 'Ram 2500 HD', 'Ram 3500 HD', 'possible impacts', '1,217 thousand units', '1,210 thousand units', '333 thousand units', 'The Company', 'successful launch', 'Consolidated shipments', 'Combined shipments', 'sequential improvement', '000 units', 'pricing', 'consequence', 'January', 'March', 'December 31', 'several', 'nameplates', 'Q4', 'policymakers', 'AGM', 'May', 'process', 'aggregate', 'difficulty', 'Change', 'data', 'Reference', 'section', 'document', 'AMSTERDAM', 'April', '14% decrease', 'decline', '9% decrease', 'reduction', 'Update', 'ramp-up', 'Peugeot', 'introduction', 'opportunities', 'leader', 'stabilization', 'Compass', '13.']",2025-04-30,2025-05-01,globenewswire.com
50424,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3071683/0/en/Convening-of-the-Annual-General-Meeting-to-approve-the-2024-financial-statements-to-be-held-on-June-13-2025-and-evolution-of-the-Atos-Board-of-Directors.html,Convening of the Annual General Meeting to approve the 2024 financial statements to be held on June 13  2025 and evolution of the Atos Board of Directors,Press Release  Convening of the Annual General Meeting to approve the 2024 financial statements to be held on June 13  2025 and evolution of the Atos...,Press ReleaseConvening of the Annual General Meeting to approve the 2024 financial statements to be held on June 13  2025 and evolution of the Atos Board of DirectorsParis  France â€“ April 30  2025Convening of the 2025 Annual General MeetingThe meeting notice (avis de rÃ©union) for the General Meeting scheduled for June 13  2025  containing the agenda  the draft resolutions  and the participation and voting procedures for this Meeting  will be published in the Official Legal Gazette (Bulletin des Annonces LÃ©gales Obligatoires - BALO) on May 5  2025  and will be available on the Companyâ€™s website (https://atos.net/en/investors/annual-general-meeting).Evolution of the composition of Atos Board of DirectorsOn the recommendation of the Nomination and Governance Committee  chaired by Lead Independent Director Elizabeth Tinkham  Atosâ€™ Board of Directors has endorsed a series of proposed changes to its composition to be submitted for approval at the General Meeting convened for June 13  2025. The proposed changes reflect the evolving needs identified by the Board and align with the Groupâ€™s ongoing transformation.It will be proposed to the vote of the shareholders at the Annual General Meeting:to renew the terms of office of FranÃ§oise Mercadal-Delasalles and Jean-Jacques Morin as directors  for a duration that will expire at the end of the General Meeting called to approve the financial statements for the fiscal year ending December 31  2027;and as directors  for a duration that will expire at the end of the General Meeting called to approve the financial statements for the fiscal year ending December 31  2027; to appoint Surojit Chatterjee as new independent director  for a duration that will expire at the end of the General Meeting called to approve the financial statements for the fiscal year ending December 31  2027; andas new independent director  for a duration that will expire at the end of the General Meeting called to approve the financial statements for the fiscal year ending December 31  2027; and to ratify the appointment of Mandy Metten as a censor  for a duration of one year expiring at the end of the General Meeting called to approve the financial statements for the fiscal year ending December 31  2025.The Board of Directors has also been informed that Elizabeth Tinkham has decided not to seek renewal of her term of office as director  which will expire at the end of the General Meeting of June 13  2025.Subject to approval of the proposed resolutions by the Annual General Meeting  the Board of Directors will comprise eight members (in addition to the director representing employees) and one censor  including 87.5%1 independent members (seven out of eight)  50%2 women and six nationalities3 represented on the Board.Philippe Salle  Chairman and Chief Executive Officer of Atos SE  declared:â€œI am pleased with the upcoming appointment of a highly qualified new director as well as the renewal of terms on our Board of Directors. These developments will support the continued effectiveness of the Board and help to strengthen its overall capabilities. I would also like to express my sincere appreciation to Elizabeth Tinkham for her commitment  which has contributed meaningfully to advancing our mission and shared visionâ€.* * *About FranÃ§oise Mercadal-DelasallesCofounder and President at Auxo  Coâ€‘chair of the National Digital Council (Conseil National du NumÃ©rique) and nonâ€‘executive Board Director  FranÃ§oise Mercadal-Delasalles was first appointed to the Board of Directors of Atos SE on January 2  2024  and currently chairs the CSR Committee and sits on the Remuneration Committee. Her experience at the intersection of senior public service and the private sector  along with her recognized expertise in digital transformation and sustainability issues  are valuable assets to the work of the Board.Biography of FranÃ§oise Mercadal-DelasallesFranÃ§oise Mercadalâ€‘Delasalles began her career in senior public service at the Ministry of the Economy and Finance from 1988 to 1992  then at the Caisse des DÃ©pÃ´ts from 2002 to 2008. Appointed Director of Resources and Innovation at SociÃ©tÃ© GÃ©nÃ©rale in 2008  she sat on the Group's Executive Committee and steered its digital transition project. In 2018  FranÃ§oise Mercadal-Delasalles became CEO of CrÃ©dit du Nord  where she introduced digital tools to position the Group in new banking services and integrated ecological concerns into the company's business model. In 2023  she co-founded Auxo  an integrated platform to manage extra-financial data and support companies in their transition to sustainability.FranÃ§oise Mercadal-Delasalles holds various non-executive positions on boards of directors and supervisory boards  notably that of Eurazeo. She has co-chaired the Conseil National du NumÃ©rique since 2021. She is a Chevalier de la LÃ©gion d'Honneur (Knight of the Legion of Honor)  Officier du MÃ©rite (Officer of the Order of Merit) and Chevalier du MÃ©rite Agricole (Knight of the Order of Agricultural Merit).FranÃ§oise Mercadal-Delasalles holds a degree in literature and law  and is a graduate of the Institut d'Ã‰tudes Politiques (IEP) de Paris  Sciences Po Paris and the Ã‰cole Nationale d'Administration (ENA).* * *About Jean-Jacques MorinDeputy CEO of the Accor Group and CEO of the Premium  Midscale & Economy Division  Jean-Jacques Morin was first appointed to the Atos SE Board of Directors on January 2  2024  and currently chairs the Audit Committee. His strong financial background and strategic insight are major assets in helping Atos meet its current challenges  and he would continue to bring his valuable expertise and leadership to the Boardâ€™s work.Biography of Jean-Jacques MorinJean-Jacques Morin began his professional career with Deloitte  where he spent five years in auditing and consulting roles in Paris and Montreal. From 1992 to 2005  he held various international positions  notably in the semiconductor sector with Motorola Semiconductors (USA  Switzerland  and France)  ON Semiconductor (USA) and Communicant AG  a start-up in Berlin. In 2005  Jean-Jacques Morin joined Alstom as CFO of the Power sectors in Zurich  then in Transport  before being appointed Group CFO from 2013 to 2015. In 2015  Jean-Jacques Morin joined Accor's Executive Committee as CFO. He is then appointed Group Deputy CEO in charge of Finance  Strategy  IT  Legal  Purchasing and Communications. In June 2023  in addition to his position as Group Deputy CEO  Jean-Jacques Morin took over the Premium  Midscale & Economy Division under his leadership  as CEO of the Division.Jean-Jacques Morin has held various non-executive positions  including with Orbis from 2016 to 2020 as a member of the Supervisory Board and the Audit Committee  and with Vallourec from 2018 to 2021 as a member of the Supervisory Board and Chairman of the Finance and Audit Committee. He is currently Chairman of the Board of Directors of Adagio since 2022 and a member of the Board of Directors of AccorInvest since 2018. He was appointed Chairman of the Audit Committee of GROUPE REEL in 2024.Jean-Jacques Morin is a graduate of the Ã‰cole Nationale SupÃ©rieure de l'AÃ©ronautique et de l'Espace  holds an MBA from Thunderbird (Arizona State University) and a DSCG from the Ordre des Experts Comptables.* * *About Surojit ChatterjeeFounder and CEO of Ema Unlimited  a generative AI company  Surojit Chatterjee is a seasoned technology executive with over two decades of experience driving innovation across global companies. His deep expertise in artificial intelligence  combined with extensive product leadership at firms like Google  Coinbase and Flipkart  would bring strategic insight and forward-thinking vision to the Board.Biography of Surojit ChatterjeeSurojit Chatterjee began his career in 1999 as a Software Developer at IBM before joining Oracle Corporation in a technical role. In 2005  he moved into product management at Symantec Corporation. He joined Google in 2007  where he held several leadership roles across payments  mobile products  and advertising. In 2015  he became Senior Vice President and Head of Product at Flipkart  before returning to Google in 2017 as Vice President of Product Management for Google Shopping. He joined Coinbase as Chief Product Officer in 2020 and founded Ema Unlimited  a generative AI startup  in 2023.Since 2024  Surojit Chatterjee has served on the Board of Directors of Meesho  a privately-owned Indian e-commerce company.Surojit Chatterjee holds a Bachelor in Technology in Computer Science and Engineering from the Indian Institute of Technology  Kharagpur  an MS in Computer Science from the University at Buffalo (SUNY)  and an MBA from the Massachusetts Institute of Technology (MIT).* * *About Mandy MettenHead of Group Executives and Strategic Functions in Atos and a long-standing leader within the Group  Mandy Metten was a member of the Board of Directors representing employees until January 31  2025  when she was appointed censor subject to the General Meetingâ€™s ratification. Her experience across organizational change  diversity initiatives and people development would continue to bring valuable insight to the Boardâ€™s work.Biography of Mandy MettenMandy Metten began her professional journey within the ATOS Group as an Executive Management Consultant specializing in Digital Transformation  Innovation  and Change from October 2007 to June 2014  during which she demonstrated expertise in critical strategic areas. In June 2014  she assumed the role of Manager of Atos Young Professionals  designing and overseeing a comprehensive 2-year development program for young professionals  providing development with training  mentoring and client exposure. As from November 2018  Mandy Metten served as Global Head of Group Campus Management  defining and implementing the Group campus strategy globally  including diversity and inclusion initiatives. Mandy Metten took additional responsibilities at Eviden in April 2023 and currently serves as Head of Group Executives & Strategic Functions.Mandy Metten was Chairman of the works council of Atos from 2010 to 2015. She also served as the Dutch delegate on Atos Societas Europaea Council (SEC) from 2012 to January 2024 and was a member of the Board Participating Committee (2017- January 2024). From August 2023  she became a Commissaris (Member of the Board of Directors) for Atos Nederland  contributing to the company's governance.Mandy Metten holds a masterâ€™s degree in social and organizational Psychology. She completed a multi-level curriculum in Strategy  Economy  and Finance at the LeFebvre Institute.* * *About AtosAtos is a global leader in digital transformation with circa 74 000 employees and annual revenue of circa â‚¬10 billion. European number one in cybersecurity  cloud and high-performance computing  the Group provides tailored end-to-end solutions for all industries in 68 countries. A pioneer in decarbonization services and products  Atos is committed to a secure and decarbonized digital for its clients. Atos is a SE (Societas Europaea) and listed on Euronext Paris.The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge  education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world  the Group enables its customers and employees  and members of societies at large to live  work and develop sustainably  in a safe and secure information space.ContactsInvestor relations:David Pierre-Kahn | investors@atos.net | +33 6 28 51 45 96Sofiane El Amri | investors@atos.net | +33 6 29 34 85 67Individual shareholders: +33 8 05 65 00 75Press contact: globalprteam@atos.net1 In accordance with article 10.3 of the AFEP-MEDEF Code  the director representing employees is not taken into account in determining the percentage of independent members.2 In accordance with the law  the director representing employees is not taken into account in determining the parity ratio on the Board of Directors.3 Seven nationalities if the censor is taken into account.Attachment,neutral,0.11,0.88,0.0,positive,0.8,0.2,0.0,True,English,"['Annual General Meeting', '2024 financial statements', 'Atos Board', 'June', 'evolution', 'Directors', 'Bulletin des Annonces LÃ©gales Obligatoires', 'Caisse des DÃ©pÃ´ts', 'SociÃ©tÃ© GÃ©nÃ©rale', 'Conseil National du NumÃ©rique', 'Lead Independent Director Elizabeth Tinkham', 'CrÃ©dit du Nord', 'Officier du MÃ©rite', 'FranÃ§oise Mercadalâ€‘Delasalles', 'MÃ©rite Agricole', 'National Digital Council', 'FranÃ§oise Mercadal-Delasalles', 'Official Legal Gazette', 'senior public service', 'new banking services', 'various non-executive positions', 'new independent director', 'qualified new director', 'Chief Executive Officer', 'Annual General Meeting', 'digital transition project', 'executive Board Director', 'LÃ©gion', '87.5%1 independent members', 'Executive Committee', 'digital transformation', 'digital tools', 'meeting notice', 'Press Release', '2024 financial statements', 'avis de', 'rÃ©union', 'voting procedures', 'Governance Committee', 'evolving needs', 'ongoing transformation', 'Jean-Jacques Morin', 'fiscal year', 'Surojit Chatterjee', 'Mandy Metten', 'one year', 'eight members', 'six nationalities3', 'Philippe Salle', 'continued effectiveness', 'overall capabilities', 'sincere appreciation', 'CSR Committee', 'Remuneration Committee', 'private sector', 'recognized expertise', 'valuable assets', 'ecological concerns', 'business model', 'integrated platform', 'extra-financial data', 'Atos SE', 'draft resolutions', 'one censor', 'upcoming appointment', 'sustainability issues', 'supervisory boards', 'Agricultural Merit', 'Atos Board', 'Atosâ€™ Board', 'atos.', 'June', 'evolution', 'Directors', 'Paris', 'France', 'April', 'agenda', 'participation', 'BALO', 'May', 'Company', 'website', 'investors', 'annual-general-meeting', 'composition', 'recommendation', 'Nomination', 'series', 'changes', 'approval', 'proposed', 'Group', 'vote', 'shareholders', 'terms', 'duration', 'December', 'renewal', 'addition', 'employees', '50%2 women', 'Chairman', 'developments', 'commitment', 'mission', 'vision', 'Cofounder', 'President', 'Auxo', 'January', 'experience', 'intersection', 'work', 'Biography', 'career', 'Ministry', 'Economy', 'Finance', 'Resources', 'Innovation', 'CEO', 'companies', 'Eurazeo', 'Chevalier', 'Honneur', 'Knight', 'Legion', 'Honor', 'Order', 'degree']",2025-04-30,2025-05-01,globenewswire.com
50425,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070943/0/en/dsm-firmenich-Q1-2025-trading-update.html,dsm-firmenich Q1 2025 trading update,Press ReleaseKaiseraugst (Switzerland)  Maastricht (Netherlands)  April 30  2025  dsm-firmenich Q1 2025 trading update  Management Report  Q1 2025......,Press ReleaseKaiseraugst (Switzerland)  Maastricht (Netherlands)  April 30  2025dsm-firmenich Q1 2025 trading updateManagement ReportQ1 2025 highlightsGood start to the year with strong organic sales and earnings growthProgressing well on 2025 strategic planSale of Feed Enzymes business for â‚¬1.5 billion announcedAnimal Nutrition & Health exit process advancing as plannedâ‚¬1 billion share buyback program commenced in AprilFY 2025 outlook unchanged: Adjusted EBITDA at least â‚¬2.4 billionKey figuresin â‚¬ millions Q1 2025 Q1 2024 % Change Sales 3 274 3 071 7 Organic sales growth (%) 8 Adj. EBITDA 650 463 40 Adj. EBITDA margin (%) 19.9 15.1Dimitri de Vreeze  CEO  commented: â€œWe are pleased to report a strong performance in the first quarter  with significant growth across our businesses and the effective execution of our strategic plan  including our comprehensive cost and revenue synergy programs.With our broad exposure to key market trends in Nutrition  Health and Beauty  we deliver innovative solutions which provide critical performance to essential everyday consumer products. Our unique portfolio positions us well to operate in the current uncertain macro environment and mitigate effects from tariffs.Our strong first-quarter performance  our focus on innovation-led growth  and the â‚¬200 million contribution from our self-help programs support our full-year 2025 outlook of at least â‚¬2.4 billion in Adjusted EBITDA  based on current business conditions.â€2025 PlanAcceleration of innovation and creation-led organic sales growthDelivery of further cost and sales synergies of about â‚¬100 million to Adjusted EBITDACompletion of the vitamin transformation program  with a contribution of about â‚¬100 million to Adjusted EBITDAExiting Animal Nutrition & Health and completing the tuning of our portfolio as announced at the 2024 CMDStrengthening our sustainability leadership for People and PlanetOutlook 2025For the group  we estimate a full-year Adjusted EBITDA of at least â‚¬2.4 billion  which now includes an about â‚¬150 million contribution from the temporary vitamin price effect from a supply disruption in the vitamin market (of which â‚¬85 million was recorded in Q1) and a (pro-rata) deconsolidation effect of about â‚¬40 million of Adjusted EBITDA owing to the divestment of the Feed Enzymes business.Share buyback programdsm-firmenich intends to repurchase ordinary shares with an aggregate market value of â‚¬1 billion and reduce its issued capital. This program started on April 1  2025 for an initial â‚¬500 million and will be increased to â‚¬1 billion upon the completion of the sale of dsm-firmenichâ€™s stake in the Feed Enzymes Alliance. This program is targeted to be completed by Q2 2026.Key figuresin â‚¬ millions Q1 2025 Q1 2024 % Change % OSG Sales 3 274 3 071 7 8 P&B 1 015 986 3 2 TTH 851 798 7 7 HNC 528 526 - 7 ANH 874 746 17 19 Corporate 6 15 Adj. EBITDA 650 463 40 P&B 230 234 (2) TTH 168 150 12 HNC 92 79 16 ANH 186 24 675 Corporate (26) (24) Adj. EBITDA margin (%) 19.9 15.1 P&B 22.7 23.7 TTH 19.7 18.8 HNC 17.4 15.0 ANH 21.3 3.2Q1 2025dsm-firmenich had a good start to the year  recording 8% organic sales growth in Q1 with positive contributions across all businesses  driving a further improvement in financial performance.Perfumery & Beauty: strong growth in Perfumery  and weak performance in Beauty due to suncare.Taste  Texture & Health: strong performance in both Taste and Ingredients Solutions  supported by sales synergies.Health  Nutrition & Care: continued recovery of Dietary Supplements and Early Life Nutrition  driving strong growth.Animal Nutrition & Health: strong underlying performance  supported by temporary vitamin price effects.Adjusted EBITDA excluding the temporary vitamin price effect increased 22%  driven by strong organic sales growth  synergies  and the vitamin transformation program. These improvement programs contributed about â‚¬45 million year-on-year in Adjusted EBITDA. Including the about â‚¬85 million temporary vitamin price effect  Adjusted EBITDA rose 40%.The Adjusted EBITDA margin improved to 19.9%.Business Unit ReviewPerfumery & BeautyPerfumery & Beauty (P&B) is a leading creation and innovation partner for the most iconic global and local brands in consumer goods  lifestyle  and luxury beauty. The business unit is home to some of the best talent in the industry  boasts an unmatched palette of ingredients including captives  and is supported by a vertically integrated supply chain. Powered by our science-based innovations in Fragrance and Beauty & Care  we make our customersâ€™ products more desirable  essential  and sustainable  driving consumer preference.Business unit resultsin â‚¬ millions Q1 2025 Q1 2024 % Change Sales 1 015 986 3 Organic sales growth (%) 2 Adj. EBITDA 230 234 (2) Adj. EBITDA margin (%) 22.7 23.7Q1 2025Perfumery delivered a strong  high-single digit organic sales growth despite a tough prior-year comparison  with very strong demand for Fine Fragrances  good demand for Consumer Fragrances  and strong demand for Ingredients. Beauty & Care experienced challenges in sun filters due to weak end-user demand and customer destocking.Overall  this resulted in a solid performance for Perfumery & Beauty of 2% organic sales growth driven by 3% higher volumes. Excluding sun filters  volume growth was 6%.Compared to a very strong first quarter last year  Adjusted EBITDA was slightly lower due to an unfavorable product mix with lower sales in high-margin Beauty & Care. The quarter saw a good Adjusted EBITDA margin of 22.7%.Taste  Texture & HealthTaste  Texture & Health (TTH) brings progress to life by tackling some of societyâ€™s biggest challenges: providing nutritious  healthy and sustainable food and beverage solutions  accelerating the diet transformation with appealing taste and texture  and nourishing a growing global population. TTH consists of Taste  which includes flavors  natural extracts  sugar reduction solutions  and Ingredients Solutions  which includes food enzymes  hydrocolloids  cultures  natural colorants  nutritional ingredients  and plant-based proteins.Business unit resultsin â‚¬ millions Q1 2025 Q1 2024 % Change Sales 851 798 7 Organic sales growth (%) 7 Adj. EBITDA 168 150 12 Adj. EBITDA margin (%) 19.7 18.8Q1 2025Taste  Texture & Health had a strong start to the year delivering 7% organic sales growth fully driven by higher volumes in both Taste and Ingredients Solutions. This was supported by volume growth of 2% from sales synergies  and a pipeline that keeps building.Market conditions remained solid across regions  except for North America. Growth was mainly driven by local and regional customers  and strong business conditions in Beverages  Dairy and Pet Food.Adjusted EBITDA was up 12% year-on-year  driven by good organic sales growth and merger synergies. This resulted in an Adjusted EBITDA margin of 19.7%.Health  Nutrition & CareHealth  Nutrition & Care (HNC) enables people to improve their health by supplementing their diet with critical nutrients and driving medical innovation forward  so helping to optimize immunity  speed up recovery and enhance quality of life.Business unit resultsin â‚¬ millions Q1 2025 Q1 2024 % Change Sales 528 526 - Organic sales growth (%) 7 Adj. EBITDA 92 79 16 Adj. EBITDA margin (%) 17.4 15.0Q1 2025Health  Nutrition & Care achieved a strong quarter with 7% organic sales growth  on 8% higher volumes.Dietary Supplements saw continued recovery  with strong growth in algal lipid solutions  vitamins  and minerals. Early Life Nutrition also showed a strong improvement with higher demand for HMOs and premix sales. All other segments experienced continued solid business conditions.Adjusted EBITDA was up 16% year-on-year  driven by good organic sales growth  supported by synergies  and the vitamin transformation program. This resulted in an Adjusted EBITDA margin of 17.4%.Animal Nutrition & HealthAnimal Nutrition & Health (ANH) helps deliver healthy animal proteins efficiently and sustainably  whilst harnessing the power of data to make animal farming practices more sustainable  productive  and transparent.Business unit resultsin â‚¬ millions Q1 2025 Q1 2024 % Change Sales 874 746 17 Organic sales growth (%) 19 Adj. EBITDA 186 24 675 Adj. EBITDA margin (%) 21.3 3.2Q1 2025Animal Nutrition & Health saw a continued improvement in business performance  with higher profitability in the underlying business  further supported by the temporary vitamin price effect. The business delivered strong organic sales growth of 19%  driven by 17% higher prices.Performance Solutions delivered a strong quarter led by volume growth  supported by innovations including Mycotoxin Risk Management Solutions and Precision Services. Essential Products saw solid volume growth in own products  offset by lower sales of externally sourced ingredients.Adjusted EBITDA was up significantly from the prior-year period  owing to good organic sales growth  the contribution from the vitamin transformation program  and about â‚¬85 million from the temporary vitamin price effect. The Adjusted EBITDA margin increased to 21.3%.DefinitionsThis press release includes information that is presented in accordance with IFRS as issued by the International Accounting Standard Board and alternative performance measures (APMs). Please refer to the section below for the definitions as applied.Alternative Performance Measures (APMs)To arrive at the Alternative Performance Measures (APMs)  adjustments are made for material items of income and expense arising from circumstances such as acquisitions and divestments  restructuring  impairments and other events (i.e.  APM adjustments). Other APM adjusting events include site closure costs  environmental cleaning  litigation settlements or other non-operational (contractual) arrangements. Other than items related to acquisition and integration costs incurred in the first year from the acquisition date (including non-recurring inventory value adjustments) as well as adjustments due to previously recognized APM adjusting events  the threshold is â‚¬10 million.The APMs used throughout this press release are:Organic sales growth (OSG)Organic sales growth is the sales growth excluding the impact of acquisitions  divestments  and currency impacts.Adjusted earnings before interest  tax  depreciation and amortization (Adj. EBITDA)Adjusted EBITDA is the IFRS metric operating profit plus depreciation  amortization  and impairments  adjusted for material items of profit or loss  as defined under â€˜Alternative Performance Measures (APMs)â€™.Adjusted EBITDA margin (Adj. EBITDA margin)Adjusted EBITDA margin is adjusted EBITDA expressed as a percentage of net sales.Notes to this trading updateThe reported financial data in this trading update have not been audited.A PDF version of this press release can be found here.Financial calendarMay 6  2025: Annual General Meeting July 31  2025: Publication of dsm-firmenich H1 2025 financial results October 30  2025: Publication of dsm-firmenich Q3 2025 trading updateAdditional informationToday dsm-firmenich will hold a webcast for investors and analysts at 9:00 am CEST. Details on how to access this call can be found on www.dsm-firmenich.com.For more informationMedia relationsRobin Roothanstel. +41 (0)79 280 03 96e-mail media@dsm-firmenich.comInvestor relationsDave Huizingtel. +31 (0)88 425 7306e-mail investors@dsm-firmenich.comAbout dsm-firmenichAs innovators in nutrition  health  and beauty  dsm-firmenich reinvents  manufactures  and combines vital nutrients  flavors  and fragrances for the worldâ€™s growing population to thrive. With our comprehensive range of solutions  with natural and renewable ingredients and renowned science and technology capabilities  we work to create what is essential for life  desirable for consumers  and more sustainable for the planet. dsm-firmenich is a Swiss company  listed on the Euronext Amsterdam  with operations in almost 60 countries and revenues of more than â‚¬12 billion. With a diverse  worldwide team of nearly 30 000 employees  we bring progress to life every day  everywhere  for billions of people.www.dsm-firmenich.comForward-looking statementsThis press release may contain forward-looking statements with respect to dsm-firmenichâ€™s future (financial) performance and position. Such statements are based on current expectations  estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance  transaction progress and positions to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release  unless required by law. This communication contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. The English language version of this press release prevails over other language versions.Attachments,neutral,0.0,1.0,0.0,positive,0.82,0.18,0.0,True,English,"['dsm-firmenich Q1 2025 trading update', 'dsm-firmenich Q1 2025 trading update Management Report', 'strong, high-single digit organic sales growth', 'â‚¬85 million temporary vitamin price effect', 'current uncertain macro environment', 'temporary vitamin price effects', 'creation-led organic sales growth', 'â‚¬1 billion share buyback program', 'essential everyday consumer products', 'strong organic sales growth', '8% organic sales growth', 'current business conditions', 'vitamin transformation program', 'Dimitri de Vreeze', 'tough prior-year comparison', 'aggregate market value', 'Q1 2024 % Change Sales', 'revenue synergy programs', 'Business Unit Review', 'Business unit results', 'key market trends', 'Feed Enzymes Alliance', 'Early Life Nutrition', 'strong underlying performance', 'Feed Enzymes business', 'Health exit process', 'Adj. EBITDA margin', 'Adjusted EBITDA margin', 'full-year Adjusted EBITDA', 'vitamin market', 'deconsolidation effect', 'strong growth', 'OSG Sales', 'earnings growth', 'significant growth', 'innovation-led growth', 'customersâ€™ products', 'sales synergies', 'strong performance', 'â‚¬200 million contribution', 'â‚¬150 million contribution', 'strong demand', 'full-year 2025 outlook', 'consumer goods', 'consumer preference', 'Consumer Fragrances', 'Q1 2025 highlights', 'Key figures', 'self-help programs', '8 Adj. EBITDA', '2 Adj. EBITDA', 'critical performance', 'first-quarter performance', 'financial performance', 'weak performance', 'Press Release', 'Good start', 'FY 2025 outlook', 'first quarter', 'effective execution', 'broad exposure', 'innovative solutions', 'sustainability leadership', 'Planet Outlook', 'supply disruption', 'ordinary shares', 'issued capital', 'P&B', 'positive contributions', 'continued recovery', 'Dietary Supplements', 'leading creation', 'iconic global', 'local brands', 'best talent', 'unmatched palette', 'supply chain', 'science-based innovations', 'Fine Fragrances', 'good demand', 'improvement programs', 'Animal Nutrition', 'millions Q1', '2025 strategic plan', 'comprehensive cost', 'unique portfolio', 'innovation partner', 'Ingredients Solutions', 'luxury beauty', '2025 Plan', 'Kaiseraugst', 'Switzerland', 'Maastricht', 'Netherlands', 'April', 'CEO', 'businesses', 'tariffs', 'focus', 'Acceleration', 'Delivery', 'Completion', 'tuning', '2024 CMD', 'People', 'group', 'divestment', 'initial', 'stake', 'Q2 2026', '2 TTH', 'HNC', '7 ANH', 'Corporate', 'Perfumery', 'suncare', 'Taste', 'Texture', 'lifestyle', 'industry', 'captives']",2025-04-30,2025-05-01,globenewswire.com
50426,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070942/0/en/Ontex-shows-margin-resilience-in-Q1-and-confirms-full-year-outlook.html,Ontex shows margin resilience in Q1  and confirms full year outlook,Regulated information   Revenue of â‚¬451 million  2.8% lower LFL  with soft market demand partly offset by mix improvement in Europe and double-digit...,Regulated informationRevenue of â‚¬451 million  2.8% lower LFL  with soft market demand partly offset by mix improvement in Europe and double-digit volume growth in North America;Adj. EBITDA margin resilient at 11.2%  with strong delivery of the cost transformation program ;Divestment of Brazilian business successfully concluded;Long-term financing secured  with new â‚¬400 million bond maturing in 2030;Full year outlook confirmed  with volume gains in H2 as main driver.CEO quoteGustavo Calvo Paz  Ontexâ€™s CEO  said: â€œThese results demonstrate Ontexâ€™s improved resilience in a more challenging economic environment  providing us confidence to confirm our full-year outlook. While we may encounter occasional challenging quarters  these are temporary fluctuations not indicative of the long-term trends our business is built on. Our focus is on achieving sustained success over the long term  and we are thereby committed to execute our strategic transformation roadmap  which fundamentally enhances our competitiveness to address the market even better. In the quarter  we also reached two significant strategic milestones  finalizing a major divestment and strengthening our balance sheet for the future  which allows us to focus even better.â€Q1 2025 resultsRevenue was â‚¬451 million  a 2.8% like-for-like decrease. Volumes  including mix effects  were 1.3% lower  with softer market demand in the quarter partly offset by mix improvement in Europe and double-digit volume growth in North America. Sales prices were 1.6% lower  as expected  due to the carry-over effect from the price decreases in the first half of 2024.Adjusted EBITDA was â‚¬51 million with a margin of 11.2%. The slight decrease reflects business resilience in a more challenging environment. The cost transformation program  including the initial contribution from the Belgian footprint optimization  delivered â‚¬15 million net savings  which fully offset the sales price decrease and the operating cost increase.Operating profit was â‚¬29 million  including â‚¬3 million one-time restructuring costs.Net financial debt for the Total Group was â‚¬656 million at the end of March. The increase over the quarter is mainly linked to temporary higher working capital needs  partly caused by the mitigation actions related to the US tariff threat. The leverage ratio thereby rose temporarily from 2.5x to 2.7x.Strategic developmentsIn January  Ontex reached a binding agreement to sell its Turkish business activities to Dilek Grup for an enterprise value of approximately â‚¬24 million. The closing is expected during the second half of 2025  subject to customary conditions.In March  Ontex issued a â‚¬400 million bond which matures in April 2030 and holds a fixed interest rate of 5.25%. This bond replaces the existing â‚¬580 million bond which matures in July 2026. Approximately 50% of this bond has been repurchased at par meanwhile  and the remainder will be repaid by the middle of this year.Early April  Ontex concluded the divestment of its Brazilian business. Aggregate net cash proceeds received at closing were â‚¬81 million. An additional â‚¬18 million [1]   currently still in escrow is expected to be received in the second quarter. The divestment proceeds will be used to further pay down Ontexâ€™s outstanding financial debt.  currently still in escrow is expected to be received in the second quarter. The divestment proceeds will be used to further pay down Ontexâ€™s outstanding financial debt. By mid-April  Ontex finalized its 1.5 million share buyback program  which had been launched in December 2024. The acquired shares will contribute to meeting Ontexâ€™s obligations under its current and future long-term incentive plans. Ontex currently holds 2.85% of its issued shares in treasury.2025 outlookWhile market conditions were soft in the first quarter  Ontex remains confident it will deliver its previously published outlook for 2025  with volume gains in the second half of the year as main driver:Revenue to grow by 3% to 5% like for like  supported by double-digit volume growth in North America  with new contracts kicking in during the second half of the year  which will also improve margin through operating leverage;Adjusted EBITDA to grow by 4% to 7%  supported by revenue growth and further improvement of operational efficiencies  and taking into account that the products Ontex imports into the US from its plant in Mexico  are manufactured under the tariff exemption provided by the USMCA  thereby minimizing the direct impacts from US tariffs;Free cash flow to remain strong  while continuing to step up investments in Ontexâ€™s transformation. This step-up will be nearing completion by the end of 2025;Leverage below 2.5x by year end.[1] Approximate amount based on BRL/EUR rate at the moment of the transaction.Key business and financial indicatorsBusiness results Q1 Q1 in â‚¬ million 2025 2024 % % LFL 2025 2024 % % LFL Revenue 450.6 460.2 -2.1% -2.8% 450.6 460.2 -2.1% -2.8% Adult Care 202.4 198.9 +1.8% +1.3% 202.4 198.9 +1.8% +1.3% Baby Care 188.2 195.5 -3.8% -4.9% 188.2 195.5 -3.8% -4.9% Feminine Care 56.2 60.3 -6.8% -7.5% 56.2 60.3 -6.8% -7.5% Operating expenses (excl. DA) (400.1) (407.3) +1.8% (400.1) (407.3) +1.8% Adj. EBITDA 50.5 52.9 -4% 50.5 52.9 -4.4% Adj. EBITDA margin 11.2% 11.5% -0.3pp 11.2% 11.5% -0.3pp (EBITDA adjustments) (2.7) (0.7) n.a. (2.7) (0.7) n.a. Depreciation & amortization (19.0) (18.0) -5.3% (19.0) (18.0) -5.3% Operating profit 28.9 34.2 -15% 28.9 34.2 -15% Net financial debt [2] 655.6 612.0 +7.1% Leverage ratio [2] 2.72x 2.46x +0.25xRevenue 2024 Vol/mix Sales 2025 Forex 2025 in â‚¬ million price LFL Q1 460.2 -5.8 -7.3 447.1 +3.6 450.6 -1.3% -1.6% -2.8% +0.8% -2.1% Adj. EBITDA 2024 Vol/mix Sales Operat. Raw Other Forex 2025 in â‚¬ million price savings mat'ls costs Q1 52.9 -2.3 -7.3 +15.3 -2.9 -4.6 -0.6 50.5 -4.4% -13.8% +28.9% -5.4% -8.6% -1.2% -4.4%[2] Balance sheet data reflect the end of the period and compare to the start of the period  i.e. 31/12/2024.Q1 2025 business reviewRevenueRevenue was â‚¬451 million  2.8% lower like for like. Volumes decreased with softer market demand in the quarter caused by the more challenging economic conditions. This was partly offset by mix improvement in Europe and growth in North America. Sales prices were lower  as expected.Volumes were down 1.3% including mix effects. Feminine care sales volumes dropped due to some temporary supply constraints and soft market demand in Europe  albeit with better relative performance for retailer brands. Adult care volumes were up  however  in line with continued market growth in the European retail channel and stable demand from the healthcare channel. Baby care volumes in Europe were lower on softer demand  albeit that retailer brands performed slightly better  despite intensified promotional activities by A-brands. Ontexâ€™s focus on selective product categories  led to a further mix improvement. In North America baby care sales volumes were up by double digits  thanks to the contract gains in the retail channel built up since mid-2024. Market demand was lower  especially for retailer brands  which were impacted by intense promotional activities by A-brands.Sales prices were lower across regions and categories  and 1.6% down overall. While these have been largely stable since mid-2024  the decrease reflects the carry-over effect of the price decreases in the first half of 2024.Forex fluctuations were supportive  adding 0.8%  mainly thanks to the appreciation of the Polish zÅ‚oty  British pound and US dollar versus the same period in 2024.Adjusted EBITDAAdjusted EBITDA was â‚¬51 million  a 4.4% year-on-year decrease  reflecting the â‚¬2 million volume and mix reduction impact. The cost transformation program fully offset the â‚¬7 million sales price decrease and the operating cost increase.The cost transformation program delivered â‚¬15 million net operating savings  leading to an improvement of the operating efficiency by 4.3% year on year  with purchasing  supply chain  product innovation and manufacturing initiatives. The transformation of Ontexâ€™s production footprint in Belgium is also starting to deliver  with the closure of the Eeklo plant finalized.Raw material prices were up by â‚¬3 million in the quarter  which was mainly attributable to higher indices for fluff since the end of last year  as well as higher prices for super-absorbent polymers  packaging and other raw materials.Other operating and SG&A costs were up by â‚¬5 million year on year  largely due to inflation of wages  as well as costs related to the ramp-up in North America and the mitigation actions related to the US tariff threat.Forex fluctuations had a â‚¬1 million net negative impact  mainly linked to the depreciation of the Mexican peso affecting the contribution from the plant in Tijuana  Mexico.The adjusted EBITDA margin was 11.2%  0.3 percentage points lower year on year.Q1 2025 financial reviewP&LOperating profit from continuing operations was â‚¬29 million  compared to â‚¬34 million in 2024. The â‚¬5 million decrease consists of the â‚¬2 million lower adjusted EBITDA  â‚¬2 million higher restructuring charges (â‚¬3 million in the period  versus â‚¬1 million in 2024)  and â‚¬1 million higher depreciation charges linked to the more intensive investment level in the recent years.Discontinued operations generated a revenue of â‚¬62 million  0.7% lower like for like. The adjusted EBITDA was â‚¬4 million  resulting in a 6.1% margin. The operating profit from discontinued operations amounted also to â‚¬4 million  in the absence of depreciation and restructuring costs.Balance sheetNet financial debt for the Total Group was up â‚¬44 million over the period to reach â‚¬656 million at the end of March. While EBITDA delivery remained robust  these only partly offset working capital needs  capital expenditure and restructuring spent. Working capital increased  reflecting working capital inefficiencies  including mitigation measures taken in anticipation of the US tariff threat. Capital expenditure remained at a higher level to support the business growth and transformation  and the remainder of the restructuring charges related to the closure of the Eeklo sites were paid in the quarter. Also  â‚¬10 million was used to finance the share buy-back program  which has meanwhile been finalized.The leverage ratio thereby rose to 2.7x  from 2.5x at the start of the year  reflecting the net debt increase and the lower last-twelve-months adjusted EBITDA.Alternative performance measuresAlternative performance measures (non-GAAP) are used in this press release since management believes that they are widely used by certain investors  securities analysts and other interested parties as supplemental measure of performance and liquidity. The alternative performance measures may not be comparable to similarly titled measures of other companies  have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of operating results  performance or liquidity under IFRS.Net financial debt and leverage ratioNet financial debt is calculated by adding short-term and long-term debt and deducting cash and cash equivalents. The leverage ratio is calculated by dividing the net financial debt by the adjusted EBITDA for the last twelve months (LTM). It excludes the contribution of businesses divested since.Reconciliation of net financial debt 31/03/2025 31/12/2024 in â‚¬ million Cont. Discont. Total Cont. Discont. Total Non-current interest-bearing debts A 676.2 10.9 687.1 667.1 10.9 678.0 Current interest-bearing debts B 91.0 5.0 95.9 53.1 5.2 58.3 Gross financial debt C = A+B 767.1 15.9 783.0 720.2 16.1 736.3 Cash & cash equivalents D 61.3 66.1 127.5 56.9 67.3 124.2 Net financial debt E = C-D 705.8 (50.2) 655.6 663.3 (51.2) 612.0 Adj. EBITDA (LTM) [3] F 220.3 21.1 241.3 222.6 25.7 248.3 Leverage ratio G = E/F 2.72x 2.46x[3] The Last-Twelve-Months (LTM) adj. EBITDA excludes the contribution from the divested Algerian and Pakistani businesses in 2024.Like-For-Like (LFL) revenue and growthLike-for-like revenue is defined as revenue at constant currency excluding change in scope of consolidation or M&A and hyperinflation impacts. The reconciliation of like-for-like revenue can be found on 2. Like-for-like growth compares the like-for-like revenue with the revenue of the previous year.Adjusted EBITDA and adjusted EBITDA marginAdjusted EBITDA is defined as earnings before net finance cost  income taxes  depreciations and amortizations (commonly defined as EBITDA) plus EBITDA adjustments. The adjusted EBITDA margin is the adjusted EBITDA divided by revenue.EBITDA adjustments are made for income and expenses that are considered by management not to relate to transactions  projects and adjustments to the value of assets and liabilities taking place in the ordinary course of activities of the Group. These income and expenses are presented separately  due to their size or nature  so as to allow users of the consolidated financial statements of the Company to get a better understanding of the normalized performance of the Company  and relate to:acquisition-related expenses;changes to the measurement of contingent considerations in the context of business combinations;changes to the Group structure  business restructuring costs  including costs related to the liquidation of subsidiaries and the closure  opening or relocations of factories;impairment of assets and major litigations.In the consolidated income statement these EBITDA adjustments are composed of the following items:income/(expenses) related to changes to Group structure; andincome/(expenses) related to impairments and major litigations.Reconciliation of Q1 income statement 2025 2024 in â‚¬ million Cont. Discont. Total Cont. Discont. Total Revenue a 450.6 62.4 513.1 460.2 91.2 551.3 Operating profit b 28.9 3.9 32.8 34.2 11.4 45.6 Depreciation & amortization c (19.0) (0.0) (19.0) (18.0) 0.0 (18.0) EBITDA d = b-c 47.9 3.9 51.8 52.2 11.4 63.6 EBITDA adjustments g 2.7 (0.1) 2.6 0.7 0.4 1.1 Adj. EBITDA h = d+g 50.5 3.8 54.4 52.9 11.8 64.6 Adj. EBITDA margin i = h/a 11.2% 6.1% 10.6% 11.5% 12.9% 11.7%More information on the EBITDA adjustments can be found on page 5.Practical informationDisclaimerThis report may include forward-looking statements. Forward-looking statements are statements regarding or based upon our managementâ€™s current intentions  beliefs or expectations relating to  among other things  Ontexâ€™s future results of operations  financial condition  liquidity  prospects  growth  strategies or developments in the industry in which we operate. By their nature  forward-looking statements are subject to risks  uncertainties and assumptions that could cause actual results or future events to differ materially from those expressed or implied thereby. These risks  uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this report regarding trends or current activities should not be taken as a report that such trends or activities will continue in the future. We undertake no obligation to update or revise any forward-looking statements  whether as a result of new information  future events or otherwise. You should not place undue reliance on any such forward-looking statements  which speak only as of the date of this report.The information contained in this report is subject to change without notice. No re-report or warranty  express or implied  is made as to the fairness  accuracy  reasonableness or completeness of the information contained herein and no reliance should be placed on it. In most of the tables of this report  amounts are shown in â‚¬ million for reasons of transparency. This may give rise to rounding differences in the tables presented in the report.Corporate informationThe financial information in this document of Ontex Group NV for the three months ended March 31  2025 was authorized for issue in accordance with a resolution of the Board on April 29  2025.Audio webcastManagement will host an audio webcast for investors and analysts on April 30  2025 at 12:00 CEST / 11:00 BST. To attend  click on https://channel.royalcast.com/landingpage/ontexgroup/20250430_1. A replay will be available on the same link shortly after the live presentation. A copy of the presentation slides will be available on ontex.com.Financial calendarMay 5  2025 2025 annual general meeting of shareholdersJuly 31  2025 Q2 & H1 2025 results publicationOctober 30  2025 Q3 2025 results publicationFebruary 12  2026 Q4 & full year 2025 results publicationEnquiriesInvestors Geoffroy Raskin +32 53 33 37 30 investor.relations@ontexglobal.comMedia Catherine Weyne +32 53 33 36 22 corporate.communications@ontexglobal.comAbout OntexOntex is a leading international developer and producer of baby care  feminine care and adult care products  for retailer and healthcare brands across Europe and North America. It employs about 5 500 people with plants and offices in 13 countries  and its innovative products are distributed in around 100 countries. The company is headquartered in Aalst  Belgium and is listed on Euronext Brussels  where it is a constituent of the Bel MidÂ® index. To keep up with the latest news  visit ontex.com or follow Ontex on LinkedIn.Attachment,neutral,0.01,0.99,0.0,positive,0.58,0.42,0.0,True,English,"['full year outlook', 'margin resilience', 'Ontex', 'temporary higher working capital needs', 'â‚¬3 million one-time restructuring costs', 'two significant strategic milestones', '1.5 million share buyback program', 'Aggregate net cash proceeds', 'future long-term incentive plans', 'Business results Q1 Q1', 'â‚¬15 million net savings', 'Free cash flow', 'Net financial debt', 'Gustavo Calvo Paz', 'Belgian footprint optimization', 'cost transformation program', 'outstanding financial debt', 'occasional challenging quarters', 'strategic transformation roadmap', 'fixed interest rate', 'double-digit volume growth', 'Turkish business activities', 'soft market demand', 'softer market demand', 'challenging economic environment', 'existing â‚¬580 million bond', 'new â‚¬400 million bond', 'US tariff threat', 'operating cost increase', 'Adj. EBITDA margin', 'sales price decrease', 'Full year outlook', 'Q1 2025 results', 'temporary fluctuations', 'challenging environment', 'Strategic developments', 'financial indicators', 'Long-term financing', 'long-term trends', 'volume gains', 'Sales prices', 'new contracts', 'tariff exemption', 'BRL/EUR rate', 'Operating profit', 'Brazilian business', 'Key business', 'divestment proceeds', 'market conditions', 'revenue growth', 'Regulated information', 'North America', 'strong delivery', 'main driver', 'sustained success', 'long term', 'balance sheet', 'mix effects', 'carry-over effect', 'first half', 'Adjusted EBITDA', 'slight decrease', 'initial contribution', 'Total Group', 'mitigation actions', 'binding agreement', 'Dilek Grup', 'enterprise value', 'second half', 'customary conditions', 'operating leverage', 'operational efficiencies', 'direct impacts', 'US tariffs', 'Approximate amount', 'Adult Care', 'Baby Care', 'business resilience', 'full-year outlook', 'mix improvement', 'leverage ratio', 'major divestment', 'CEO quote', 'second quarter', 'first quarter', 'year end', 'LFL Revenue', '2025 outlook', 'Europe', 'H2', 'Ontex', 'confidence', 'focus', 'competitiveness', 'Volumes', 'March', '2.5x', 'January', 'closing', 'April', 'July', 'par', 'remainder', 'middle', 'escrow', 'December', 'shares', 'obligations', 'current', 'issued', 'treasury', 'account', 'products', 'plant', 'Mexico', 'USMCA', 'investments', 'step-up', 'completion', 'moment', 'transaction', '11.']",2025-04-30,2025-05-01,globenewswire.com
50427,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070961/0/en/Strong-Q1-2025-financial-results-and-integration-gaining-momentum.html,Strong Q1 2025 financial results and integration gaining momentum,Q1 2025 RESULTS   Gross operating income stood at EUR 819 million  up +3.3% vs. EUR 793 million in Q1 2024  Leasing and Services margins stood at EUR...,Q1 2025 RESULTSGross operating income stood at EUR 819 million  up +3.3% vs. EUR 793 million in Q1 2024Leasing and Services margins stood at EUR 708 million  up +2.9% vs. EUR 689 million in Q1 2024. Underlying margins1 stood at 562 bps of average earning assets in Q1 2025 vs. 522 bps in Q1 2024.Used car sales (UCS) result and depreciation adjustments stood at EUR 111 million up +5.8% vs. EUR 105 million in Q1 2024 thanks to slower used car sales market normalization and lower depreciation adjustments. UCS result and depreciation adjustments per unit stood at EUR 703 up vs. EUR 689 in Q1 2024 and EUR 239 in Q4 2024Synergies2 stood at EUR 61 million in Q1 2025  up from EUR 20 million in Q1 2024 and EUR 41 million in Q4 2024.Cost to income ratio1 stood at 58.0%  down 9.7pp vs. Q1 2024 which stood at 67.7%Cost of risk3 stood at 23 bps vs. 25 bps in Q1 2024Net income group share stood at EUR 220 million  up 21.3% vs. EUR 181 million in Q1 2024Return on Tangible Equity (ROTE)4 stood at 11.0% vs. 9.4% in Q1 2024Earnings per share5 stood at EUR 0.24 vs. EUR 0.20 in Q1 2024Earning assets6 up 1.4% vs. end March 2024  underpinned by the increase in vehiclesâ€™ valueCET1 ratio at 13.2% as at end March 2025  including favourable impact of CRR3 implementationOn 30 April 2025  Tim Albertsen  CEO of Ayvens  commenting on the Q1 2025 Group results  stated:â€œI am happy to share that Ayvens has delivered a strong financial performance across the board for the first quarter of 2025 and has continued on its integration and transformational journey at a high pace.Integration is progressing according to plans and in line with budget without deviation. Eleven out of twenty-one overlapping countries have migrated and today more than half of the total fleet is managed on a single IT platform in each country. Besides  following the approvals by work councils on the Groupâ€™s restructuring plans  Ayvens has now started to implement its target operating model for all corporate functions and IT activities to make our organization leaner  simpler and more efficient. As a result of the outstanding execution completed so far  synergies have accelerated  both on revenues and operating expenses.As several key milestones have now been reached on our integration roadmap and after the 2024 thorough review of our business portfolio  we are now building-up a sustainable and profitable growth path for the coming quarters through targeted and complementary commercial initiatives with all our clients and partners  showing a commercial momentum that we expect to materialize towards the end of the year.Lastly  I want to thank warmly all our teams for their high commitment  professionalism and resilience  keeping clients and partners in strong focus. I also want to thank our clients and partners who have been with us all the way. Together  weâ€™re making this journey an outstanding success.â€Q1 2025 FINANCIAL RESULTSAsset growth driven by increase in vehicle valueEarning assets increased by 1.4% year-on-year to EUR 53.5 billion as at 31 March 2025. Growth was driven by the transition to EVs  which have a higher value than ICE cars.Ayvensâ€™ total fleet amounted to 3.246 million at end March 2025  down -3.8%7 year-on-year and down -1.3% vs. end December 2024  reflecting the continued impacts of the portfolio review that was operated throughout 2024 and the proactive actions taken to restore profitability.Fleet management contracts reached 662 thousand vehicles as at 31 March 2025  a decrease of -3.5% vs. end March 2024 and -1.5% vs. end December 2024.Full-service leasing contracts reached 2 584 thousand vehicles as at end March 2025  down -3.9%7 year-on-year and -1.2% vs. end December 2024.EV penetration reached 41%8 of new passenger car registrations in Q1 2025 vs. 36% in Q1 2024 and stable overall vs. 2024. Ayvensâ€™ BEV9 and PHEV9 penetration stood at 30% and 11% respectively in Q1 2025.Income statementAyvens net income (Group share) stood at EUR 220 million in Q1 2025  marking a 21.3% increase vs. Q1 2024. This strong performance results from the combined effects of increasing revenues  both in margins and used car sales  and lower operating expenses  highlighting the strength of Ayvensâ€™ business model and the growing benefits of the integration.Gross operating incomeIn Q1 2025  gross operating income reached EUR 819 million  up +3.3% compared to Q1 2024 and up +14.9% compared to Q4 2024  thanks to increased margins and higher used car sales result and depreciation adjustments compared to both Q1 2024 and Q4 2024.Leasing contract and Services marginsTaken together  Leasing and Services margins reached EUR 708 million in Q1 2025  an increase of +2.9% compared to Q1 2024 and +4.9% compared to Q4 2024.Underlying margins increased by +10.1% compared to Q1 2024 and +4.3% in euros compared to Q4 2024  supported by the continued measures to increase margins and by the robust ramp-up of revenue synergies  mainly from procurement and insurance  at EUR 42 million this quarter vs. EUR 20 million in Q1 202410. Underlying margins11 are trending higher  at 562 bps vs. 522 bps in Q1 2024 and 541 bps in Q4 2024.Non-recurring items totaled EUR -44 million in Q1 2025 vs. EUR +5 million in Q1 2024  consisting in impact of hyperinflation in Turkey for EUR -34 million (vs. EUR -2 million in Q1 2024)  mark-to-market (MtM) of derivatives and breakage revenues for EUR -7 million (vs. EUR +10 million in Q1 2024) and PPA impacts for EUR -2 million  unchanged vs. Q1 2024.Used car sales result and Depreciation adjustmentsAyvensâ€™ Q1 2025 UCS result and Depreciation adjustments reached EUR 111 million  higher than in Q1 2024 which stood at EUR 105 million. While the normalization of the UCS market is slowing  the UCS result and depreciation adjustments was positively impacted by the reduction in the release of prospective depreciation and PPA depreciation as well as by an increase in volume of cars sold:UCS result per unit stood at EUR 1 229 in Q1 2025  vs. EUR 1 267 in Q4 2024 and EUR 1 661 in Q1 2024;PPA impact amounted to EUR -28 million in Q1 2025 vs. EUR -75 million in Q1 2024 and release of prospective depreciation amounted to EUR -55 million vs. EUR â€“ 72 million in Q1 2024.Volume of cars sold amounted to 157 thousand units vs. 152 thousand in Q1 2024.As a result  UCS result and Depreciation adjustment per unit reached EUR 703 in Q1 2025 vs. EUR 689 in Q1 2024.As at 31 March 2025  PPA on lease assets has been fully depreciated  hence will have no more impact on future UCS and depreciation adjustments going forward. As from Q2 2025  the Groupâ€™s stock of reduction in depreciation costs yet to be reversed was EUR 248 million.Operating expensesIn Q1 2025  Ayvensâ€™ operating expenses amounted to EUR 473 million  down from EUR 490 million in the same period last year and from EUR 475 million in Q4 2024.Cost to achieve12 (CTA) amounted to EUR 36 million compared to EUR 26 million in Q1 2024 and EUR 41 million in Q4 2024.Excluding non-recurring items  operating expenses decreased by -5.6% vs. Q1 2024. Restated for the impact of IFRIC 21 on business taxes  Q1 2025 underlying operating expenses stood at EUR 431 million compared to EUR 434 million in Q4 2024. With the combined effect of increased underlying revenues and operating expenses  the Cost/Income ratio (excl. UCS result and depreciation adjustments) improved to 58.0% from 67.7% in Q1 2024 and from 60.2% in Q4 2024.Cost of riskImpairment charges on receivables came in at EUR 31 million in Q1 2025  compared to EUR 33 million in Q1 2024 and EUR 36 million in Q4 2024. The cost of risk13 stood at 23 bps in Q1 2025 vs. 25 bps in Q1 2024  at mid-cycle level.Net incomeIncome tax expense came in at EUR -95 million up from EUR -88 million in Q1 2024  as a result of a higher profit before tax. The effective tax rate decreased to 30.0% from 31.5% in Q1 2024  still impacted by non-deductible expenses related to hyperinflation accounting in Turkey.Non-controlling interests were EUR -1 million vs. EUR -11 million in Q1 2024 following the redemption of LeasePlanâ€™s Tier 1 capital with third parties on 29 May 2024.Ayvensâ€™ net income group share reached EUR 220 million in Q1 2025  compared to EUR 181 million in Q1 2024 and EUR 160 million in Q4 2024.Diluted Earnings per share14 was EUR 0.24 vs. EUR 0.20 in Q1 2024.The Return on Tangible Equity (ROTE) came in at 11.0% in Q1 2025 vs. 9.4% in Q1 2024 and 7.8% in Q4 2024.BALANCE SHEET AND REGULATORY CAPITALFinancial structureGroup shareholdersâ€™ equity15 totalled EUR 10.6 billion as at 31 March 2025 compared to EUR 10.4 billion as at 31 December 2024. Net asset value per share16 (NAV) was EUR 12.94 and net tangible asset value per share (NTAV) was EUR 9.52 as at 31 March 2025  compared to EUR 12.70 and EUR 9.28 respectively as at 31 December 2024.Total balance sheet decreased from EUR 75.1 billion as at 31 December 2024 to EUR 73.6 billion as at 31 March 2025  due to lower financial debt.Financial debt stood at EUR 38.2 billion at the end of March 2025 compared to EUR 40.1 billion at the end of December 2024  while deposits reached EUR 14.5 billion compared to EUR 13.9 billion at the end of December 2024.As part of its active liquidity management strategy  Ayvens continued to diversify its funding by issuing EUR 1 billion bonds in Q1 2025  of which a EUR 500 million tranche maturing in November 2027 and EUR 500 million tranche maturing in February 2030. The amounts and maturities raised confirm the marketâ€™s robust appetite for Ayvens debt instruments.The Group has access to ample short-term liquidity  with cash holdings at central bank reaching EUR 4.5 billion and an undrawn committed Revolving Credit Facility of EUR 2.2 billion in place. Ayvens has strong long-term debt credit ratings from Moodyâ€™s (A1)  S&P Global Ratings and Fitch Ratings (A-).Regulatory capitalFrom 1 January 2025  Ayvens has applied CRR3/CRD5 rules to compute risk-weighted assets (RWA) and prudential capital ratios resulting in an increase in its CET 1 ratio.Ayvensâ€™ risk-weighted assets (RWA) totaled EUR 56.7 billion as at 31 March 2025  with credit risk-weighted assets accounting for 90% of the total. The EUR 2.3 billion decrease compared to 31 December 2024 is mainly explained by a EUR 3.4 billion decrease in operational RWA under CRR3/CRD5 rules offset by a EUR 1.1 billion increase in off balance sheet (order bank  guarantees  forward deposit) and miscellaneous items vs. 31 December 2024.Ayvens had a strong Common Equity Tier 1 ratio of 13.2%  i.e. 385 basis points above the regulatory requirement of 9.35%  and Total Capital ratio of 17.2% as at 31 March 2025 compared to 12.6% and 16.4% respectively as at 31 December 2024.CONFERENCE CALL FOR INVESTORS AND ANALYSTSDate: 30 April  at 10.00 am Paris time â€“ 9.00 am London time30 April  at 10.00 am Paris time â€“ 9.00 am London time Speakers: Tim Albertsen  CEO / Patrick Sommelet  Deputy CEO and CFOCONNECTION DETAILSWebcast: Click https://edge.media-server.com/mmc/p/7dj3p2nbClick https://edge.media-server.com/mmc/p/7dj3p2nb Conference call: FR: +33 1 70 91 87 04 UK: +44 121 281 8004 US: +1 718 705 8796 Other countries: + 39 02 802 09 11 Access code: 457698AGENDA19 May 2025: General assembly of shareholdersGeneral assembly of shareholders 26 May 2025: Dividend detachmentDividend detachment 28 May 2025: Dividend paymentDividend payment 31 July 2025: Q2 and H1 2025 resultsQ2 and H1 2025 results 30 October 2025: Q3 and 9M 2025 resultsAbout Ayvens Ayvens is a leading global sustainable mobility player committed to making life flow better. Weâ€™ve been improving mobility for decades  providing full-service leasing  flexible subscription services  fleet management and multi-mobility solutions to large international corporates  SMEs  professionals and private individuals. With more than 14 000 employees across 41 countries  3.2 million vehicles and the worldâ€™s largest multi-brand EV fleet  we are in a unique position to lead the way to net zero and spearhead the digital transformation of the mobility sector. The company is listed on Compartment A of Euronext Paris (ISIN: FR0013258662; Ticker: AYV). Societe Generale Group is Ayvens majority shareholder.Find out more at ayvens.comPress contact Elise BoorÃ©eCommunications DepartmentTel: +33 (0)6 25 01 24 16elise.booree@ayvens.comThe information contained in this document (the â€œInformationâ€) has been prepared by Ayvens (the â€œCompanyâ€) solely for informational purposes. The Information is proprietary to the Company. This document and its content may not be reproduced or distributed or published  directly or indirectly  in whole or in part  to any other person for any purpose without the prior written permission of the Company.â€œAyvensâ€ refers to the Company and its consolidated entities.The Information is not an offer to buy or sell or a solicitation of an offer to buy or sell any security or instrument or to participate in any trading strategy  and does not constitute a recommendation of  or advice regarding investment in  any security or an offer to provide  or solicitation with respect to  any securities-related services of the Company. This document is information given in a summary form and does not purport to be complete. It is not intended to be relied upon as advice to investors or potential investors and does not take into account the investment objectives  financial situation or needs of any particular investor. Investors should consult the relevant offering documentation  with or without professional advice when deciding whether an investment is appropriate.This document contains forward-looking statements relating to the targets and strategies of the Company. These forward-looking statements are based on a series of assumptions  both general and specific  in particular the application of accounting principles and methods in accordance with IFRS (International Financial Reporting Standards) as adopted in the European Union. These forward-looking statements have also been developed from scenarios based on a number of economic assumptions in the context of a given competitive and regulatory environment. The Company may be unable to:- anticipate all the risks  uncertainties or other factors likely to affect its business and to appraise their potential consequences;- evaluate the extent to which the occurrence of a risk or a combination of risks could cause actual results to differ materially from those provided in this document.Therefore  although the Company believes that these statements are based on reasonable assumptions  these forward-looking statements are subject to various risks and uncertainties  including matters not yet known to it or its management or not currently considered material  and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include  among others  overall trends in general economic activity and in the Companyâ€™s markets in particular  regulatory and prudential changes  and the success of the Companyâ€™s strategic  operating and financial initiatives. Unless otherwise specified  the sources for the business rankings and market positions are internal.Other than as required by applicable law  the Company does not undertake any obligation to update or revise any forward-looking information or statements  opinion  projection  forecast or estimate set forth herein. More detailed information on the potential risks that could affect the Companyâ€™s financial results can be found in the 2024 Universal Registration Document filed with the French financial markets authority (AutoritÃ© des marchÃ©s financiers).Investors are advised to take into account factors of uncertainty and risk likely to impact the operations of the Company when considering the information contained in such forward-looking statements. To the maximum extent permitted by law  none of the Company or any of its affiliates  directors  officers  advisors and employees shall bear any liability (in negligence or otherwise) for any direct or indirect loss or damage which may be suffered by any recipient through use or reliance on anything contained in or omitted from this document and the related document or any other information or material arising from any use of its materials or their contents or otherwise arising in connection with these materials.The financial information presented for the three-month period ending 31 March 2025 was reviewed by the Board of Directors on 29 April 2025 and has been prepared in accordance with IFRS as adopted in the European Union and applicable at this date.By receiving this document and/or attending this document  you will be deemed to have represented  warranted and undertaken to have read and understood the above notice and to comply with its contents.AppendixCONSOLIDATED INCOME STATEMENTin EUR million Q1 2025 Q1 2024 Var. Leasing revenues 2 846.3 2 659.9 7.0% Leasing costs - depreciation (2 075.0) (2 008.9) -3.3% Leasing costs - financing (487.3) (443.1) -10.0% Unrealised gains/losses on financial instruments (18.9) 73.3 -125.8% Leasing margin 265.1 281.2 -5.7% Services revenues 1 270.0 1 414.1 -10.2% Cost of services revenues (826.7) (1 006.7) 17.9% Services margin 443.3 407.4 8.8% Leasing & Services margins 708.4 688.6 2.9% Proceeds of cars sold 2 313.4 2 157.9 7.2% Cost of cars sold (2 120.0) (1 905.9) -11.2% Depreciation costs adjustments (82.7) (147.5) 43.9% Used car sales result and Depreciation adjustments 110.6 104.5 5.8% Gross Operating Income 819.0 793.1 3.3% Staff expenses (289.6) (301.3) 3.9% General and administrative expenses (137.8) (140.1) 1.6% Depreciation and amortisation (45.4) (48.2) 5.8% Total operating expenses (472.8) (489.6) 3.4% Impairment charges on receivables (30.7) (33.1) 7.2% Other income / (expense) (1.0) 9.0 -110.8% Operating result 314.5 279.4 12.5% Share of profit of associates and jointly controlled entities 1.6 1.5 4.7% Profit before tax 316.0 280.9 12.5% Income tax expense (94.9) (88.4) -7.3% Net income 221.2 192.5 14.9% Non-controlling interests (1.2) (11.1) 89.0% Net income group share 219.9 181.3 21.3%BALANCE SHEET AS AT 31 MARCH 2025in EUR million 31 March 2025 31 December 2024 Earning assets 53 483 53 565 o/w Rental fleet 51 464 51 550 o/w Finance lease receivables 2 019 2 015 Cash & Cash deposits with the ECB 5 377 5 023 Intangibles (incl. goodwill) 2 788 2 791 Operating lease and other receivables 7 581 8 786 Other 4 410 4 951 Total assets 73 638 75 116 Group shareholders' equity 11 351 11 135 o/w Group shareholdersâ€™ equity excl. AT1 10 601 10 385 o/w AT1 750 750 Tangible shareholdersâ€™ equity 7 772 7 572 Non-controlling interests 28.9 27.2 Total equity 11 380 11 162 Deposits 14 500 13 891 Financial debt 38 209 40 142 Trade and other payables 6 321 6 465 Other liabilities 3 229 3 456 Total liabilities and equity 73 638 75 116EARNINGS PER SHARE (EPS)Basic EPS Q1 2025 Q1 2024 Existing shares 816 960 428 816 960 428 Shares allocated to cover stock options and shares awarded to staff (432 602) (839 734) Treasury shares in liquidity contracts (163 293) (143 312) End of period number of shares 816 364 533 815 977 382 Weighted average number of shares used for EPS calculation17 (A) 816 163 003 815 843 462 in EUR million Net income group share 219.9 181.3 Deduction of interest on AT1 capital (18.7) (18.3) Net income group share after deduction of interest on AT1 capital (B) 201.3 163.0 Basic EPS (in EUR) (B/A) 0.25 0.20 Diluted EPS Q1 2024 Q1 2023 Existing shares 816 960 428 816 960 428 Shares issued for no consideration18 19 530 557 17 995 041 End of period number of shares 836 490 985 834 955 469 Weighted average number of shares used for EPS calculation (A) 835 640 591 835 066 308 Diluted EPS (in EUR) (B/Aâ€™) 0.24 0.20Return on tangible equity (ROTE)in EUR million Q1 2025 Q1 202419 Group shareholders' equity 11 350.7 11 036.1 AT1 Capital (750.0) (750.0) Dividend provision and interest on AT1 capital20 (459.1) (520.5) OCI excluding conversion reserves 11.6 20.7 Equity base for ROE end of period 10 153.2 9 786.3 Goodwill 2 128.3 2 128.3 Intangible assets 659.6 660.3 Average equity base for ROE calculation 10 103.3 9 704.9 Average Goodwill 2 128.3 2 128.3 Average Intangible assets 661.3 653.1 Average tangible equity for ROTE calculation 7 313.8 6 923.5 Group net income after non-controlling interests 219.9 181.3 Interest on AT1 capital (18.7) (18.3) Adjusted Group net income 201.3 163.0 ROTE 11.0% 9.4%CRR2/CRD5 prudential capital ratios and Risk Weighted Assetsin EUR million 31-Mar-25 31-Dec-24 Group shareholdersâ€™ equity 11 351 11 135 AT1 capital (750) (750) Dividend provision & interest on AT1 capital21 (459) (340) Goodwill and intangible assets (2 788) (2 791) Deductions and regulatory adjustments 133 149 Common Equity Tier 1 capital 7 487 7 403 AT1 capital 750 750 Tier 1 capital 8 237 8 153 Tier 2 capital 1 500 1 500 Total capital (Tier 1 + Tier 2) 9 737 9 653 Risk-Weighted Assets 56 700 58 960 Credit Risk Weighted Assets 50 980 49 955 Market Risk Weighted Assets 2 666 2 547 Operational Risk Weighted Assets 3 054 6 458 Common Equity Tier 1 ratio 13.2% 12.6% Tier 1 ratio 14.5% 13.8% Total Capital ratio 17.2% 16.4%Tangible book value per sharein EUR million Q1 2025 Q1 2024 Group shareholders' equity 11 350.7 11 036.1 AT1 capital (750.0) (750.0) Interest on AT1 capital (56.2) (55.4) Book value of treasury shares 15.3 18.1 Net Asset Value (NAV) 10 559.8 10 248.8 Goodwill (2 128.3) (2 128.3) Intangible assets (659.6) (660.3) Net Tangible Asset Value (NTAV) 7 771.9 7 460.3 Number of shares22 816 364 533 815 977 382 NAV per share 12.94 12.6 NTAV per share 9.52 9.14 Net Tangible Asset Value (NTAV) after dividend provision23 7 369.0 6 995.2 NTAV per share after dividend provision 9.03 8.57 NTAV before dividend provision 9.52 9.14Quarterly series(in EUR million) Q1 2023 Q2 2023 Q3 2023 Q4 202324 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Leasing margin25 26 210.6 247.7 239.6 77.6 281.2 260.2 231.7 297.7 265.1 Services margin 26 156.2 293.2 413.1 388.4 407.4 426.7 414.8 377.5 443.3 Leasing and Services margins 366.7 540.9 652.7 466.1 688.6 686.9 646.5 675.2 708.4 Used Car Sales (UCS) result 233.2 269.5 321.1 254.7 252.0 234.0 222.3 199.6 193.4 Depreciation adjustments 131.7 (24.5) (141.7) (161.0) (147.5) (136.3) (145.2) (162.0) (82.7) UCS result and Depreciation adjustments 25 364.9 245.0 179.4 93.7 104.5 97.7 77.2 37.7 110.6 Gross operating income 731.6 785.9 832.2 559.8 793.1 784.5 723.7 712.9 819.0 Total operating expenses (260.5) (369.7) (444.5) (516.9) (489.6) (475.3) (459.9) (474.6) (472.8) Impairment charges on receivables (8.8) (15.7) (21.8) (24.4) (33.1) (30.5) (28.8) (36.1) (30.7) Other income/(expense) (20.6) 33.1 (12.4) (28.8) 9.0 (1.2) (7.3) (2.7) (1.0) Net result from equity method 0.8 0.8 3.3 1.6 1.5 2.3 2.0 4.4 1.6 Profit before tax 442.6 434.3 356.7 (8.7) 280.9 279.9 229.7 203.9 316.0 Income tax expense (125.6) (101.4) (131.5) (0.8) (88.4) (71.4) (81.6) (42.7) (94.9) Result from discontinued operations - (91.3) 14.0 (0.2) - - - - - Non-controlling interests (1.5) (4.8) (11.2) (10.4) (11.1) (12.5) (1.4) (1.6) (1.2) Net income group share 315.5 236.7 228.0 (20.2) 181.3 195.9 146.7 159.7 219.9 (in '000) Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Total Contracts 1 815 3 496 3 394 3 420 3 386 3 373 3 332 3 288 3 246 Full service leasing contracts 1 473 2 755 2 692 2 709 2 699 2 686 2 653 2 616 2 584 Fleet management contracts 342 741 703 710 686 686 680 672 6621 Excluding UCS result  non-recurring items and impact of PPA2 Management information3 Annualized impairment charges on receivables expressed as a percentage of average earning assets4 Net income group share after deduction of interest on AT1 capital divided by average shareholder equity before nonâ€‘controlling interests  goodwill and intangible assets5 Diluted Earnings per share  calculated according to IAS 33. Basic EPS for Q1 2025 at EUR 0.256 Net carrying amount of the rental fleet plus net receivables on finance leases7 Q1 2024 on a like-for-like perimeter  restated due to derecognition of Morocco as at 31 December 20248 Management information  in EU+: European Union  UK  Norway  Switzerland9 Battery Electric Vehicles (BEV) and Plug-in Hybrids (PHEV)10 Management information11 Annualized12 Management information13 Annualized impairment charges on receivables expressed as a percentage of arithmetic average of earning assets14 Calculated according to IAS 33. Basic EPS at EUR 0.25. Under IAS 33  EPS is computed using the average number of shares weighted by time apportionment15 Excluding Additional Tier 1 capital16 Before dividend provision17 Average number of shares weighted by time apportionment18 Assuming exercise of warrants as per IAS 3319 Group shareholdersâ€™ equity restated for PPA update and provision for UK motor finance commissions20 The dividend provision assumes a payout ratio of 50% of net Income group share  after deduction of interest on AT1 capital21 The dividend provision assumes a payout ratio of 50% of Net Income group share  after deduction of interest on AT1 capital22 The number of shares considered is the number of ordinary shares outstanding at end of period  excluding treasury shares23 The dividend provision assumes a payout ratio of 50% of net Income group share  after deduction of interest on AT1 capital24 Restated for the provision related to the UK motor finance commissions25 Change in presentation of GOI components: prospective depreciation was reclassified from Leasing costs â€“ depreciation in Leasing margin to Depreciation costs adjustments in Used car sales result and depreciation adjustments. This change is applied retrospectively to all periods.26 Reclassification of depreciation costs for short-term rental vehicles from Leasing to Services margin applied retrospectively to all periods from 2023.Attachment,neutral,0.37,0.63,0.0,mixed,0.7,0.2,0.09,True,English,"['Strong Q1 2025 financial results', 'integration', 'momentum', 'slower used car sales market normalization', 'new passenger car registrations', 'Net income group share', 'car sales result', 'twenty-one overlapping countries', 'several key milestones', 'target operating model', 'Gross operating income', 'strong financial performance', 'single IT platform', 'complementary commercial initiatives', 'strong performance results', 'Fleet management contracts', 'lower operating expenses', 'Ayvens net income', 'profitable growth path', 'average earning assets', 'Full-service leasing contracts', 'lower depreciation adjustments', 'Ayvensâ€™ business model', 'Q1 2025 FINANCIAL RESULTS', 'Q1 2025 Group results', 'higher used', 'income ratio1', 'Income statement', 'strong focus', 'IT activities', 'business portfolio', 'commercial momentum', 'Earning assets6', 'total fleet', 'Underlying margins1', 'UCS) result', 'UCS result', 'Tangible Equity', 'vehiclesâ€™ value', 'CET1 ratio', 'favourable impact', 'CRR3 implementation', 'Tim Albertsen', 'first quarter', 'high pace', 'work councils', 'corporate functions', 'outstanding execution', '2024 thorough review', 'coming quarters', 'high commitment', 'outstanding success', 'Asset growth', 'vehicle value', 'higher value', 'ICE cars', 'continued impacts', 'portfolio review', 'proactive actions', '662 thousand vehicles', '2,584 thousand vehicles', 'EV penetration', 'PHEV9 penetration', 'combined effects', 'growing benefits', 'robust ramp-up', 'Q1 2025 RESULTS', 'end December', 'Ayvensâ€™ BEV9', 'end March', 'Services margins', 'transformational journey', 'restructuring plans', 'increasing revenues', 'revenue synergies', 'integration roadmap', '31 March', 'unit', 'Q4', 'Synergies2', 'EUR', 'Cost', 'risk3', 'Return', 'ROTE', 'Earnings', 'share5', 'increase', '30 April', 'CEO', 'board', 'line', 'budget', 'deviation', 'half', 'country', 'approvals', 'organization', 'sustainable', 'targeted', 'clients', 'partners', 'year', 'teams', 'professionalism', 'resilience', 'transition', 'EVs', 'profitability', 'decrease', 'strength', 'measures', 'procurement', 'insurance', '562', '522', '23', '11.', '13.']",2025-04-30,2025-05-01,globenewswire.com
50428,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070959/0/en/Technip-Energies-First-Quarter-2025-Financial-Results.html,Technip Energies First Quarter 2025 Financial Results,TECHNIP ENERGIES Q1 2025 FINANCIAL RESULTS   A strong company in any scenario  Â   Â   Â   Â    Significant growth in the first quarter: Revenue +22% Y/Y...,TECHNIP ENERGIES Q1 2025 FINANCIAL RESULTSA strong company in any scenarioSignificant growth in the first quarter: Revenue +22% Y/Y to â‚¬1.85bn and Recurring EBITDA +19% Y/Y â‚¬162m2025 Group guidance confirmed with segment revenues updated and EBITDA margins unchanged: Project Delivery revenue: from â‚¬5.0 - 5.4bn to â‚¬5.2 - 5.6bn; Technology  Product & Services revenue: from â‚¬2.0 - 2.2bn to â‚¬1.8 - 2.2bnCommercial momentum remains strong across key markets including LNG  blue molecules and sustainable fuelsParis  Wednesday  April 30  2025. Technip Energies (the â€œCompanyâ€)  a global technology & engineering powerhouse leading in energy and decarbonization infrastructure  today announces its unaudited financial results for the first quarter of 2025.Arnaud Pieton  Chief Executive Officer of Technip Energies  commented:â€œTechnip Energies (T.EN) has made a solid start to 2025 with year-over-year growth of 22% in revenues and 19% in EBITDA. This performance is reflective of the quality of our order intake over the last two years  and our teamsâ€™ relentless focus on execution.â€â€œ2025 Group guidance is confirmed with robust revenue growth and segment EBITDA margins unchanged. Visibility for Project Delivery has improved year-to-date and accordingly we raise the segmentâ€™s 2025 revenue guidance. As a result of the uncertainty surrounding policies and the macro-economic environment  we have widened the revenue range for our shorter cycle segment - Technology  Products & Services. T.ENâ€™s vitals are strong - we have a world-class backlog providing extensive revenue coverage  we generate consistently strong free cash flows  and have a robust balance sheet that enables us to return cash to shareholders and capitalize on value enhancing investment opportunities.â€â€œAs we began 2025 with our highest ever backlog position  our foremost priority is execution. This involves key project completions over the next several quarters  as well as continued ramp-up of major projects awarded during 2023 and 2024. Concurrently  we are progressing on strategic initiatives  including implementation of our digital acceleration plan that will generate â‚¬100 million of annualized cost savings beyond 2028.â€â€œT.EN remains very active in terms of front-end engagement and bid proposals across many of our markets. Our commercial pipeline remains intact with more than â‚¬70 billion of opportunities over the next two years that are well diversified by geography and market. We are offering clients flexible sourcing and execution schemes to enable their projects to move forward with the assurance of T.ENâ€™s delivery capabilities and financial strength. Based on our customer engagement and the maturity of specific prospects  we remain positive about our order intake outlook in the coming periods.â€â€œAs an illustration  in April  we were awarded a major contract in the United States for Blue Point Number One ATR  the worldâ€™s largest low-carbon ammonia production facility. This award highlights our proven capabilities in modularization and delivering large-scale facilities that integrate state-of-the-art technologies. Technip Energies is part of the solution in a global effort towards a pragmatic  yet ambitious decarbonization.â€Key financials â€“ adjusted IFRS(In â‚¬ millions  except EPS and %) Q1 2025 Q1 2024 Revenue 1 853.1 1 520.8 Recurring EBITDA 162.0 136.6 Recurring EBITDA margin % 8.7% 9.0% Recurring EBIT 131.7 110.7 Recurring EBIT margin % 7.1% 7.3% Net profit 100.9 90.1 Diluted earnings per share(1) â‚¬0.56 â‚¬0.50Order intake 662.7 849.9 Backlog 18 207.0 15 258.8 Financial information is presented under adjusted IFRS (see Appendix 8.0 for complete definition). Reconciliation of IFRS to non-IFRS financial measures are provided in appendices.(1)Q1 2025 and Q1 2024 diluted earnings per share have been calculated using the weighted average number of outstanding shares of 180 562 144 and 182 050 239 respectively.Key financials â€“ IFRS(In â‚¬ millions  except EPS) Q1 2025 Q1 2024 Revenue 1 826.0 1 498.1 Net profit 102.6 90.8 Diluted earnings per share(1) â‚¬0.57 â‚¬0.50 (1) Q1 2025 and Q1 2024 diluted earnings per share have been calculated using the weighted average number of outstanding shares of 180 562 144 and 182 050 239 respectively.Updated 2025 full company guidance â€“ adjusted IFRSProject Delivery Technology  Products and Services Revenue â‚¬5.2 - 5.6 billion(prior guidance: â‚¬5.0 - 5.4 billion) â‚¬1.8 - 2.2 billion(prior guidance: â‚¬2.0 - 2.2 billion) EBITDA margin ~8% ~13.5% Corporate costs â‚¬50 - 60 million Effective tax rate(1) 26 - 30%Adjacent business model investment(2) < â‚¬50 million Financial information is presented under adjusted IFRS (see Appendix 8.0 for complete definition). Reconciliation of IFRS to non-IFRS financial measures are provided in appendices.(1) Subject to fiscal regime changes in key jurisdictions.(2) As part of its capital allocation framework for long-term value creation  the Company may invest in adjacent business models including Build Own Operate (BOO) and co-development. Since Q3 2024  these investment costs are recorded as non-recurring items.Conference call informationTechnip Energies will host its Q1 2025 results conference call and webcast on Wednesday  April 30  2025 at 14:00 CET. Dial-in details:France: +33 1 70 91 87 04United Kingdom: +44 121 281 8004United States: +1 718 7058796Conference Code: 880901The event will be webcast simultaneously and can be accessed at: T.EN Q1 2025 Results WebcastContactsInvestor RelationsPhillip LindsayVice President  Investor RelationsTel: +44 20 7585 5051Email: investor.relations@ten.comMedia RelationsJason HyonneManager  Press Relations & Social MediaTel: +33 1 47 78 22 89Email: media_@ten.comAbout Technip EnergiesTechnip Energies is a global technology and engineering powerhouse. With leadership positions in LNG  hydrogen  ethylene  sustainable chemistry  and CO 2 management  we are contributing to the development of critical markets such as energy  energy derivatives  decarbonization  and circularity. Our complementary business segments  Technology  Products and Services (TPS) and Project Delivery  turn innovation into scalable and industrial reality.Through collaboration and excellence in execution  our 17 000+ employees across 34 countries are fully committed to bridging prosperity with sustainability for a world designed to last.Technip Energies generated revenues of â‚¬6.9 billion in 2024 and is listed on Euronext Paris. The Company also has American Depositary Receipts trading over the counter.For further information: www.ten.com.Operational and financial reviewOrder intake  backlog and backlog schedulingAdjusted order intake for Q1 2025 amounted to â‚¬663 million  equivalent to a book-to-bill of 0.4.Adjusted order intake in the first quarter of 2025 included a Front-End Engineering Design (FEED) contract for the proposed new build Combined Cycle Gas Turbine (â€˜CCGTâ€™) power station with Carbon Capture and Storage  at Uniperâ€™s Connahâ€™s Quay site in the UK  as well as other studies  services contracts and smaller projects.(In â‚¬ millions) Q1 2025 Q1 2024 Adjusted order intake 662.7 849.9 Project Delivery 189.9 230.0 Technology  Products & Services 472.8 619.8 Reconciliation of IFRS to non-IFRS financial measures are provided in appendices.Adjusted backlog decreased by 7% to â‚¬18.2 billion compared to December 31  2024  equivalent to 2.7x FY 2024 adjusted revenue.(In â‚¬ millions) Q1 2025 FY 2024 Adjusted backlog 18 207.0 19 556.0 Project Delivery 16 254.0 17 536.2 Technology  Products & Services 1 953.0 2 019.8 Reconciliation of IFRS to non-IFRS financial measures are provided in appendices.Adjusted backlog at March 31  2025  has been negatively impacted by foreign exchange of â‚¬(269.0) million.The table below provides estimated backlog scheduling as of March 31  2025.(In â‚¬ millions) 2025 (9M) FY 2026 FY 2027+ Adjusted backlog 4 671.6 6 031.8 7 503.6 Project Delivery 3 642.6 5 514.9 7 096.4 Technology  Products & Services 1 028.9 516.9 407.2Company financial performanceAdjusted statement of income(In â‚¬ millions  except %) Q1 2025 Q1 2024 % Change Adjusted revenue 1 853.1 1 520.8 22% Adjusted recurring EBITDA 162.0 136.6 19% Adjusted recurring EBIT 131.7 110.7 19% Non-recurring items (9.9) (1.6) N/A EBIT 121.8 109.1 12% Financial income (expense)  net 25.7 19.9 29% Profit (loss) before income tax 147.5 129.0 14% Income tax (expense) profit (42.5) (33.7) 26% Net profit (loss) 105.0 95.3 10% Net profit (loss) attributable to Technip Energies Group 100.9 90.1 12% Net profit (loss) attributable to non-controlling interests 4.1 5.2 (21)%Business highlightsProject Delivery â€“ adjusted IFRS(In â‚¬ millions  except % and bps) Q1 2025 Q1 2024 % Change Revenue 1 402.7 1 045.5 34% Recurring EBITDA 113.8 89.1 28% Recurring EBITDA margin % 8.1% 8.5% (40) bps Recurring EBIT 101.1 78.5 29% Recurring EBIT margin % 7.2% 7.5% (30) bps Financial information is presented under adjusted IFRS (see Appendix 8.0 for complete definition).Q1 2025 Adjusted revenue increased by 34% year-over-year to â‚¬1 402.7 million driven by high activity on LNG projects in Qatar and the ramp-up of a new wave of projects  including GranMorgu.Q1 2025 Adjusted recurring EBITDA increased by 28% year-over-year to â‚¬113.8 million and Q1 2025 Adjusted recurring EBIT increased by 29% year-over-year to â‚¬101.1 million.Q1 2025 Adjusted recurring EBITDA / EBIT margin decreased year-over-year by 40 bps / 30 bps to 8.1% / 7.2%. After a period of strong order intake in 2023 and 2024  the margins reflect a re-balancing in our project portfolio  with a higher proportion of early-phase projects for which we recognize limited margin contribution.Q1 2025 Key operational milestonesQatarEnergy North Field Expansion (Qatar)Plant energization in progress and first water produced from desalination unit.Marsa LNG (Oman)Start of piling activity.Ruwais LNG (UAE)Piling activities and start of first foundation of LNG train.Assiut Hydrocracking Complex (Egypt)Pre-commissioning activities commenced. ~10 million workhours without a loss time incident (LTI).bp Net Zero Teesside Power Project (UK)First purchase orders placed; site officially open in preparation for the construction phase.Q1 2025 Key commercial and strategic highlightsTechnip Energies selected by Uniper to provide the FEED of Connahâ€™s Quay New Combined Cycle Power Plant with Carbon Capture (UK)Technip Energies has been awarded a Front-End Engineering Design (FEED) contract for the proposed new build Combined Cycle Gas Turbine (â€˜CCGTâ€™) power station with Carbon Capture and Storage (CCS)  at Uniperâ€™s Connahâ€™s Quay site; the Connahâ€™s Quay Low Carbon Power project. The facility would connect into nearby COâ‚‚ transport and storage infrastructure as part of the Hynet Cluster  located in the North West of the UK  which is one of the most industrialised areas of the country with significant sources of CO 2 emissions. Technip Energies  supported by Balfour Beatty and GE Vernova  will provide FEED services for the integration of the CCGT with Carbon Capture. In this first phase  Technip Energies will leverage its unique and state-of-the-art carbon capture solution  Canopy by T.EN TM   powered by Shellâ€™s CANSOLV* CO 2 Capture System. *CANSOLV is a Shell trademarkemissions. Technip Energies  supported by Balfour Beatty and GE Vernova  will provide FEED services for the integration of the CCGT with Carbon Capture. In this first phase  Technip Energies will leverage its unique and state-of-the-art carbon capture solution  Canopy by T.EN   powered by Shellâ€™s CANSOLV* CO Capture System.Technology  Products & Services (TPS) â€“ adjusted IFRS(In â‚¬ millions  except % and bps) Q1 2025 Q1 2024 Change Revenue 450.4 475.3 (5)% Recurring EBITDA 65.3 60.2 8% Recurring EBITDA margin % 14.5% 12.7% 180 bps Recurring EBIT 48.0 44.5 8% Recurring EBIT margin % 10.6% 9.4% 120 bps Financial information is presented under adjusted IFRS (see Appendix 8.0 for complete definition).Q1 2025 Adjusted revenue decreased year-over-year by 5% to â‚¬450.4 million  resulting from reduced proprietary equipment contribution  partially offset by strong volumes of services / studies  including decarbonization.Q1 2025 Adjusted recurring EBITDA increased year-over-year by 8% to â‚¬65.3 million and Adjusted recurring EBIT increased year-over-year by 8% to â‚¬48.0 million.Q1 2025 Adjusted recurring EBITDA margin increased by 180 bps to 14.5% and Adjusted recurring EBIT margin increased by 120 bps to 10.6% benefiting from technology licensing and proprietary equipment deliveries in ethylene.Q1 2025 Key operational milestonesINEOS Project One (Belgium)Last furnace modules shipment arrived in Antwerp and the furnaces have been positioned on their foundations.Neste Renewable Products Refinery Expansion - Capacity Growth Project  Rotterdam (Netherlands)98% of equipment and material delivered at site and 73% overall project progress.Numarligarh refinery expansion (India)Successful transportation and installation of the vacuum distillation column.Rakkestad C10 carbon capture project on waste incineration (Norway)Absorber and stripper columns installed. All major process modules installed.Shell Skyline Ethylene Furnace Revamp EPF (Netherlands)The 4th furnace  out of eight  was started up in March.AM Green Kakinada Project (India) - RelyStart of pilling activity.Q1 2025 Key commercial and strategic highlightsRely to support Verso Energy in the development of Seven e-Fuels Production Plants WorldwideRely  a joint venture between Technip Energies and John Cockerill  and Verso Energy signed a Memorandum of Understanding (MoU)  in view of the development by Verso Energy of seven e-Fuels production plants worldwide: four in France  two in Finland  and one in the United States. These facilities are expected to produce more than 500 000 tons of sustainable aviation fuel per year  with up to 90% lower lifecycle emissions than conventional jet fuel. This MoU is a first milestone in Rely becoming Verso Energyâ€™s partner of choice to conduct all pre-FID studies (Basic Engineering  pre-FEED  and FEED) for each of these plants  aiming to develop a standardized platform for Methanol-to-Jet production to reduce the levelized cost of the molecules through innovation  standardization and replication.Technip Energies expands in India with a new office and a Research & Innovation CenterTechnip Energies announces a strategic expansion in India with the opening of a new office near Ahmedabad in Gujarat International Finance Tec-City (GIFT City) and the inauguration of a state-of-the-art Research and Innovation Center set up within the Indian Institute of Technology Madras (IITM) Research Park in Chennai. These strategic initiatives strengthen Technip Energies' presence in India  enabling the company to deliver innovative  sustainable  and cost-effective energy solutions to clients both domestically and globally. The new office in Ahmedabad is Technip Energies' fourth operating center in India. Strategically located between Ahmedabad and Gandhinagar in GIFT City Indiaâ€™s first operational Smart city  it will offer a thriving ecosystem including world-class facilities and a business-friendly environment. With access to Gujaratâ€™s skilled talent pool and robust infrastructure  the new office will employ around 300 people in 2025  supporting Technip Energiesâ€™ expansion while contributing to the regionâ€™s economic development.Q1 2025 Other key commercial and strategic highlightsReju Partners with Cibutex to Establish a Circular Textile EcosystemRejuâ„¢  the progressive textile-to-textile regeneration company  and Cibutex  a cooperative of companies dedicated to establishing a more sustainable textile supply chain  announced they have signed a partnership. Through this collaboration  Reju and Cibutex will work to establish an ecosystem among Cibutex member companies. This partnership will deliver feedstock supply of secondary raw materials derived from post-consumer textile waste to Reju for the recycling and the production of regenerated Reju Polyesterâ„¢. This provides circular regeneration opportunities using Rejuâ€™s innovative textile-to-textile recycling technology. Reju is pioneering a global infrastructure for large-scale textile waste regeneration  starting with polyester. Reju Polyesterâ„¢  will have a 50% lower carbon footprint compared to virgin polyester and can be regenerated infinitely. This partnership with Cibutex will see materials from the cooperativeâ€™s member companies processed at Rejuâ€™s Regeneration Hub Zero in Frankfurt  Germany  which will be fully operational in 2025 and at future Reju Regeneration Hubs.Corporate and other itemsCorporate costs  excluding non-recurring items  were â‚¬17.4 million for the first quarter of 2025  and included the impact of supplemental French social charges on long-term incentive plans.Non-recurring expense amounted to â‚¬9.9 million and includes costs incurred relating to adjacent business models  notably for Reju.Net financial income of â‚¬25.7 million benefited from interest income generated from cash and cash equivalents  partially offset by the cost of debt  lease expense and pension costs.Effective tax rate on an adjusted IFRS basis was 28.8% for Q1 2025  consistent with the 2025 guidance range of 26%-30%.Depreciation and amortization expense was â‚¬30.3 million  of which â‚¬19.2 million is related to IFRS 16.Gross cash at March 31  2025 was â‚¬4.0 billion  which compares to â‚¬4.1 billion at December 31  2024. Gross debt was â‚¬0.7 billion at March 31  2025  which is consistent with the position at December 31  2024.Adjusted free cash flow was â‚¬84.9 million for Q1 2025. Adjusted free cash flow  excluding the working capital and provisions variance of â‚¬94.4 million  was â‚¬179.3 million benefiting from strong operational performance and consistently high conversion from Adjusted recurring EBITDA of 111% (conversion from Adjusted recurring EBIT was 136%). Free cash flow is stated after capital expenditures of â‚¬19.1 million. Adjusted operating cash flow was â‚¬104.0 million.LiquidityAdjusted liquidity of â‚¬4.8 billion at March 31  2025 comprised of â‚¬4.0 billion of cash and â‚¬750 million of liquidity provided by the Companyâ€™s undrawn revolving credit facility.The Companyâ€™s revolving credit facility was successfully refinanced in March 2025 with five years maturity to March 2030  with two additional one-year extension options. The facility is available for general use and serves as a backstop for the Companyâ€™s commercial paper program.Forward-looking statementsThis press release contains forward-looking statements that reflect Technip Energiesâ€™ (the â€œCompanyâ€) intentions  beliefs or current expectations and projections about the Companyâ€™s future results of operations  anticipated revenues  earnings  cashflows  financial condition  liquidity  performance  prospects  anticipated growth  strategies and opportunities and the markets in which the Company operates. Forward-looking statements are often identified by the words â€œbelieveâ€  â€œexpectâ€  â€œanticipateâ€  â€œplanâ€  â€œintendâ€  â€œforeseeâ€  â€œshouldâ€  â€œwouldâ€  â€œcouldâ€  â€œmayâ€  â€œestimateâ€  â€œoutlookâ€  and similar expressions  including the negative thereof. The absence of these words  however  does not mean that the statements are not forward-looking. These forward-looking statements are based on the Companyâ€™s current expectations  beliefs and assumptions concerning future developments and business conditions and their potential effect on the Company. While the Company believes that these forward-looking statements are reasonable as and when made  there can be no assurance that future developments affecting the Company will be those that the Company anticipates.All of the Companyâ€™s forward-looking statements involve risks and uncertainties  some of which are significant or beyond the Companyâ€™s control  and assumptions that could cause actual results to differ materially from the Companyâ€™s historical experience and the Companyâ€™s present expectations or projections. Should one or more of these risks or uncertainties materialize  or should underlying assumptions prove incorrect  actual results may vary materially from those set forth in the forward-looking statements.For information regarding known material factors that could cause actual results to differ from projected results  please see the Companyâ€™s risk factors set forth in the Companyâ€™s 2024 Annual Financial Report filed on March 10  2025  with the Dutch Autoriteit FinanciÃ«le Markten (AFM) and the French AutoritÃ© des MarchÃ©s Financiers (AMF)  which includes a discussion of factors that could affect the Companyâ€™s future performance and the markets in which the Company operates.Forward-looking statements involve inherent risks and uncertainties and speak only as of the date they are made. The Company undertakes no duty to and will not necessarily update any of the forward-looking statements in light of new information or future events  except to the extent required by applicable law.APPENDIXAPPENDIX 1.0: ADJUSTED STATEMENT OF INCOME - FIRST QUARTER 2025(In â‚¬ millions)ProjectDelivery Technology  Products & Services Corporate/non allocable Total Q1 25 Q1 24 Q1 25 Q1 24 Q1 25 Q1 24 Q1 25 Q1 24 Adjusted revenue 1 402.7 1 045.5 450.4 475.3 â€” â€” 1 853.1 1 520.8 Adjusted recurring EBIT 101.1 78.5 48.0 44.5 (17.4) (12.3) 131.7 110.7 Non-recurring items (transaction & one-off costs) (3.4) (0.1) (4.4) 0.5 (2.1) (2.0) (9.9) (1.6) EBIT 97.7 78.4 43.6 45.0 (19.5) (14.3) 121.8 109.1 Financial income35.1 38.2 Financial expense(9.3) (18.3) Profit (loss) before income tax147.5 129.0 Income tax (expense) profit(42.5) (33.7) Net profit (loss)105.0 95.3 Net profit (loss) attributable to Technip Energies Group100.9 90.1 Net profit (loss) attributable to non-controlling interests4.1 5.2APPENDIX 1.1: STATEMENT OF INCOME - RECONCILIATION BETWEEN IFRS AND ADJUSTED - FIRST QUARTER 2025(In â‚¬ millions) Q1 25IFRS Adjustments Q1 25Adjusted Revenue 1 826.0 27.1 1 853.1 Costs and expensesCost of sales (1 579.8) (23.7) (1 603.5) Selling  general and administrative expense (98.5) (0.6) (99.1) Research and development expense (14.1) â€” (14.1) Impairment  restructuring and other expense (9.9) â€” (9.9) Other operating income (expense)  net (2.3) (1.3) (3.6) Operating profit (loss) 121.3 1.6 122.9 Share of profit (loss) of equity-accounted investees 3.9 (5.0) (1.1) Profit (loss) before financial income (expense)  net and income tax 125.2 (3.4) 121.8 Financial income 33.8 1.3 35.1 Financial expense (9.3) â€” (9.3) Profit (loss) before income tax 149.6 (2.1) 147.5 Income tax (expense) profit (42.9) 0.4 (42.5) Net profit (loss) 106.7 (1.7) 105.0 Net profit (loss) attributable to Technip Energies Group 102.6 (1.7) 100.9 Net profit (loss) attributable to non-controlling interests 4.1 â€” 4.1APPENDIX 1.2: STATEMENT OF INCOME - RECONCILIATION BETWEEN IFRS AND ADJUSTED - FIRST QUARTER 2024(In â‚¬ millions) Q1 24IFRS Adjustments Q1 24Adjusted Revenue 1 498.1 22.7 1 520.8 Costs and expensesCost of sales (1 279.2) (17.6) (1 296.8) Selling  general and administrative expense (100.6) (0.4) (101.0) Research and development expense (14.4) 0.3 (14.1) Impairment  restructuring and other expense (1.6) â€” (1.6) Other operating income (expense)  net 3.1 (1.3) 1.8 Operating profit (loss) 105.2 3.8 109.0 Share of profit (loss) of equity-accounted investees 5.9 (5.8) 0.1 Profit (loss) before financial income (expense)  net and income tax 111.1 (2.0) 109.1 Financial income 36.5 1.7 38.2 Financial expense (18.2) (0.1) (18.3) Profit (loss) before income tax 129.4 (0.4) 129.0 Income tax (expense) profit (33.7) â€” (33.7) Net profit (loss) 95.7 (0.4) 95.3 Net profit (loss) attributable to Technip Energies Group 90.8 (0.7) 90.1 Net profit (loss) attributable to non-controlling interests 4.9 0.3 5.2APPENDIX 2.0: ADJUSTED STATEMENT OF FINANCIAL POSITION(In â‚¬ millions) Q1 25 FY 24 Goodwill 2 100.1 2 118.0 Intangible assets 150.0 145.3 Property  plant and equipment 164.7 167.4 Right-of-use assets 214.0 201.8 Equity accounted investees 18.7 20.1 Other non-current assets 323.7 331.1 Total non-current assets 2 971.2 2 983.7 Trade receivables 1 266.7 1 078.7 Contract assets 525.6 485.9 Other current assets 791.1 785.8 Cash and cash equivalents 4 028.8 4 058.0 Total current assets 6 612.2 6 408.4 Total assets 9 583.4 9 392.0 Total equity 2 224.0 2 114.8 Long-term debt  less current portion 642.4 642.4 Lease liabilities 191.7 192.4 Accrued pension and other post-retirement benefits  less current portion 127.8 126.0 Other non-current liabilities 151.6 169.7 Total non-current liabilities 1 113.5 1 130.5 Short-term debt 89.8 93.8 Lease liabilities 66.1 57.4 Accounts payable  trade 1 639.5 1 642.6 Contract liabilities 3 581.4 3 466.3 Other current liabilities 869.1 886.6 Total current liabilities 6 245.9 6 146.7 Total liabilities 7 359.4 7 277.2 Total equity and liabilities 9 583.4 9 392.0APPENDIX 2.1: STATEMENT OF FINANCIAL POSITION - RECONCILIATION BETWEEN IFRS AND ADJUSTED - FIRST QUARTER 2025(In â‚¬ millions) Q1 25IFRS Adjustments Q1 25Adjusted Goodwill 2 100.1 â€” 2 100.1 Intangible assets 150.0 â€” 150.0 Property  plant and equipment 163.3 1.4 164.7 Right-of-use assets 213.6 0.4 214.0 Equity accounted investees 98.9 (80.2) 18.7 Other non-current assets 324.7 (1.0) 323.7 Total non-current assets 3 050.6 (79.4) 2 971.2 Trade receivables 1 254.6 12.1 1 266.7 Contract assets 524.5 1.1 525.6 Other current assets 752.6 38.5 791.1 Cash and cash equivalents 3 869.4 159.4 4 028.8 Total current assets 6 401.1 211.1 6 612.2 Total assets 9 451.7 131.7 9 583.4 Total equity 2 225.6 (1.6) 2 224.0 Long-term debt  less current portion 637.8 4.6 642.4 Lease liabilities 191.7 â€” 191.7 Accrued pension and other post-retirement benefits  less current portion 126.7 1.1 127.8 Other non-current liabilities 242.0 (90.4) 151.6 Total non-current liabilities 1 198.2 (84.7) 1 113.5 Short-term debt 89.8 â€” 89.8 Lease liabilities 65.8 0.3 66.1 Accounts payable  trade 1 542.6 96.9 1 639.5 Contract liabilities 3 465.9 115.5 3 581.4 Other current liabilities 863.8 5.3 869.1 Total current liabilities 6 027.9 218.0 6 245.9 Total liabilities 7 226.1 133.3 7 359.4 Total equity and liabilities 9 451.7 131.7 9 583.4APPENDIX 2.2: STATEMENT OF FINANCIAL POSITION - RECONCILIATION BETWEEN IFRS AND ADJUSTED - FIRST QUARTER 2024(In â‚¬ millions) Q1 24IFRS Adjustments Q1 24Adjusted Goodwill 2 099.6 â€” 2 099.6 Intangible assets 122.7 (2.8) 119.9 Property  plant and equipment 118.8 1.4 120.2 Right-of-use assets 201.5 0.6 202.1 Equity accounted investees 106.9 (81.4) 25.5 Other non-current assets 312.6 (3.4) 309.2 Total non-current assets 2 962.1 (85.6) 2 876.5 Trade receivables 1 207.1 (12.1) 1 195.0 Contract assets 444.6 3.2 447.8 Other current assets 791.6 34.6 826.2 Cash and cash equivalents 3 285.3 205.1 3 490.4 Total current assets 5 728.6 230.8 5 959.4 Total assets 8 690.7 145.2 8 835.9 Total equity 2 015.7 5.4 2 021.1 Long-term debt  less current portion 637.3 4.5 641.8 Lease liabilities 169.6 0.2 169.8 Accrued pension and other post-retirement benefits  less current portion 113.4 1.6 115.0 Other non-current liabilities 232.2 (81.9) 150.3 Total non-current liabilities 1 152.5 (75.6) 1 076.9 Short-term debt 135.2 â€” 135.2 Lease liabilities 65.8 0.4 66.2 Accounts payable  trade 1 408.1 83.9 1 492.0 Contract liabilities 3 076.8 118.5 3 195.3 Other current liabilities 836.6 12.6 849.2 Total current liabilities 5 522.5 215.4 5 737.9 Total liabilities 6 675.0 139.8 6 814.8 Total equity and liabilities 8 690.7 145.2 8 835.9APPENDIX 3.0: ADJUSTED STATEMENT OF CASH FLOWS(In â‚¬ millions) Q1 25 Q1 24 Net profit (loss) 105.0 95.3 Change in working capital and provisions (94.4) (177.5) Non-cash items and other 93.4 31.9 Cash provided (required) by operating activities 104.0 (50.3) Acquisition of property  plant  equipment and intangible assets (19.5) (7.9) Acquisition of financial assets (0.7) (4.4) Acquisition of subsidiary  net of cash acquired â€” 1.2 Proceeds from disposal of assets 0.4 â€” Proceeds from disposals of subsidiaries  net of cash disposed â€” (1.3) Other 0.3 â€” Cash provided (required) by investing activities (19.5) (12.4) Net increase (repayment) in long-term  short-term debt and commercial paper (4.2) 8.8 Payments for acquisition of treasury shares â€” (9.0) Share issue and buy-back transaction costs â€” (0.7) Payments for the principal portion of lease liabilities (20.3) (14.5) Other (of which dividends paid to non-controlling interests) (17.7) (18.7) Cash provided (required) by financing activities (42.3) (34.1) Effect of changes in foreign exchange rates on cash and cash equivalents (71.4) 18.0 (Decrease) Increase in cash and cash equivalents (29.2) (78.8) Cash and cash equivalents  beginning of period 4 058.0 3 569.2 Cash and cash equivalents  end of period 4 028.8 3 490.4APPENDIX 3.1: STATEMENT OF CASH FLOWS - RECONCILIATION BETWEEN IFRS AND ADJUSTED - FIRST QUARTER 2025(In â‚¬ millions) Q1 25IFRS Adjustments Q1 25Adjusted Net profit (loss) 106.7 (1.7) 105.0 Change in working capital and provisions (48.3) (46.1) (94.4) Non-cash items and other 94.9 (1.5) 93.4 Cash provided (required) by operating activities 153.3 (49.3) 104.0 Acquisition of property  plant  equipment and intangible assets (19.5) â€” (19.5) Acquisition of financial assets (0.7) â€” (0.7) Proceeds from disposal of assets 0.4 â€” 0.4 Other 0.3 â€” 0.3 Cash provided (required) by investing activities (19.5) â€” (19.5) Net increase (repayment) in long-term  short-term debt and commercial paper (4.3) 0.1 (4.2) Payments for the principal portion of lease liabilities (20.2) (0.1) (20.3) Other (of which dividends paid to non-controlling interests) (17.7) â€” (17.7) Cash provided (required) by financing activities (42.2) (0.1) (42.3) Effect of changes in foreign exchange rates on cash and cash equivalents (68.9) (2.5) (71.4) (Decrease) Increase in cash and cash equivalents 22.7 (51.9) (29.2) Cash and cash equivalents  beginning of period 3 846.7 211.3 4 058.0 Cash and cash equivalents  end of period 3 869.4 159.4 4 028.8APPENDIX 3.2: STATEMENT OF CASH FLOWS - RECONCILIATION BETWEEN IFRS AND ADJUSTED - FIRST QUARTER 2024(In â‚¬ millions) Q1 24IFRS Adjustments Q1 24Adjusted Net profit (loss) 95.7 (0.4) 95.3 Change in working capital and provisions (159.3) (18.2) (177.5) Non-cash items and other 23.6 8.3 31.9 Cash provided (required) by operating activities (40.0) (10.3) (50.3) Acquisition of property  plant  equipment and intangible assets (7.5) (0.4) (7.9) Acquisition of financial assets (4.4) â€” (4.4) Acquisition of subsidiary  net of cash acquired â€” 1.2 1.2 Proceeds from disposals of subsidiaries  net of cash disposed (1.3) â€” (1.3) Cash provided (required) by investing activities (13.2) 0.8 (12.4) Net increase (repayment) in long-term  short-term debt and commercial paper 8.5 0.3 8.8 Payments for acquisition of treasury shares (9.0) â€” (9.0) Share issue and buy-back transaction costs (0.7) â€” (0.7) Settlements of mandatorily redeemable financial liability (16.0) 16.0 â€” Payments for the principal portion of lease liabilities (14.4) (0.1) (14.5) Other (of which dividends paid to non-controlling interests) (18.7) â€” (18.7) Cash provided (required) by financing activities (50.3) 16.2 (34.1) Effect of changes in foreign exchange rates on cash and cash equivalents 17.8 0.2 18.0 (Decrease) Increase in cash and cash equivalents (85.7) 6.9 (78.8) Cash and cash equivalents  beginning of period 3 371.0 198.2 3 569.2 Cash and cash equivalents  end of period 3 285.3 205.1 3 490.4APPENDIX 4.0: ADJUSTED ALTERNATIVE PERFORMANCE MEASURES - FIRST QUARTER 2025(In â‚¬ millions  except %) Q1 25 % of revenues Q1 24 % of revenues Adjusted revenue 1 853.11 520.8Cost of sales (1 603.5) 86.5% (1 296.8) 85.3% Adjusted gross margin 249.7 13.5% 224.0 14.7% Adjusted recurring EBITDA 162.0 8.7% 136.6 9.0% Amortization  depreciation and impairment (30.3)(25.9)Adjusted recurring EBIT 131.7 7.1% 110.7 7.3% Non-recurring items (9.9)(1.6)Adjusted profit (loss) before financial income (expense)  net and income tax 121.8 6.6% 109.1 7.2% Financial income (expense)  net 25.719.9Adjusted profit (loss) before tax 147.5 8.0% 129.0 8.5% Income tax (expense) profit (42.5)(33.7)Adjusted net profit (loss) 105.0 5.7% 95.3 6.3%APPENDIX 5.0: ADJUSTED RECURRING EBIT AND EBITDA RECONCILIATION - FIRST QUARTER 2025(In â‚¬ millions)ProjectDelivery Technology  Products & Services Corporate/non allocable Total Q1 25 Q1 24 Q1 25 Q1 24 Q1 25 Q1 24 Q1 25 Q1 24 Revenue 1 402.7 1 045.5 450.4 475.3 â€” â€” 1 853.1 1 520.8 Profit (loss) before financial income (expense)  net and income tax121.8 109.1 Non-recurring items:Other non-recurring income/(expense)9.9 1.6 Adjusted recurring EBIT 101.1 78.5 48.0 44.5 (17.4) (12.3) 131.7 110.7 Adjusted recurring EBIT margin % 7.2% 7.5% 10.6% 9.4% â€”% â€”% 7.1% 7.3% Adjusted amortization and depreciation (12.7) (10.6) (17.3) (15.7) (0.4) 0.3 (30.3) (25.9) Adjusted recurring EBITDA 113.8 89.1 65.3 60.2 (17.0) (12.7) 162.0 136.6 Adjusted recurring EBITDA margin % 8.1% 8.5% 14.5% 12.7% â€”% â€”% 8.7% 9.0%APPENDIX 6.0: BACKLOG - RECONCILIATION BETWEEN IFRS AND ADJUSTED(In â‚¬ millions) Q1 25IFRS Adjustments Q1 25Adjusted Project Delivery 16 359.4 (105.4) 16 254.0 Technology  Products & Services 1 934.8 18.2 1 953.0 Total 18 294.218 207.0APPENDIX 7.0: ORDER INTAKE - RECONCILIATION BETWEEN IFRS AND ADJUSTED(In â‚¬ millions) Q1 25IFRS Adjustments Q1 25Adjusted Project Delivery 190.7 (0.8) 189.9 Technology  Products & Services 465.4 7.4 472.8 Total 656.1662.7APPENDIX 8.0: Definition of Alternative Performance Measures (APMs)Certain parts of this Press Release contain the following non-IFRS financial measures: Adjusted Revenue  Adjusted Recurring EBIT  Adjusted Recurring EBITDA  Adjusted net (debt) cash  Adjusted Backlog  and Adjusted Order Intake  which are not recognized as measures of financial performance or liquidity under IFRS and which the Company considers to be APMs. APMs should not be considered an alternative to  or more meaningful than  the equivalent measures as determined in accordance with IFRS or as an indicator of the Companyâ€™s operating performance or liquidity.Each of the APMs is defined below:Adjusted revenue: represents the revenue recognized under IFRS as adjusted according to the method described below. For the periods presented in this Press Release  the Companyâ€™s proportionate share of joint venture revenue from the following most material projects was included: the revenue from ENI CORAL FLNG and NFE is included at 50% and the revenue from BAPCO Sitra Refinery is included at 36%. The Company believes that presenting the proportionate share of its joint venture revenue in construction projects carried out in joint arrangements enables management and investors to better evaluate the performance of the Companyâ€™s core business period-over-period by assisting them in more accurately understanding the activities actually performed by the Company on these projects.represents the revenue recognized under IFRS as adjusted according to the method described below. For the periods presented in this Press Release  the Companyâ€™s proportionate share of joint venture revenue from the following most material projects was included: the revenue from ENI CORAL FLNG and NFE is included at 50% and the revenue from BAPCO Sitra Refinery is included at 36%. The Company believes that presenting the proportionate share of its joint venture revenue in construction projects carried out in joint arrangements enables management and investors to better evaluate the performance of the Companyâ€™s core business period-over-period by assisting them in more accurately understanding the activities actually performed by the Company on these projects. Adjusted recurring EBIT: represents profit before financial income (expense)  net  and income taxes recorded under IFRS as adjusted to reflect line-by-line for their respective share incorporated construction project entities that are not fully owned by the Company (applying to the method described above under Adjusted Revenue) and adds or removes  as appropriate  items that are considered as non-recurring from EBIT (such as restructuring expenses  costs arising out of significant litigation that have arisen outside of the ordinary course of business and other non-recurring expenses). The Company believes that the exclusion of such expenses or profits from these financial measures enables investors and management to evaluate the Companyâ€™s operations and consolidated results of operations period-over-period  and to identify operating trends that could otherwise be masked to both investors and management by the excluded items.represents profit before financial income (expense)  net  and income taxes recorded under IFRS as adjusted to reflect line-by-line for their respective share incorporated construction project entities that are not fully owned by the Company (applying to the method described above under Adjusted Revenue) and adds or removes  as appropriate  items that are considered as non-recurring from EBIT (such as restructuring expenses  costs arising out of significant litigation that have arisen outside of the ordinary course of business and other non-recurring expenses). The Company believes that the exclusion of such expenses or profits from these financial measures enables investors and management to evaluate the Companyâ€™s operations and consolidated results of operations period-over-period  and to identify operating trends that could otherwise be masked to both investors and management by the excluded items. Adjusted recurring EBITDA: corresponds to the adjusted recurring EBIT as described above before depreciation and amortization expenses.corresponds to the adjusted recurring EBIT as described above before depreciation and amortization expenses. Adjusted net (debt) cash: reflects cash and cash equivalents  net of debt (including short-term debt)  as adjusted according to the method described above under adjusted revenue. Management uses this APM to evaluate the Companyâ€™s capital structure and financial leverage. The Company believes adjusted net (debt) cash  is a meaningful financial measure that may assist investors in understanding the Companyâ€™s financial condition and recognizing underlying trends in its capital structure.reflects cash and cash equivalents  net of debt (including short-term debt)  as adjusted according to the method described above under adjusted revenue. Management uses this APM to evaluate the Companyâ€™s capital structure and financial leverage. The Company believes adjusted net (debt) cash  is a meaningful financial measure that may assist investors in understanding the Companyâ€™s financial condition and recognizing underlying trends in its capital structure. Adjusted backlog: backlog is calculated as the estimated sales value of unfilled  confirmed customer orders at the relevant reporting date. Adjusted backlog takes into account the Companyâ€™s proportionate share of backlog related to equity affiliates (mainly in relation to ENI Coral FLNG  BAPCO Sitra Refinery and two affiliates of the NFE joint-venture). The Company believes that the adjusted backlog enables management and investors to evaluate the level of the Companyâ€™s core business forthcoming activities by including its proportionate share in the estimated sales coming from construction projects in joint arrangements.backlog is calculated as the estimated sales value of unfilled  confirmed customer orders at the relevant reporting date. Adjusted backlog takes into account the Companyâ€™s proportionate share of backlog related to equity affiliates (mainly in relation to ENI Coral FLNG  BAPCO Sitra Refinery and two affiliates of the NFE joint-venture). The Company believes that the adjusted backlog enables management and investors to evaluate the level of the Companyâ€™s core business forthcoming activities by including its proportionate share in the estimated sales coming from construction projects in joint arrangements. Adjusted order intake: order intake corresponds to signed contracts which have come into force during the reporting period. Adjusted order intake adds the proportionate share of orders signed related to equity affiliates (mainly in relation to ENI Coral FLNG  BAPCO Sitra Refinery and two affiliates of the NFE joint-venture). This financial measure is closely connected with the adjusted backlog in the evaluation of the level of the Companyâ€™s forthcoming activities by presenting its proportionate share of contracts which came into force during the period and that will be performed by the Company.â€¢ContactsInvestor RelationsPhillip LindsayVice President  Investor RelationsTel: +44 20 7585 5051Email: investor.relations@ten.comMedia RelationsJason HyonneManager  Press Relations & Social MediaTel: +33 1 47 78 22 89Email: media_@ten.comAttachment,neutral,0.0,1.0,0.0,positive,0.7,0.3,0.01,True,English,"['First Quarter 2025 Financial Results', 'Technip Energies', 'largest low-carbon ammonia production facility', 'Blue Point Number One ATR', 'highest ever backlog position', 'Adjacent business model investment', 'strong free cash flows', 'adjacent business models', 'Chief Executive Officer', 'last two years', 'robust balance sheet', 'next several quarters', 'digital acceleration plan', 'annualized cost savings', 'next two years', 'Effective tax rate', 'fiscal regime changes', 'capital allocation framework', 'Build Own Operate', 'extensive revenue coverage', 'long-term value creation', 'key project completions', 'unaudited financial results', 'shorter cycle segment', 'order intake outlook', 'Recurring EBIT margin', 'robust revenue growth', 'Project Delivery revenue', 'Q1 2024 diluted earnings', 'Recurring EBITDA margin', 'Project Delivery Technology', '2025 full company guidance', 'IFRS financial measures', 'TECHNIP ENERGIES Q1', 'blue molecules', 'world-class backlog', 'average number', 'strong company', 'investment opportunities', 'delivery capabilities', 'financial strength', 'Financial information', 'Significant growth', '2025 revenue guidance', 'Q1 2024 Revenue', 'Key financials', 'key jurisdictions', '2025 Group guidance', 'prior guidance', 'revenue range', 'first quarter', 'EBITDA margins', 'Commercial momentum', 'sustainable fuels', 'engineering powerhouse', 'decarbonization infrastructure', 'Arnaud Pieton', 'T.EN', 'solid start', 'relentless focus', 'macro-economic environment', 'foremost priority', 'strategic initiatives', 'front-end engagement', 'bid proposals', 'commercial pipeline', 'flexible sourcing', 'customer engagement', 'specific prospects', 'coming periods', 'major contract', 'United States', 'proven capabilities', 'large-scale facilities', 'art technologies', 'global effort', 'ambitious decarbonization', 'Net profit', 'complete definition', 'outstanding shares', 'Corporate costs', 'year growth', 'Services revenue', 'global technology', 'key markets', 'major projects', 'execution schemes', 'segment revenues', 'scenario', 'LNG', 'Paris', 'Wednesday', 'April', 'energy', 'performance', 'quality', 'Visibility', 'uncertainty', 'policies', 'Products', 'vitals', 'shareholders', 'ramp-up', 'implementation', 'terms', 'â‚¬70 billion', 'geography', 'clients', 'assurance', 'maturity', 'illustration', 'award', 'modularization', 'part', 'solution', 'EPS', 'Appendix', 'Reconciliation', 'appendices', 'millions', 'BOO', 'development', 'Q3', '2023']",2025-04-30,2025-05-01,globenewswire.com
50429,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2025/04/30/3070930/0/en/Societe-Generale-First-quarter-2025-earnings.html,Societe Generale: First quarter 2025 earnings,RESULTS AT 31 MARCH 2025Press......,RESULTS AT 31 MARCH 2025Press releaseParis  30 April 2025STRONG QUARTERLY RESULTS  AHEAD OF OUR 2025 TARGETSQuarterly revenues of EUR 7.1 billion  +6.6% vs. Q1 24 and +10.2% excluding asset disposals(vs. an annual target of more than +3%). Positive contribution from all businesses  driven by a strong rebound in French Retail Banking  a solid performance of Global Banking and Investor Solutions and a sustained activity in Mobility  International Retail Banking and Financial ServicesStrict cost management with operating expenses down -4.4% vs. Q1 24  excluding asset disposals. Ahead of our 2025 target to reduce operating expenses by more than -1%  excluding asset disposalsCost-to-income ratio at 65.0% in Q1 25  ahead of our 2025 target (<66%)Low cost of risk at 23 basis points in Q1 25  below the 2025 target of 25 to 30 basis points. The amount of S1/S2 provisions remains high at EUR 3.1 billion (more than 2x 2024 cost of risk)  and has been further increasedGroup net income of EUR 1 608 million  x2.4 vs. Q1 24Profitability (ROTE) at 11.0%  ahead of our 2025 target of more than 8%. Even if restated for net gains on asset disposals of around EUR 200 million and considering a quarterly linear distribution of taxes (IFRIC 21) for an amount of around EUR 300 million  the ROTE stands at 10.9%SOLID CAPITAL AND LIQUIDITY PROFILECET1 ratio of 13.4%1 at end-Q1 25  around 320 basis points above the regulatory requirementLiquidity Coverage Ratio at 140% at end-Q1 25Provision for distribution of EUR 0.912 per share  at end-March 2025Completion of the 2024 share buy-back programme of EUR 872 millionORDERLY EXECUTION OF ASSET DISPOSALSDisposal of SGEFâ€™s activities completed on 28 February 2025  except for those in the Czech Republic and Slovakia  representing a positive impact of around +30 basis points on the Groupâ€™s CET1 ratio in Q1 25Disposals of Societe Generale Private Banking Suisse and SG Kleinwort Hambros completed on 31 January 2025 and 31 March 2025  for a total impact of around +10 basis points on the Groupâ€™s CET1 ratioSlawomir Krupa  the Groupâ€™s Chief Executive Officer  commented:Â« We are releasing today a very good set of results. Our revenues have grown across all our businesses. Our costs and our cost-to-income ratio have decreased across all our businesses. Our first quarter results are above all our annual targets  putting us in a favourable position to achieve them  thanks to our disciplined execution and prudent and rigorous risk management. Since the presentation of our Strategic Plan  we have built a strong capital position  and we have delivered a steady and material increase in our performance. Our diversified and resilient model allows us to navigate efficiently in the current environment. This is the result of the precise execution of our strategy by fully focused and talented teams whom I warmly thank for their commitment. We measure how far we've come and how far we still have to go. We will therefore pursue our work with the same focus and discipline  confident in our ability to deliver our 2026 roadmap and beyond  a sustainable and profitable growth. Â»GROUP CONSOLIDATED RESULTSIn EURm Q1 25 Q1 24 Change Net banking income 7 083 6 645 +6.6% +9.9%* Operating expenses (4 604) (4 980) -7.6% -4.6%* Gross operating income 2 479 1 665 +48.9% +53.0%* Net cost of risk (344) (400) -13.9% -9.5%* Operating income 2 135 1 265 +68.8% +72.1%* Net profits or losses from other assets 202 (80) n/s n/s Income tax (490) (274) +79.0% +84.8%* Net income 1 855 917 x 2.0 x 2.1* O.w. non-controlling interests 247 237 +4.0% +12.0%* Group net income 1 608 680 x 2.4 x 2.4* ROE 9.7% 3.6% ROTE 11.0% 4.1% Cost to income 65.0% 74.9%Asterisks* in the document refer to data at constant perimeter and exchange ratesSociete Generaleâ€™s Board of Directors  which met on 29 April 2025 under the chairmanship of Lorenzo Bini Smaghi  examined the Societe Generale Groupâ€™s results for the first quarter of 2025.Net banking incomeNet banking income stood at EUR 7.1 billion  up +6.6% vs. Q1 24 and up +10.2% vs. Q1 24  excluding asset disposals.Revenues of French Retail  Private Banking and Insurance were up +14.1% vs. Q1 24 (+16.5% excluding asset disposals and +2.5% excluding both asset disposals and short-term hedge impact) to stand at EUR 2.3 billion in Q1 25. Net interest income recovered sharply in Q1 25 (+28.4% vs. Q1 24) and was broadly stable when restated for asset disposals and short-term hedges accounted for in Q1 24 (around EUR -270 million). Assets under management in Private Banking and Insurance grew by +6% and +5%  respectively (excluding asset disposals in Switzerland and in the United Kingdom) in Q1 25 vs. Q1 24. Lastly  BoursoBank continued its strong commercial development with nearly 460 000 new customers during the quarter  reaching a customer base of around 7.6 million clients at end-March 2025.Global Banking and Investor Solutions registered a +10.0% increase in revenues relative to Q1 24. These totalled EUR 2.9 billion for the quarter  driven by strong momentum in equities and in Financing and Advisory. Global Markets grew by +10.9% in Q1 25 vs. Q1 24. Equity revenues were up +21.8%  reaching a quarterly record level3  driven by strong momentum in flow and listed products. Fixed income and currencies were down -2.4% due to lower client activity on rates investment solutions and margin compression in financing activities. Commercial activity nevertheless remained buoyant in rates and forex brokerage due to high volatility. In Global Banking and Advisory  revenues are up +10.5% with a solid commercial momentum in asset finance. Furthermore  the performance was resilient in Mergers and Acquisitions (M&A) and Debt Capital Markets (DCM). Similarly  Global Transaction and Payment Services posted an +8.7% increase in revenues vs. Q1 24  driven by higher payment volumes with institutional clients and strong commercial development for corporate clients.Mobility  International Retail Banking and Financial Servicesâ€™ revenues were down -7.4% vs. Q1 24  mainly due to a perimeter effect of EUR -176 million in Q1 25. Excluding the impact of asset disposals  they were up +0.8%. International Retail Banking recorded a -12.1% fall in revenues vs. Q1 24 to EUR 0.9 billion  due to a perimeter effect related to the disposals completed in Africa (Morocco  Chad  Madagascar). They rose by +1.9% at constant perimeter and exchange rates. Revenues from Mobility and Financial Services were also down -3.0% vs. Q1 24 due to the disposal of SGEFâ€™s operations (except for those in the Czech Republic and Slovakia) in Q1 25. Besides  Ayvensâ€™ revenues were stable vs. Q1 24 owing to improved margins  offsetting the normalisation of the results of used car sales.The Corporate Centre recorded revenues of EUR -112 million in Q1 25.Operating expensesOperating expenses came to EUR 4 604 million in Q1 25  down -7.6% vs. Q1 24 and -4.4% excluding asset disposals. The decrease in operating expenses is notably explained by a decrease in transformation charges of EUR 278 million  an increase of EUR 29 million related to taxes on variable compensation  an increase in expenses of EUR 22 million related to Bernstein perimeter  and EUR 5 million related to disposal transaction costs. Excluding these non-recurring items  operating expenses were slightly up  confirming the strong cost discipline.The cost-to-income ratio stood at 65.0% in Q1 25  down sharply from Q1 24 (74.9%) and below the target of <66% estimated for 2025.Cost of riskThe cost of risk was stable over the quarter at 23 basis points (or EUR 344 million). It comprises a provision for non-performing loans of EUR 330 million (around 22 basis points) and a provision for performing loans of EUR 14 million.At end-March  the Group had a stock of provisions for performing loans of EUR 3 131 million  slightly up +0.4% compared with 31 December 2024  which represents more than 2x 2024 cost of risk.The gross non-performing loan ratio stood at 2.82%4 5 at 31 March 2025  broadly stable compared to its end - December 2024 level (2.81%). The net coverage ratio on the Groupâ€™s non-performing loans stood at 82%6 at 31 March 2025 (after netting of guarantees and collateral).Net profits from other assetsThe Group recorded a net gain of EUR +202 million in Q1 25  mainly related to the accounting impacts of completed asset sales of SGEF7  Societe Generale Private Banking Suisse and SG Kleinwort Hambros.Group net IncomeGroup net income stood at EUR 1 608 million for the quarter  equating to a Return on Tangible Equity (ROTE) of 11.0%.DELIVERING ON OUR ESG AMBITIONSThe Group is in line with its portfolio alignment targets in the most carbon-emitting sectors  including since 2019 a reduction of more than 50% in its upstream exposure to oil and gas  and a reduction of around 50% of its carbon emission intensity in power.Reflecting progress on portfolio alignment  the Group's contribution to sustainable finance amounted to around 80 billion euros at the end of 2024  ahead of its target of 500 billion euros for the 2024-2030 period.The Group is well positioned to seize new opportunities in the environmental transition. Societe Generale has acted as exclusive financial advisor for the UKâ€™s Net Zero Teesside Power and Northern Endurance Partnership projects  which aim to be the world's first gas-fired power station project with carbon capture and storage.These actions are recognized externally  with best-in-class ratings from extra-financial rating agencies and through numerous awards.THE GROUPâ€™S FINANCIAL STRUCTUREAt 31 March 2025  the Groupâ€™s Common Equity Tier 1 ratio stood at 13.4%  or around 320 basis points above the regulatory requirement. Likewise  the Liquidity Coverage Ratio (LCR) was well above regulatory requirements at 140% at end-March 2025 (an average of 150% for the quarter)  while the Net Stable Funding Ratio (NSFR) stood at 115% at end-March 2025.All liquidity and solvency ratios are well above the regulatory requirements.31/03/2025 31/12/2024 Requirements CET1(1) 13.4% 13.3% 10.22% Tier 1 ratio(1) 16.1% 16.1% 12.14% Total Capital(1) 19.1% 18.9% 14.70% Leverage ratio(1) 4.4% 4.3% 3.60% TLAC (% RWA)(1) 29.7% 29.7% 22.32% TLAC (% leverage)(1) 8.2% 8.0% 6.75% MREL (% RWA)(1) 33.3% 34.2% 27.59% MREL (% leverage)(1) 9.2% 9.2% 6.23% End of period LCR 140% 162% >100% Period average LCR 150% 150% >100% NSFR 115% 117% >100%In EURbn 31/03/2025 31/12/2024 Total consolidated balance sheet 1 5541 574Group shareholdersâ€™ equity 71 70 Risk-weighted assets 393 390 O.w. credit risk 318 327 Total funded balance sheet 931 952 Customer loans 459 463 Customer deposits 596 6148As of 31 March 2025  the parent company has issued EUR 9.0 billion of medium/long-term debt under its 2025 financing programme  including EUR 4.5 billion of pre-financing raised at the end of 2024. The subsidiaries had issued EUR 1.0 billion. In all  the Group has issued a total of EUR 10.0 billion in medium/long-term debt.At end of April 2025  the parent companyâ€™s 2025 funding programme is 54% complete for vanilla notes.The Group is rated by four rating agencies: (i) FitchRatings - long-term rating â€œA-â€  stable outlook  senior preferred debt rating â€œAâ€  short-term rating â€œF1â€; (ii) Moodyâ€™s - long-term rating (senior preferred debt) â€œA1â€  negative outlook  short-term rating â€œP-1â€; (iii) R&I - long-term rating (senior preferred debt) â€œAâ€  stable outlook; and (iv) S&P Global Ratings - long-term rating (senior preferred debt) â€œAâ€  stable outlook  short-term rating â€œA-1â€.FRENCH RETAIL  PRIVATE BANKING AND INSURANCEIn EURm Q1 25 Q1 24 Change Net banking income 2 299 2 016 +14.1% +16.5%* Of which net interest income 1 061 827 +28.4% +31.6%* Of which fees 1 056 1 018 +3.7% +6.2%* Operating expenses (1 566) (1 728) -9.4% -6.6%* Gross operating income 734 288 x 2.5 x 2.5* Net cost of risk (171) (247) -30.8% -30.8%* Operating income 563 41 x 13.7 x 11.2* Net profits or losses from other assets 7 0 x 19.2 x 19.2* Group net income 421 31 x 13.4 x 10.9* Cost to income 68.1% 85.7%Commercial activitySG network  Private Banking and InsuranceThe SG networkâ€™s average deposit outstandings amounted to EUR 230 billion in Q1 25  down -1% from Q1 24  with a shift of inflows into savings life insurance.The SG networkâ€™s average loan outstandings contracted by -3% vs. Q1 24 to EUR 193 billion  andby -1.8% vs. Q1 24 excluding repayments of state-guaranteed loans. Mortgage loan production saw a sharp increase of +115% vs. Q1 24.The average loan-to-deposit ratio stood at 83.8% in Q1 25  down 1.1 percentage point relative to Q1 24.In Private Banking  assets under management9 strongly rose by +6% vs. Q1 24 at EUR 130 billion. Net asset inflows totalled EUR 2 billion in Q1 25  with asset gathering (annualised net new money divided by AuM) standing at +6% in Q1 25. Net banking income came to EUR 361 million for the quarter  a +3.4% increase at constant perimeter1 and exchange rates  down -3.9% vs. Q1 24.Insurance  which covers activities in and outside France  posted a very strong commercial performance. Life insurance outstandings increased sharply by +5% vs. Q1 24 to reach a record EUR 148 billion at end- March 2025. The share of unit-linked products remained high at 40%. Gross life insurance savings inflows amounted to EUR 5.4 billion in Q1 25.In France  personal protection and Property & Casualty premia were up by +4% vs. Q1 24.BoursoBankBoursoBank reached almost 7.6 million clients in Q1 25. The bank recorded growth of +20.7% in the number of clients vs. Q1 24 (+1.3 million year-on-year)  with onboarding still high this quarter (~458 000 new clients in Q1 25) while the churn rate remained low.BoursoBank has once again confirmed its leading position in France in terms of client satisfaction with an NPS (Net Promoter Score) of +5410. The online bank is also ranked as the best digital bank in France11.Average loan outstandings rose by +7.3% compared with Q1 24 to EUR 16 billion in Q1 25.Average outstanding savings  including deposits and financial savings  totalled EUR 67 billion  an increase of +15.5% vs. Q1 24. Deposits outstanding totalled EUR 41 billion in Q1 25  posting another sharp increase of +16.3% vs. Q1 24. Average life insurance outstandings  at EUR 13 billion in Q1 25  rose by +8.9% vs. Q1 24 (of which 49.2% in unit-linked products). This activity continued to register strong gross inflows over the quarter (+24.6% vs. Q1 24  57% in unit-linked products). The brokerage activity recorded more than 3 million transactions in Q1 25  a record quarter with an increase of +48.4%vs. Q1 24.Net banking incomeIn Q1 25  revenues came to EUR 2 299 million (including PEL/CEL provision)  up +14.1% vs. Q1 24. Net interest income grew by +28.4% vs. Q1 24 and was broadly stable excluding asset disposals and the impact of short-term hedges in Q1 24. Fee income rose by +3.7% relative to Q1 24.Operating expensesOperating expenses came to EUR 1 566 million for the quarter  including around EUR 23 million euros of transformation charges  down -9.4% vs. Q1 24. The cost-to-income ratio stood at 68.1% in Q1 25  an improvement of 17.6 percentage points vs. Q1 24.Cost of riskIn Q1 25  the cost of risk amounted to EUR 171 million  or 29 basis points  which was higher than in Q4 24 (20 basis points).Group net IncomeGroup net income totalled EUR 421 million for the quarter. RONE stood at 9.5% in Q1 25.GLOBAL BANKING AND INVESTOR SOLUTIONSIn EUR m Q1 25 Q1 24 Change Net banking income 2 896 2 631 +10.0% +8.8%* Operating expenses (1 755) (1 757) -0.1% -0.6%* Gross operating income 1 140 874 +30.4% +27.6%* Net cost of risk (55) 20 n/s n/s Operating income 1 085 894 +21.3% +18.9%* Group net income 856 697 +22.8% +19.6%* Cost to income 60.6% 66.8% 0 +0.0%*Net banking incomeGlobal Banking and Investor Solutions reported strong results in Q1 25  with revenues up +10.0% vs. Q1 24 to stand at EUR 2 896 million.Global Markets and Investor Services recorded solid growth of +10.0% over the quarter compared with Q1 24  at EUR 1 922 million.Market Activities grew in the first quarter with revenues of EUR 1 759 million  up +10.9% vs. Q1 24 in a volatile market environment.The Equities business delivered a record performance12 in Q1 25 with revenues of EUR 1 061 million  a sharp increase of +21.8% compared with Q1 24  driven by positive momentum particularly in flow and listed products.Fixed Income and Currencies were slightly down -2.4% to EUR 698 million in Q1 25  due to lower client activity on rates investment solutions and margin compression in financing activities. Commercial momentum also remained strong in flow activities  particularly for rates and forex products  driven by higher volatility.In Securities Services  revenues were up +1.4% compared with Q1 24 at EUR 163 million and overall stable (-0.2%) excluding participation. The level of fees is good in comparison to a high Q1 24  notably thanks to a strong commercial performance in fund distribution. Assets under Custody and Assets under Administration amounted to EUR 5 194 billion and EUR 637 billion  respectively.Revenues for the Financing and Advisory business totalled EUR 973 million  a sharp increase of +10.0% vs. Q1 24.Global Banking & Advisory posted significant revenues  up +10.5% compared with Q1 24  driven by buoyant activity in asset finance. Asset-Backed Products are steady despite less conducive market conditions compared to Q1 24. Furthermore  the performance was resilient in Mergers and Acquisitions (M&A) and Debt Capital Markets (DCM).Global Transaction & Payment Services once again delivered a strong performance compared with Q1 24  with a sharp increase in revenues of +8.7%  notably due to higher payment volumes with institutional clients and good commercial performance on the corporate franchise.Operating expensesOperating expenses came to EUR 1 755 million for the quarter and included around EUR 12 million in transformation charges. These are stable relative to Q1 24. The cost-to-income ratio stood at 60.6% in Q1 25.Cost of riskOver the quarter  the cost of risk was EUR 55 million  or 13 basis points vs. -5 basis points in Q1 24.Group net IncomeGroup net income increased by +22.8% vs. Q1 24 to EUR 856 million.Global Banking and Investor Solutions reported a strong RONE of 18.7% for the quarter.MOBILITY  INTERNATIONAL RETAIL BANKING AND FINANCIAL SERVICESIn EURm Q1 25 Q1 24 Change Net banking income 2 000 2 161 -7.4% +1.1%* Operating expenses (1 180) (1 350) -12.6% -4.8%* Gross operating income 820 810 +1.2% +10.8%* Net cost of risk (124) (182) -31.8% -23.1%* Operating income 696 629 +10.7% +20.3%* Net profits or losses from other assets 0 4 -98.3% -98.3%* Non-controlling interests 212 195 +8.3% +16.1%* Group net income 319 278 +14.5% +24.4%* Cost to income 59.0% 62.5%Commercial activityInternational Retail BankingInternational Retail Banking posted robust commercial activity with loan outstandings ofEUR 61 billion  up +4.3%* vs. Q1 24  and deposits of EUR 75 billion  slightly up +1.1%* vs. Q1 24.In Europe  loan outstandings rose by 6.1%* vs. Q1 24 to EUR 45 billion in Q1 25 for both client segments of KB and BRD  particularly in home loans. Deposit outstandings totalled EUR 55 billion inQ1 25  slightly up +0.6%* vs. Q1 24  mainly driven by Romania.Overall  loan outstandings in Africa  Mediterranean Basin and French Overseas Territories amounted to EUR 16 billion  broadly stable* vs. Q1 24  with mixed situations across geographies. Deposit outstandings increased by +2.5%* vs. Q1 24 to EUR 20 billion in Q1 25  mainly driven by sight deposits from corporate clients.Mobility and Financial ServicesOverall  Mobility and Financial Services maintained a good commercial performance.Ayvensâ€™ earning assets totalled EUR 53.5 billion at end-March 2025  a +1.4% increase vs. end-March 2024.Consumer Finance posted loans outstanding of EUR 23 billion  still down -3.0% vs. Q1 24  but decreasing at a slower pace than previously.Net banking incomeIn Q1 25  Mobility  International Retail Banking and Financial Services recorded revenues of EUR 2 000 million  up slightly (+1.1%* vs. Q1 24).International Retail Banking revenues increased slightly by +1.9%* vs. Q1 24  to EUR 913 million inQ1 25.Revenues in Europe increased by +5.4%* vs. Q1 24  to EUR 520 million in Q1 25. This robust growth  both in the Czech Republic and Romania  was driven by a solid performance of net interest income and a sharp increase in fees.In Africa  Mediterranean Basin and French Overseas Territories  revenues remained high atEUR 393 million in Q1 25  a slight down -2.3%* compared with a strong first quarter of 2024.Overall  revenues from Mobility and Financial Services were stable* vs. Q1 24  to EUR 1 087 million in Q1 25.At Ayvens  net banking income stood at EUR 796 million in Q1 25  stable vs. Q1 24  with an increase in margins13. Margins are continuing to improve  standing at 562 basis points in Q1 25  vs. 522 basis points in Q1 24. The secondary market for vehicle sales is gradually returning to normal  as expected  with an average profit margin per vehicle of EUR 1 22914 per unit this quarter  vs. EUR 1 2672 in Q4 24 andEUR 1 6611 in Q1 24. At its level  Ayvens has a cost-to-income ratio of 58.0%15  in line with the 2025 target (57%-59%).Revenues for the Consumer Finance business stabilised vs. Q1 24 at EUR 223 million in Q1 25.Operating expensesOver the quarter  operating expenses decreased significantly by -4.8%* vs. Q1 24  to EUR 1 180 million in Q1 25 (of which EUR 39 million of transformation charges). The cost-to-income ratio improved in Q1 25 to 59.0% vs. 62.5% in Q1 24.International Retail Banking posted costs of EUR 546 million in Q1 25  down by -3.2%* vs. Q1 24.Mobility and Financial Services costs reached EUR 635 million in Q1 25  a sharp decrease of -6.1%*vs. Q1 24  with cost synergies materialising at Ayvens driven by the continued LeasePlan integration.Cost of riskOver the quarter  the cost of risk amounted to EUR 124 million or 31 basis points  which was considerably lower than in Q1 24 (43 basis points).Group net IncomeOver the quarter  Group net income came to EUR 319 million  up +24.4%* vs. Q1 24. RONE stood at 11.2% in Q1 25. RONE was 14.1% in International Retail Banking and 9.4% in Mobility and Financial Services in Q1 25.CORPORATE CENTREIn EURm Q1 25 Q1 24 Net banking income (112) (162) Operating expenses (103) (145) Gross operating income (215) (308) Net cost of risk 6 9 Net profits or losses from other assets 192 (84) Income tax 61 90 Group net income 12 (327)The Corporate Centre includes:the property management of the Groupâ€™s head office the Groupâ€™s equity portfolio the Treasury function for the Group certain costs related to cross-functional projects  as well as several costs incurred by the Group that are not re-invoiced to the businesses.Net banking incomeThe Corporate Centreâ€™s net banking income totalled EUR -112 million for the quarter  vs. EUR - 162 million in Q1 24  notably thanks to management actions to more efficiently use excess liquidity.Operating expensesOver the quarter  operating expenses totalled EUR -103 million  vs. EUR -145 million in Q1 24  notably thanks to a decrease in transformation charges.Net profits from other assetsThe Group recorded EUR +192 million in net profits from other assets during the quarter at the Corporate Centre level  notably following asset disposals of SGEF16  Societe Generale Private Banking Suisse and SG Kleinwort Hambros.Group net IncomeThe Corporate Centreâ€™s net income totalled EUR +12 million for the quarter  vs. EUR -327 millionin Q1 24.2025 FINANCIAL CALENDAR2025 Financial communication calendarMay 20th  2025 Combined General MeetingMay 26th  2025 Dividend detachmentMay 28th  2025 Dividend paymentJuly 31st  2025 Second quarter and first half 2025 resultsOctober 30th  2025 Third quarter and nine months 2025 resultsThe Alternative Performance Measures  notably the notions of net banking income for the pillars  operating expenses  cost of risk in basis points  ROE  ROTE  RONE  net assets and tangible net assets are presented in the methodology notes  as are the principles for the presentation of prudential ratios.This document contains forward-looking statements relating to the targets and strategies of the Societe Generale Group.These forward-looking statements are based on a series of assumptions  both general and specific  in particular the application of accounting principles and methods in accordance with IFRS (International Financial Reporting Standards) as adopted in the European Union  as well as the application of existing prudential regulations.These forward-looking statements have also been developed from scenarios based on a number of economic assumptions in the context of a given competitive and regulatory environment. The Group may be unable to:- anticipate all the risks  uncertainties or other factors likely to affect its business and to appraise their potential consequences;- evaluate the extent to which the occurrence of a risk or a combination of risks could cause actual results to differ materially from those provided in this document and the related presentation.Therefore  although Societe Generale believes that these statements are based on reasonable assumptions  these forward-looking statements are subject to numerous risks and uncertainties  including matters not yet known to it or its management or not currently considered material  and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include  among others  overall trends in general economic activity and in Societe Generaleâ€™s markets in particular  regulatory and prudential changes  and the success of Societe Generaleâ€™s strategic  operating and financial initiatives.More detailed information on the potential risks that could affect Societe Generaleâ€™s financial results can be found in the section â€œRisk Factorsâ€ in our Universal Registration Document filed with the French AutoritÃ© des MarchÃ©s Financiers (which is available on https://investors.societegenerale.com/en).Investors are advised to take into account factors of uncertainty and risk likely to impact the operations of the Group when considering the information contained in such forward-looking statements. Other than as required by applicable law  Societe Generale does not undertake any obligation to update or revise any forward-looking information or statements. Unless otherwise specified  the sources for the business rankings and market positions are internal.APPENDIX 1: FINANCIAL DATAGROUP NET INCOME BY CORE BUSINESSIn EURm Q1 25 Q1 24 Variation French Retail  Private Banking and Insurance 421 31 x 13.4 Global Banking and Investor Solutions 856 697 +22.8% Mobility  International Retail Banking & Financial Services 319 278 +14.5% Core Businesses 1 596 1 007 +58.5% Corporate Centre 12 (327) n/s Group 1 608 680 x 2.4MAIN EXCEPTIONAL ITEMSIn EURm Q1 25 Q1 24 Operating expenses - Total one-off items and transformation charges (74) (352) Transformation charges (74) (352) Of which French Retail  Private Banking and Insurance (23) (81) Of which Global Banking & Investor Solutions (12) (154) Of which Mobility  International Retail Banking & Financial Services (39) (69) Of which Corporate Centre 0 (47) Other one-off items - Total 202 (80) Net profits or losses from other assets 202 (80)CONSOLIDATED BALANCE SHEETIn EUR m 31/03/2025 31/12/2024 Cash  due from central banks 169 891 201 680 Financial assets at fair value through profit or loss 548 999 526 048 Hedging derivatives 8 171 9 233 Financial assets at fair value through other comprehensive income 99 248 96 024 Securities at amortised cost 41 224 32 655 Due from banks at amortised cost 91 527 84 051 Customer loans at amortised cost 447 815 454 622 Revaluation differences on portfolios hedged against interest rate risk (480) (292) Insurance and reinsurance contracts assets 545 615 Tax assets 4 170 4 687 Other assets 73 618 70 903 Non-current assets held for sale 2 911 26 426 Investments accounted for using the equity method 414 398 Tangible and intangible fixed assets 61 250 61 409 Goodwill 5 085 5 086 Total 1 554 388 1 573 545In EUR m 31/03/2025 31/12/2024 Due to central banks 10 661 11 364 Financial liabilities at fair value through profit or loss 405 056 396 614 Hedging derivatives 14 028 15 750 Debt securities issued 154 356 162 200 Due to banks 100 825 99 744 Customer deposits 521 141 531 675 Revaluation differences on portfolios hedgedagainst interest rate risk (6 168) (5 277) Tax liabilities 2 301 2 237 Other liabilities 96 417 90 786 Non-current liabilities held for sale 2 560 17 079 Insurance and reinsurance contracts liabilities 152 899 150 691 Provisions 4 098 4 085 Subordinated debts 16 148 17 009 Total liabilities 1 474 322 1 493 957 Shareholder's equity - - Shareholders' equity  Group share - - Issued common stocks and capital reserves 20 812 21 281 Other equity instruments 9 873 9 873 Retained earnings 37 863 33 863 Net income 1 608 4 200 Sub-total 70 156 69 217 Unrealised or deferred capital gains and losses 400 1 039 Sub-total equity  Group share 70 556 70 256 Non-controlling interests 9 510 9 332 Total equity 80 066 79 588 Total 1 554 388 1 573 545APPENDIX 2: METHODOLOGY1 â€“The financial information presented for the first quarter 2025 was examined by the Board of Directors on April 29th  2025 and has been prepared in accordance with IFRS as adopted in the European Union and applicable at that date. The information has not been audited.2 - Net banking incomeThe pillarsâ€™ net banking income is defined on page 38 of Societe Generaleâ€™s 2025 Universal Registration Document. The terms â€œRevenuesâ€ or â€œNet Banking Incomeâ€ are used interchangeably. They provide a normalised measure of each pillarâ€™s net banking income taking into account the normative capital mobilised for its activity.3 - Operating expensesOperating expenses correspond to the â€œOperating Expensesâ€ as presented in note 5 to the Groupâ€™s consolidated financial statements as at December 31st  2024. The term â€œcostsâ€ is also used to refer to Operating Expenses. The Cost/Income Ratio is defined on page 38 of Societe Generaleâ€™s 2025 Universal Registration Document.4 - Cost of risk in basis points  coverage ratio for doubtful outstandingsThe cost of risk is defined on pages 39 and 748 of Societe Generaleâ€™s 2025 Universal Registration Document. This indicator makes it possible to assess the level of risk of each of the pillars as a percentage of balance sheet loan commitments  including operating leases.In EURm Q1 25 Q1 24 French Retail  Private Banking and InsuranceNet Cost Of Risk 171 247 Gross loan Outstandings 233 536 238 394 Cost of Risk in bps 29 41 Global Banking and Investor SolutionsNet Cost Of Risk 55 (20) Gross loan Outstandings 172 782 162 457 Cost of Risk in bps 13 (5) Mobility  International Retail Banking & Financial ServicesNet Cost Of Risk 124 182 Gross loan Outstandings 159 126 167 892 Cost of Risk in bps 31 43 Corporate CentreNet Cost Of Risk (6) (9) Gross loan Outstandings 25 592 23 365 Cost of Risk in bps (9) (15) Societe Generale GroupNet Cost Of Risk 344 400 Gross loan Outstandings 591 036 592 108 Cost of Risk in bps 23 27The gross coverage ratio for doubtful outstandings is calculated as the ratio of provisions recognised in respect of the credit risk to gross outstandings identified as in default within the meaning of the regulations  without taking account of any guarantees provided. This coverage ratio measures the maximum residual risk associated with outstandings in default (â€œdoubtfulâ€).5 - ROE  ROTE  RONEThe notions of ROE (Return on Equity) and ROTE (Return on Tangible Equity)  as well as their calculation methodology  are specified on pages 39 and 40 of Societe Generaleâ€™s 2025 Universal Registration Document. This measure makes it possible to assess Societe Generaleâ€™s return on equity and return on tangible equity.RONE (Return on Normative Equity) determines the return on average normative equity allocated to the Groupâ€™s businesses  according to the principles presented on page 40 of Societe Generaleâ€™s 2025 Universal Registration Document. Starting from Q1 25 results  normative return to businesses is based on a 13% capital allocation. The Q1 25 allocated capital includes the regulatory impacts related to Basel IV  applicable since 1 January 2025.Group net income used for the ratio numerator is the accounting Group net income adjusted for â€œInterest paid and payable to holders of deeply subordinated notes and undated subordinated notes  issue premium amortisationâ€. For ROTE  income is also restated for goodwill impairment.Details of the corrections made to the accounting equity in order to calculate ROE and ROTE for the period are given in the table below:ROTE calculation: calculation methodologyEnd of period (in EURm) Q1 25 Q1 24 Shareholders' equity Group share 70 556 67 342 Deeply subordinated and undated subordinated notes (10 153) (10 166) Interest payable to holders of deeply & undated subordinated notes  issue premium amortisation(1) (60) (71) OCI excluding conversion reserves 582 696 Distribution provision(2) (710) (256) Distribution N-1 to be paid (1 718) (999) ROE equity end-of-period 58 496 56 545 Average ROE equity 58 609 56 522 Average Goodwill(3) (4 191) (4 006) Average Intangible Assets (2 835) (2 956) Average ROTE equity 51 583 49 560 Group net Income 1 608 680 Interest paid and payable to holders of deeply subordinated notes and undated subordinated notes  issue premium amortisation (188) (166) Adjusted Group net Income 1 420 514 ROTE 11.0% 4.1%171819RONE calculation: Average capital allocated to Core Businesses (in EURm)In EURm Q1 25 Q1 24 Change French Retail  Private Banking and Insurance 17 687 16 518 +7.1% Global Banking and Investor Solutions 18 324 16 011 +14.4% Mobility  International Retail Banking & Financial Services 11 376 11 252 +1.1% Core Businesses 47 386 43 781 +8.2% Corporate Centre 11 223 12 741 -11.9% Group 58 609 56 522 +3.7%6 - Net assets and tangible net assetsNet assets and tangible net assets are defined in the methodology  page 41 of the Groupâ€™s 2025 Universal Registration Document. The items used to calculate them are presented below:2021End of period (in EURm) Q1 25 2024 2023 Shareholders' equity Group share 70 556 70 256 65 975 Deeply subordinated and undated subordinated notes (10 153) (10 526) (9 095) Interest of deeply & undated subordinated notes  issue premium amortisation(1) (60) (25) (21) Book value of own shares in trading portfolio (44) 8 36 Net Asset Value 60 299 59 713 56 895 Goodwill(2) (4 175) (4 207) (4 008) Intangible Assets (2 798) (2 871) (2 954) Net Tangible Asset Value 53 326 52 635 49 933 Number of shares used to calculate NAPS(3) 783 671 796 498 796 244 Net Asset Value per Share 76.9 75.0 71.5 Net Tangible Asset Value per Share 68.0 66.1 62.77 - Calculation of Earnings Per Share (EPS)The EPS published by Societe Generale is calculated according to the rules defined by the IAS 33 standard (see pages 40-41 of Societe Generaleâ€™s 2025 Universal Registration Document). The corrections made to Group net income in order to calculate EPS correspond to the restatements carried out for the calculation of ROE and ROTE.The calculation of Earnings Per Share is described in the following table:Average number of shares (thousands) Q1 25 2024 2023 Existing shares 800 317 801 915 818 008 Deductions Shares allocated to cover stock option plans and free shares awarded to staff 2 586 4 402 6 802 Other own shares and treasury shares 7 646 2 344 11 891 Number of shares used to calculate EPS(4) 790 085 795 169 799 315 Group net Income (in EUR m) 1 608 4 200 2 493 Interest on deeply subordinated notes and undated subordinated notes (in EUR m) (188) (720) (759) Adjusted Group net income (in EUR m) 1 420 3 481 1 735 EPS (in EUR) 1.80 4.38 2.1722238 - Solvency and leverage ratiosShareholderâ€™s equity  risk-weighted assets and leverage exposure are calculated in accordance with applicable CRR3/CRD6 rules  including the procedures provided by the regulation for the calculation of phased-in and fully loaded ratios. The solvency ratios and leverage ratio are presented on a pro-forma basis for the current yearâ€™s accrued results  net of dividends  unless otherwise stated.9 â€“ Funded balance sheet  loan to deposit ratioThe funded balance sheet is based on the Group financial statements. It is obtained in two steps:A first step aiming at reclassifying the items of the financial statements into aggregates allowing for a more economic reading of the balance sheet. Main reclassifications:Insurance: grouping of the accounting items related to insurance within a single aggregate in both assets and liabilities.Customer loans: include outstanding loans with customers (net of provisions and write-downs  including net lease financing outstanding and transactions at fair value through profit and loss); excludes financial assets reclassified under loans and receivables in accordance with the conditions stipulated by IFRS 9 (these positions have been reclassified in their original lines).Wholesale funding: includes interbank liabilities and debt securities issued. Financing transactions have been allocated to medium/long-term resources and short-term resources based on the maturity of outstanding  more or less than one year.Reclassification under customer deposits of the share of issues placed by French Retail Banking networks (recorded in medium/long-term financing)  and certain transactions carried out with counterparties equivalent to customer deposits (previously included in short term financing).Deduction from customer deposits and reintegration into short-term financing of certain transactions equivalent to market resources.A second step aiming at excluding the contribution of insurance subsidiaries  and netting derivatives  repurchase agreements  securities borrowing/lending  accruals and â€œdue to central banksâ€.The Group loan/deposit ratio is determined as the division of the customer loans by customer deposits as presented in the funded balance sheet.NB (1) The sum of values contained in the tables and analyses may differ slightly from the total reported due to rounding rules.(2) All the information on the results for the period (notably: press release  downloadable data  presentation slides and supplement) is available on Societe Generaleâ€™s website www.societegenerale.com in the â€œInvestorâ€ section.Societe GeneraleSociete Generale is a top tier European Bank with around 119 000 employees serving more than 26 million clients in 62 countries across the world. We have been supporting the development of our economies for 160 years  providing our corporate  institutional  and individual clients with a wide array of value-added advisory and financial solutions. Our long-lasting and trusted relationships with the clients  our cutting-edge expertise  our unique innovation  our ESG capabilities and leading franchises are part of our DNA and serve our most essential objective - to deliver sustainable value creation for all our stakeholders.The Group runs three complementary sets of businesses  embedding ESG offerings for all its clients:French Retail  Private Banking and Insurance   with leading retail bank SG and insurance franchise  premium private banking services  and the leading digital bank BoursoBank.  with leading retail bank SG and insurance franchise  premium private banking services  and the leading digital bank BoursoBank. Global Banking and Investor Solutions   a top tier wholesale bank offering tailored-made solutions with distinctive global leadership in equity derivatives  structured finance and ESG.  a top tier wholesale bank offering tailored-made solutions with distinctive global leadership in equity derivatives  structured finance and ESG. Mobility  International Retail Banking and Financial Services  comprising well-established universal banks (in Czech Republic  Romania and several African countries)  Ayvens (the new ALD I LeasePlan brand)  a global player in sustainable mobility  as well as specialized financing activities.Committed to building together with its clients a better and sustainable future  Societe Generale aims to be a leading partner in the environmental transition and sustainability overall. The Group is included in the principal socially responsible investment indices: DJSI (Europe)  FTSE4Good (Global and Europe)  Bloomberg Gender-Equality Index  Refinitiv Diversity and Inclusion Index  Euronext Vigeo (Europe and Eurozone)  STOXX Global ESG Leaders indexes  and the MSCI Low Carbon Leaders Index (World and Europe).In case of doubt regarding the authenticity of this press release  please go to the end of the Group News page on societegenerale.com website where official Press Releases sent by Societe Generale can be certified using blockchain technology. A link will allow you to check the documentâ€™s legitimacy directly on the web page.For more information  you can follow us on Twitter/X @societegenerale or visit our website societegenerale.com .1 Including Basel IV phasing2 Based on a pay-out ratio of 50% of the Group net income restated from non-cash items and after deduction of interest on deeply subordinated notes and undated subordinated notes  pro forma including Q1 25 results3 At comparable business model post GFC (Global Financial Crisis) regulatory regime4 Ratio calculated according to EBA methodology published on 16 July 20195 Ratio excluding loans outstanding of companies currently being disposed of in compliance with IFRS 56 Ratio of S3 provisions  guarantees and collaterals over gross outstanding non-performing loans7 Except for operations in the Czech Republic and Slovakia8 Including Basel IV phasing and pro forma Q1 25 resultsNB: SG network  Private Banking and Insurance - end Q1 25 loans and deposits exclude disposals9 Excluding asset disposals in Switzerland and the United Kingdom10 Jointly with another bank in 2025  Bain and Company  April 202511 Deloitte  January 202512 At comparable business model post GFC (Global Financial Crisis) regulatory regime13 Excluding non-recurring items14 Excluding impacts of depreciation adjustments15 As communicated by Ayvens in its Q1 25 results (excluding used car sales result and non-recurring items)16 Except for operations in the Czech Republic and Slovakia17 Interest net of tax18 The distribution provision is calculated based on a pay-out ratio of 50%  restated from non-cash items and after deduction of interest on deeply subordinated notes and on undated subordinated notes19 Excluding goodwill arising from non-controlling interests20 Interest net of tax21 Excluding goodwill arising from non-controlling interests22 The number of shares considered is the number of ordinary shares outstanding at end of period  excluding treasury shares and buybacks  but including the trading shares held by the Group (expressed in thousands of shares)23 The number of shares considered is the average number of ordinary shares outstanding during the period  excluding treasury shares and buybacks  but including the trading shares held by the Group (expressed in thousands of shares)Attachment,neutral,0.0,1.0,0.0,mixed,0.45,0.22,0.33,True,English,"['First quarter 2025 earnings', 'Societe Generale', 'Societe Generale Private Banking Suisse', 'O.w. non-controlling interests', 'SG Kleinwort Hambros', 'Chief Executive Officer', 'Lorenzo Bini Smaghi', 'Societe Generale Group', 'strong commercial development', 'International Retail Banking', 'Net interest income', '2024 share buy-back programme', 'French Retail Banking', 'Net banking income', 'short-term hedge impact', 'quarterly linear distribution', 'Liquidity Coverage Ratio', 'Gross operating income', 'strong capital position', 'STRONG QUARTERLY RESULTS', '25 to 30 basis points', 'Group net income', 'GROUP CONSOLIDATED RESULTS', 'Strict cost management', 'rigorous risk management', 'first quarter results', 'Global Banking', 'income ratio', 'strong rebound', 'net gains', 'Net profits', 'strong momentum', 'SOLID CAPITAL', 'LIQUIDITY PROFILE', 'favourable position', 'short-term hedges', 'Income tax', 'positive impact', 'total impact', 'Net cost', '23 basis points', '+30 basis points', '+10 basis points', 'operating expenses', 'CET1 ratio', 'Press release', 'Positive contribution', 'Investor Solutions', 'sustained activity', 'Financial Services', 'S1/S2 provisions', 'regulatory requirement', 'ORDERLY EXECUTION', 'Czech Republic', 'Slawomir Krupa', 'good set', 'disciplined execution', 'Strategic Plan', 'resilient model', 'current environment', 'precise execution', 'talented teams', 'same focus', 'profitable growth', 'constant perimeter', 'exchange rates', 'United Kingdom', '460,000 new customers', 'customer base', '7.6 million clients', 'Quarterly revenues', 'asset disposals', 'Low cost', '2x 2024 cost', 'solid performance', 'annual targets', 'material increase', 'other assets', 'EURm Q1', '320 basis', '2025 TARGETS', '+10.0% increase', '31 MARCH', 'Paris', '30 April', 'businesses', 'Mobility', 'amount', 'Profitability', 'ROTE', 'taxes', 'IFRIC', 'end-Q1', 'end-March', 'Completion', 'SGEF', 'activities', '28 February', 'Slovakia', '31 January', 'costs', 'prudent', 'presentation', 'steady', 'diversified', 'strategy', 'focused', 'commitment', 'work', '2026 roadmap', 'sustainable', 'losses', 'ROE', 'Asterisks', 'document', 'data', 'Board', 'Directors', '29 April', 'chairmanship', 'Insurance', 'Switzerland', 'BoursoBank', 'equities', '65']",2025-04-30,2025-05-01,globenewswire.com
